id	sid	tid	token	lemma	pos
eshr-8982	1	1	epidemiology	epidemiology	NOUN
eshr-8982	1	2	and	and	CCONJ
eshr-8982	1	3	society	society	NOUN
eshr-8982	1	4	health	health	PROPN
eshr-8982	1	5	review|	review|	PROPN
eshr-8982	1	6	eshr	eshr	PROPN
eshr-8982	1	7	vol	vol	NOUN
eshr-8982	1	8	.	.	PROPN
eshr-8982	2	1	6	6	NUM
eshr-8982	2	2	,	,	PUNCT
eshr-8982	2	3	no	no	INTJ
eshr-8982	2	4	.	.	NOUN
eshr-8982	2	5	2	2	NUM
eshr-8982	2	6	,	,	PUNCT
eshr-8982	2	7	2024	2024	NUM
eshr-8982	2	8	,	,	PUNCT
eshr-8982	2	9	pp	pp	ADJ
eshr-8982	2	10	.	.	PUNCT
eshr-8982	3	1	74	74	NUM
eshr-8982	3	2	-	-	SYM
eshr-8982	3	3	86	86	NUM
eshr-8982	3	4	issn	issn	PROPN
eshr-8982	3	5	2656	2656	NUM
eshr-8982	3	6	-	-	SYM
eshr-8982	3	7	6052	6052	NUM
eshr-8982	3	8	(	(	PUNCT
eshr-8982	3	9	online	online	NOUN
eshr-8982	3	10	)	)	PUNCT
eshr-8982	3	11	|	|	ADV
eshr-8982	3	12	2656	2656	NUM
eshr-8982	3	13	-	-	SYM
eshr-8982	3	14	1107	1107	NUM
eshr-8982	3	15	(	(	PUNCT
eshr-8982	3	16	print	print	NOUN
eshr-8982	3	17	)	)	PUNCT
eshr-8982	3	18	http://journal2.uad.ac.id/index.php/eshr/index	http://journal2.uad.ac.id/index.php/eshr/index	NOUN
eshr-8982	3	19	eshr@ikm.uad.ac.id	eshr@ikm.uad.ac.id	X
eshr-8982	4	1	10.26555	10.26555	NUM
eshr-8982	4	2	/	/	SYM
eshr-8982	4	3	eshr.v6i2.8982	eshr.v6i2.8982	NUM
eshr-8982	4	4	74	74	NUM
eshr-8982	4	5	review	review	NOUN
eshr-8982	4	6	article	article	NOUN
eshr-8982	4	7	the	the	DET
eshr-8982	4	8	importance	importance	NOUN
eshr-8982	4	9	of	of	ADP
eshr-8982	4	10	uacr	uacr	NOUN
eshr-8982	4	11	(	(	PUNCT
eshr-8982	4	12	urinary	urinary	ADJ
eshr-8982	4	13	albumin	albumin	ADJ
eshr-8982	4	14	creatinine	creatinine	NOUN
eshr-8982	4	15	ratio	ratio	NOUN
eshr-8982	4	16	)	)	PUNCT
eshr-8982	4	17	examination	examination	NOUN
eshr-8982	4	18	in	in	ADP
eshr-8982	4	19	patients	patient	NOUN
eshr-8982	4	20	with	with	ADP
eshr-8982	4	21	diabetes	diabetes	NOUN
eshr-8982	4	22	mellitus	mellitus	NOUN
eshr-8982	4	23	type	type	VERB
eshr-8982	4	24	2	2	NUM
eshr-8982	4	25	:	:	PUNCT
eshr-8982	4	26	a	a	DET
eshr-8982	4	27	systematic	systematic	ADJ
eshr-8982	4	28	review	review	NOUN
eshr-8982	4	29	tetrina	tetrina	PROPN
eshr-8982	4	30	purtaria1	purtaria1	PROPN
eshr-8982	4	31	*	*	NOUN
eshr-8982	4	32	,	,	PUNCT
eshr-8982	4	33	sulistyawati	sulistyawati	ADJ
eshr-8982	4	34	sulistyawati1	sulistyawati1	NOUN
eshr-8982	4	35	1	1	NUM
eshr-8982	4	36	faculty	faculty	NOUN
eshr-8982	4	37	of	of	ADP
eshr-8982	4	38	public	public	ADJ
eshr-8982	4	39	health	health	NOUN
eshr-8982	4	40	,	,	PUNCT
eshr-8982	4	41	universitas	universita	NOUN
eshr-8982	4	42	ahmad	ahmad	PROPN
eshr-8982	4	43	dahlan	dahlan	PROPN
eshr-8982	4	44	,	,	PUNCT
eshr-8982	4	45	yogyakarta	yogyakarta	PROPN
eshr-8982	4	46	,	,	PUNCT
eshr-8982	4	47	indonesia	indonesia	PROPN
eshr-8982	4	48	*	*	PUNCT
eshr-8982	4	49	correspondence	correspondence	NOUN
eshr-8982	4	50	:	:	PUNCT
eshr-8982	5	1	tetrina.p@gmail.com	tetrina.p@gmail.com	PROPN
eshr-8982	5	2	.	.	PROPN
eshr-8982	5	3	phone	phone	NOUN
eshr-8982	5	4	:	:	PUNCT
eshr-8982	5	5	+6281	+6281	X
eshr-8982	5	6	-	-	SYM
eshr-8982	5	7	2158	2158	NUM
eshr-8982	5	8	-	-	SYM
eshr-8982	5	9	5959	5959	NUM
eshr-8982	5	10	received	receive	VERB
eshr-8982	5	11	07	07	NUM
eshr-8982	5	12	sept	sept	PROPN
eshr-8982	5	13	2023	2023	NUM
eshr-8982	5	14	;	;	PUNCT
eshr-8982	5	15	accepted	accept	VERB
eshr-8982	5	16	01	01	NUM
eshr-8982	5	17	dec	dec	PROPN
eshr-8982	5	18	2024	2024	NUM
eshr-8982	5	19	;	;	PUNCT
eshr-8982	5	20	published	publish	VERB
eshr-8982	5	21	19	19	NUM
eshr-8982	5	22	dec	dec	PROPN
eshr-8982	5	23	2024	2024	NUM
eshr-8982	5	24	abstract	abstract	ADJ
eshr-8982	5	25	background	background	NOUN
eshr-8982	5	26	:	:	PUNCT
eshr-8982	5	27	diabetes	diabetes	NOUN
eshr-8982	5	28	mellitus	mellitus	NOUN
eshr-8982	5	29	is	be	AUX
eshr-8982	5	30	a	a	DET
eshr-8982	5	31	chronic	chronic	ADJ
eshr-8982	5	32	metabolic	metabolic	NOUN
eshr-8982	5	33	condition	condition	NOUN
eshr-8982	5	34	causing	cause	VERB
eshr-8982	5	35	elevated	elevated	ADJ
eshr-8982	5	36	blood	blood	NOUN
eshr-8982	5	37	glucose	glucose	NOUN
eshr-8982	5	38	levels	level	NOUN
eshr-8982	5	39	,	,	PUNCT
eshr-8982	5	40	leading	lead	VERB
eshr-8982	5	41	to	to	ADP
eshr-8982	5	42	microvascular	microvascular	NOUN
eshr-8982	5	43	and	and	CCONJ
eshr-8982	5	44	macrovascular	macrovascular	ADJ
eshr-8982	5	45	consequences	consequence	NOUN
eshr-8982	5	46	.	.	PUNCT
eshr-8982	6	1	it	it	PRON
eshr-8982	6	2	is	be	AUX
eshr-8982	6	3	a	a	DET
eshr-8982	6	4	leading	lead	VERB
eshr-8982	6	5	cause	cause	NOUN
eshr-8982	6	6	of	of	ADP
eshr-8982	6	7	end	end	NOUN
eshr-8982	6	8	-	-	PUNCT
eshr-8982	6	9	stage	stage	NOUN
eshr-8982	6	10	kidney	kidney	NOUN
eshr-8982	6	11	disease	disease	NOUN
eshr-8982	6	12	(	(	PUNCT
eshr-8982	6	13	eskd	eskd	PROPN
eshr-8982	6	14	)	)	PUNCT
eshr-8982	6	15	and	and	CCONJ
eshr-8982	6	16	end	end	NOUN
eshr-8982	6	17	-	-	PUNCT
eshr-8982	6	18	stage	stage	NOUN
eshr-8982	6	19	renal	renal	ADJ
eshr-8982	6	20	disease	disease	NOUN
eshr-8982	6	21	(	(	PUNCT
eshr-8982	6	22	esrd	esrd	PROPN
eshr-8982	6	23	)	)	PUNCT
eshr-8982	6	24	.	.	PUNCT
eshr-8982	7	1	diabetes	diabetes	NOUN
eshr-8982	7	2	causes	cause	VERB
eshr-8982	7	3	diabetic	diabetic	ADJ
eshr-8982	7	4	nephropathy	nephropathy	NOUN
eshr-8982	7	5	,	,	PUNCT
eshr-8982	7	6	which	which	PRON
eshr-8982	7	7	is	be	AUX
eshr-8982	7	8	the	the	DET
eshr-8982	7	9	leading	lead	VERB
eshr-8982	7	10	cause	cause	NOUN
eshr-8982	7	11	of	of	ADP
eshr-8982	7	12	end	end	NOUN
eshr-8982	7	13	-	-	PUNCT
eshr-8982	7	14	stage	stage	NOUN
eshr-8982	7	15	renal	renal	ADJ
eshr-8982	7	16	disease	disease	NOUN
eshr-8982	7	17	.	.	PUNCT
eshr-8982	8	1	the	the	DET
eshr-8982	8	2	urinary	urinary	ADJ
eshr-8982	8	3	albumin	albumin	NOUN
eshr-8982	8	4	-	-	PUNCT
eshr-8982	8	5	to	to	ADP
eshr-8982	8	6	-	-	PUNCT
eshr-8982	8	7	creatinine	creatinine	NOUN
eshr-8982	8	8	ratio	ratio	NOUN
eshr-8982	8	9	(	(	PUNCT
eshr-8982	8	10	uacr	uacr	INTJ
eshr-8982	8	11	)	)	PUNCT
eshr-8982	8	12	is	be	AUX
eshr-8982	8	13	a	a	DET
eshr-8982	8	14	clinically	clinically	ADV
eshr-8982	8	15	used	use	VERB
eshr-8982	8	16	tool	tool	NOUN
eshr-8982	8	17	to	to	PART
eshr-8982	8	18	evaluate	evaluate	VERB
eshr-8982	8	19	albuminuria	albuminuria	NOUN
eshr-8982	8	20	and	and	CCONJ
eshr-8982	8	21	prevent	prevent	VERB
eshr-8982	8	22	the	the	DET
eshr-8982	8	23	progression	progression	NOUN
eshr-8982	8	24	of	of	ADP
eshr-8982	8	25	diabetic	diabetic	ADJ
eshr-8982	8	26	nephropathy	nephropathy	NOUN
eshr-8982	8	27	.	.	PUNCT
eshr-8982	9	1	acr	acr	NOUN
eshr-8982	9	2	measurements	measurement	NOUN
eshr-8982	9	3	are	be	AUX
eshr-8982	9	4	predictive	predictive	ADJ
eshr-8982	9	5	markers	marker	NOUN
eshr-8982	9	6	for	for	ADP
eshr-8982	9	7	renal	renal	ADJ
eshr-8982	9	8	outcomes	outcome	NOUN
eshr-8982	9	9	,	,	PUNCT
eshr-8982	9	10	cardiovascular	cardiovascular	ADJ
eshr-8982	9	11	outcomes	outcome	NOUN
eshr-8982	9	12	,	,	PUNCT
eshr-8982	9	13	and	and	CCONJ
eshr-8982	9	14	mortality	mortality	NOUN
eshr-8982	9	15	in	in	ADP
eshr-8982	9	16	diabetics	diabetic	NOUN
eshr-8982	9	17	.	.	PUNCT
eshr-8982	10	1	microalbuminuria	microalbuminuria	PROPN
eshr-8982	10	2	,	,	PUNCT
eshr-8982	10	3	a	a	DET
eshr-8982	10	4	condition	condition	NOUN
eshr-8982	10	5	characterized	characterize	VERB
eshr-8982	10	6	by	by	ADP
eshr-8982	10	7	30	30	NUM
eshr-8982	10	8	to	to	PART
eshr-8982	10	9	300	300	NUM
eshr-8982	10	10	mg	mg	NOUN
eshr-8982	10	11	/	/	SYM
eshr-8982	10	12	g	g	NOUN
eshr-8982	10	13	in	in	ADP
eshr-8982	10	14	spot	spot	NOUN
eshr-8982	10	15	urine	urine	NOUN
eshr-8982	10	16	,	,	PUNCT
eshr-8982	10	17	is	be	AUX
eshr-8982	10	18	an	an	DET
eshr-8982	10	19	independent	independent	ADJ
eshr-8982	10	20	predictor	predictor	NOUN
eshr-8982	10	21	of	of	ADP
eshr-8982	10	22	coronary	coronary	ADJ
eshr-8982	10	23	artery	artery	NOUN
eshr-8982	10	24	disease	disease	NOUN
eshr-8982	10	25	,	,	PUNCT
eshr-8982	10	26	cardiovascular	cardiovascular	ADJ
eshr-8982	10	27	disease	disease	NOUN
eshr-8982	10	28	,	,	PUNCT
eshr-8982	10	29	and	and	CCONJ
eshr-8982	10	30	allcause	allcause	ADP
eshr-8982	10	31	mortality	mortality	NOUN
eshr-8982	10	32	.	.	PUNCT
eshr-8982	11	1	this	this	DET
eshr-8982	11	2	systematic	systematic	ADJ
eshr-8982	11	3	review	review	NOUN
eshr-8982	11	4	aimed	aim	VERB
eshr-8982	11	5	to	to	PART
eshr-8982	11	6	understand	understand	VERB
eshr-8982	11	7	the	the	DET
eshr-8982	11	8	role	role	NOUN
eshr-8982	11	9	of	of	ADP
eshr-8982	11	10	acr	acr	PROPN
eshr-8982	11	11	(	(	PUNCT
eshr-8982	11	12	albumin	albumin	ADJ
eshr-8982	11	13	creatinine	creatinine	NOUN
eshr-8982	11	14	ratio	ratio	NOUN
eshr-8982	11	15	)	)	PUNCT
eshr-8982	11	16	urine	urine	NOUN
eshr-8982	11	17	in	in	ADP
eshr-8982	11	18	patients	patient	NOUN
eshr-8982	11	19	with	with	ADP
eshr-8982	11	20	type	type	NOUN
eshr-8982	11	21	2	2	NUM
eshr-8982	11	22	diabetes	diabetes	NOUN
eshr-8982	11	23	mellitus	mellitus	NOUN
eshr-8982	11	24	based	base	VERB
eshr-8982	11	25	on	on	ADP
eshr-8982	11	26	the	the	DET
eshr-8982	11	27	published	publish	VERB
eshr-8982	11	28	article	article	NOUN
eshr-8982	11	29	.	.	PUNCT
eshr-8982	12	1	method	method	PROPN
eshr-8982	12	2	:	:	PUNCT
eshr-8982	12	3	the	the	DET
eshr-8982	12	4	systematic	systematic	ADJ
eshr-8982	12	5	review	review	NOUN
eshr-8982	12	6	followed	follow	VERB
eshr-8982	12	7	preferred	preferred	ADJ
eshr-8982	12	8	reporting	reporting	NOUN
eshr-8982	12	9	items	item	NOUN
eshr-8982	12	10	for	for	ADP
eshr-8982	12	11	systematic	systematic	ADJ
eshr-8982	12	12	reviews	review	NOUN
eshr-8982	12	13	and	and	CCONJ
eshr-8982	12	14	meta	meta	NOUN
eshr-8982	12	15	-	-	PUNCT
eshr-8982	12	16	analyses	analysis	NOUN
eshr-8982	12	17	(	(	PUNCT
eshr-8982	12	18	prisma	prisma	NOUN
eshr-8982	12	19	)	)	PUNCT
eshr-8982	12	20	guidelines	guideline	NOUN
eshr-8982	12	21	and	and	CCONJ
eshr-8982	12	22	used	use	VERB
eshr-8982	12	23	databases	database	NOUN
eshr-8982	12	24	sciencedirect	sciencedirect	PROPN
eshr-8982	12	25	,	,	PUNCT
eshr-8982	12	26	pubmed	pubmed	PROPN
eshr-8982	12	27	,	,	PUNCT
eshr-8982	12	28	and	and	CCONJ
eshr-8982	12	29	sage	sage	NOUN
eshr-8982	12	30	journal	journal	NOUN
eshr-8982	12	31	to	to	PART
eshr-8982	12	32	search	search	VERB
eshr-8982	12	33	for	for	ADP
eshr-8982	12	34	articles	article	NOUN
eshr-8982	12	35	on	on	ADP
eshr-8982	12	36	urinary	urinary	ADJ
eshr-8982	12	37	albumin	albumin	ADJ
eshr-8982	12	38	creatinine	creatinine	NOUN
eshr-8982	12	39	ratio	ratio	NOUN
eshr-8982	12	40	in	in	ADP
eshr-8982	12	41	type	type	NOUN
eshr-8982	12	42	2	2	NUM
eshr-8982	12	43	diabetes	diabetes	NOUN
eshr-8982	12	44	mellitus	mellitus	NOUN
eshr-8982	12	45	.	.	PUNCT
eshr-8982	13	1	the	the	DET
eshr-8982	13	2	search	search	NOUN
eshr-8982	13	3	used	use	VERB
eshr-8982	13	4	keyword	keyword	NOUN
eshr-8982	13	5	,	,	PUNCT
eshr-8982	13	6	inclusion	inclusion	NOUN
eshr-8982	13	7	and	and	CCONJ
eshr-8982	13	8	exclusion	exclusion	NOUN
eshr-8982	13	9	criteria	criterion	NOUN
eshr-8982	13	10	to	to	PART
eshr-8982	13	11	screen	screen	VERB
eshr-8982	13	12	the	the	DET
eshr-8982	13	13	article	article	NOUN
eshr-8982	13	14	.	.	PUNCT
eshr-8982	14	1	10	10	NUM
eshr-8982	14	2	articles	article	NOUN
eshr-8982	14	3	met	meet	VERB
eshr-8982	14	4	our	our	PRON
eshr-8982	14	5	criteria	criterion	NOUN
eshr-8982	14	6	and	and	CCONJ
eshr-8982	14	7	were	be	AUX
eshr-8982	14	8	included	include	VERB
eshr-8982	14	9	in	in	ADP
eshr-8982	14	10	this	this	DET
eshr-8982	14	11	research	research	NOUN
eshr-8982	14	12	.	.	PUNCT
eshr-8982	15	1	results	result	NOUN
eshr-8982	15	2	:	:	PUNCT
eshr-8982	15	3	acr	acr	PROPN
eshr-8982	15	4	(	(	PUNCT
eshr-8982	15	5	albumin	albumin	ADJ
eshr-8982	15	6	creatinine	creatinine	NOUN
eshr-8982	15	7	ratio	ratio	NOUN
eshr-8982	15	8	)	)	PUNCT
eshr-8982	15	9	levels	level	NOUN
eshr-8982	15	10	are	be	AUX
eshr-8982	15	11	linked	link	VERB
eshr-8982	15	12	to	to	ADP
eshr-8982	15	13	cardiovascular	cardiovascular	ADJ
eshr-8982	15	14	risk	risk	NOUN
eshr-8982	15	15	in	in	ADP
eshr-8982	15	16	patients	patient	NOUN
eshr-8982	15	17	with	with	ADP
eshr-8982	15	18	diabetes	diabetes	NOUN
eshr-8982	15	19	mellitus	mellitus	NOUN
eshr-8982	15	20	(	(	PUNCT
eshr-8982	15	21	dm	dm	NOUN
eshr-8982	15	22	)	)	PUNCT
eshr-8982	15	23	,	,	PUNCT
eshr-8982	15	24	and	and	CCONJ
eshr-8982	15	25	high	high	ADJ
eshr-8982	15	26	uacr	uacr	INTJ
eshr-8982	15	27	(	(	PUNCT
eshr-8982	15	28	urinary	urinary	ADJ
eshr-8982	15	29	albumin	albumin	ADJ
eshr-8982	15	30	creatinine	creatinine	NOUN
eshr-8982	15	31	ratio	ratio	NOUN
eshr-8982	15	32	levels	level	NOUN
eshr-8982	15	33	are	be	AUX
eshr-8982	15	34	linked	link	VERB
eshr-8982	15	35	to	to	ADP
eshr-8982	15	36	an	an	DET
eshr-8982	15	37	increased	increase	VERB
eshr-8982	15	38	risk	risk	NOUN
eshr-8982	15	39	of	of	ADP
eshr-8982	15	40	ckd	ckd	PROPN
eshr-8982	15	41	(	(	PUNCT
eshr-8982	15	42	chronic	chronic	ADJ
eshr-8982	15	43	kidney	kidney	NOUN
eshr-8982	15	44	diseases	disease	NOUN
eshr-8982	15	45	)	)	PUNCT
eshr-8982	15	46	.	.	PUNCT
eshr-8982	16	1	the	the	DET
eshr-8982	16	2	patient	patient	NOUN
eshr-8982	16	3	's	's	PART
eshr-8982	16	4	diabetes	diabetes	NOUN
eshr-8982	16	5	duration	duration	NOUN
eshr-8982	16	6	also	also	ADV
eshr-8982	16	7	impacts	impact	VERB
eshr-8982	16	8	acr	acr	PROPN
eshr-8982	16	9	levels	level	NOUN
eshr-8982	16	10	.	.	PUNCT
eshr-8982	17	1	the	the	DET
eshr-8982	17	2	kdi	kdi	PROPN
eshr-8982	17	3	is	be	AUX
eshr-8982	17	4	a	a	DET
eshr-8982	17	5	composite	composite	NOUN
eshr-8982	17	6	of	of	ADP
eshr-8982	17	7	egfr	egfr	NOUN
eshr-8982	17	8	(	(	PUNCT
eshr-8982	17	9	estimated	estimate	VERB
eshr-8982	17	10	glomerular	glomerular	ADJ
eshr-8982	17	11	filtration	filtration	NOUN
eshr-8982	17	12	rate	rate	NOUN
eshr-8982	17	13	)	)	PUNCT
eshr-8982	17	14	and	and	CCONJ
eshr-8982	17	15	acr	acr	PROPN
eshr-8982	17	16	risk	risk	NOUN
eshr-8982	17	17	variables	variable	VERB
eshr-8982	17	18	with	with	ADP
eshr-8982	17	19	a	a	DET
eshr-8982	17	20	clear	clear	ADJ
eshr-8982	17	21	linear	linear	ADJ
eshr-8982	17	22	relationship	relationship	NOUN
eshr-8982	17	23	with	with	ADP
eshr-8982	17	24	all	all	DET
eshr-8982	17	25	three	three	NUM
eshr-8982	17	26	outcomes	outcome	NOUN
eshr-8982	17	27	.	.	PUNCT
eshr-8982	18	1	it	it	PRON
eshr-8982	18	2	may	may	AUX
eshr-8982	18	3	aid	aid	VERB
eshr-8982	18	4	in	in	ADP
eshr-8982	18	5	the	the	DET
eshr-8982	18	6	identification	identification	NOUN
eshr-8982	18	7	of	of	ADP
eshr-8982	18	8	high	high	ADJ
eshr-8982	18	9	-	-	PUNCT
eshr-8982	18	10	risk	risk	NOUN
eshr-8982	18	11	individuals	individual	NOUN
eshr-8982	18	12	who	who	PRON
eshr-8982	18	13	will	will	AUX
eshr-8982	18	14	benefit	benefit	VERB
eshr-8982	18	15	the	the	DET
eshr-8982	18	16	most	most	ADJ
eshr-8982	18	17	from	from	ADP
eshr-8982	18	18	prophylactic	prophylactic	ADJ
eshr-8982	18	19	medications	medication	NOUN
eshr-8982	18	20	.	.	PUNCT
eshr-8982	19	1	conclusion	conclusion	NOUN
eshr-8982	19	2	:	:	PUNCT
eshr-8982	19	3	patients	patient	NOUN
eshr-8982	19	4	should	should	AUX
eshr-8982	19	5	be	be	AUX
eshr-8982	19	6	taught	teach	VERB
eshr-8982	19	7	how	how	SCONJ
eshr-8982	19	8	better	well	ADJ
eshr-8982	19	9	blood	blood	NOUN
eshr-8982	19	10	glucose	glucose	NOUN
eshr-8982	19	11	and	and	CCONJ
eshr-8982	19	12	albuminuria	albuminuria	PROPN
eshr-8982	19	13	control	control	PROPN
eshr-8982	19	14	might	might	AUX
eshr-8982	19	15	help	help	VERB
eshr-8982	19	16	delay	delay	VERB
eshr-8982	19	17	the	the	DET
eshr-8982	19	18	progression	progression	NOUN
eshr-8982	19	19	of	of	ADP
eshr-8982	19	20	ckd	ckd	PROPN
eshr-8982	19	21	.	.	PUNCT
eshr-8982	20	1	the	the	DET
eshr-8982	20	2	male	male	ADJ
eshr-8982	20	3	sex	sex	NOUN
eshr-8982	20	4	is	be	AUX
eshr-8982	20	5	protective	protective	ADJ
eshr-8982	20	6	;	;	PUNCT
eshr-8982	20	7	however	however	ADV
eshr-8982	20	8	,	,	PUNCT
eshr-8982	20	9	most	most	ADJ
eshr-8982	20	10	female	female	ADJ
eshr-8982	20	11	patients	patient	NOUN
eshr-8982	20	12	were	be	AUX
eshr-8982	20	13	postmenopausal	postmenopausal	ADJ
eshr-8982	20	14	with	with	ADP
eshr-8982	20	15	low	low	ADJ
eshr-8982	20	16	estrogen	estrogen	NOUN
eshr-8982	20	17	levels	level	NOUN
eshr-8982	20	18	,	,	PUNCT
eshr-8982	20	19	eliminating	eliminate	VERB
eshr-8982	20	20	any	any	DET
eshr-8982	20	21	potential	potential	ADJ
eshr-8982	20	22	renoprotective	renoprotective	ADJ
eshr-8982	20	23	advantage	advantage	NOUN
eshr-8982	20	24	.	.	PUNCT
eshr-8982	21	1	dipsticks	dipstick	NOUN
eshr-8982	21	2	may	may	AUX
eshr-8982	21	3	be	be	AUX
eshr-8982	21	4	used	use	VERB
eshr-8982	21	5	for	for	ADP
eshr-8982	21	6	uacr	uacr	NOUN
eshr-8982	21	7	testing	testing	NOUN
eshr-8982	21	8	,	,	PUNCT
eshr-8982	21	9	making	make	VERB
eshr-8982	21	10	it	it	PRON
eshr-8982	21	11	more	more	ADV
eshr-8982	21	12	convenient	convenient	ADJ
eshr-8982	21	13	.	.	PUNCT
eshr-8982	22	1	keywords	keyword	NOUN
eshr-8982	22	2	:	:	PUNCT
eshr-8982	22	3	dm	dm	PROPN
eshr-8982	22	4	1	1	NUM
eshr-8982	22	5	;	;	PUNCT
eshr-8982	22	6	esrd	esrd	PROPN
eshr-8982	22	7	2	2	NUM
eshr-8982	22	8	;	;	PUNCT
eshr-8982	22	9	acr	acr	PROPN
eshr-8982	22	10	3	3	NUM
eshr-8982	22	11	;	;	PUNCT
eshr-8982	22	12	diabetic	diabetic	ADJ
eshr-8982	22	13	nephropathy	nephropathy	NOUN
eshr-8982	22	14	4	4	NUM
eshr-8982	22	15	;	;	PUNCT
eshr-8982	22	16	uacr	uacr	PROPN
eshr-8982	22	17	5	5	NUM
eshr-8982	22	18	;	;	PUNCT
eshr-8982	22	19	microalbuminuria	microalbuminuria	PROPN
eshr-8982	22	20	6	6	NUM
eshr-8982	22	21	http://journal2.uad.ac.id/index.php/eshr/index	http://journal2.uad.ac.id/index.php/eshr/index	NOUN
eshr-8982	22	22	mailto:eshr@ikm.uad.ac.id	mailto:eshr@ikm.uad.ac.id	NOUN
eshr-8982	22	23	https://doi.org/10.26555/eshr.v3i1.3629	https://doi.org/10.26555/eshr.v3i1.3629	PROPN
eshr-8982	22	24	https://doi.org/10.26555/eshr.v3i1.3629	https://doi.org/10.26555/eshr.v3i1.3629	PROPN
eshr-8982	22	25	purtaria	purtaria	NOUN
eshr-8982	22	26	et	et	PROPN
eshr-8982	22	27	al	al	PROPN
eshr-8982	22	28	.	.	PUNCT
eshr-8982	23	1	(	(	PUNCT
eshr-8982	23	2	the	the	DET
eshr-8982	23	3	importance	importance	NOUN
eshr-8982	23	4	of	of	ADP
eshr-8982	23	5	uacr	uacr	NOUN
eshr-8982	23	6	(	(	PUNCT
eshr-8982	23	7	urinary	urinary	ADJ
eshr-8982	23	8	albumin	albumin	ADJ
eshr-8982	23	9	creatinine	creatinine	NOUN
eshr-8982	23	10	ratio	ratio	NOUN
eshr-8982	23	11	)	)	PUNCT
eshr-8982	23	12	examination	examination	NOUN
eshr-8982	23	13	in	in	ADP
eshr-8982	23	14	patients	patient	NOUN
eshr-8982	23	15	)	)	PUNCT
eshr-8982	23	16	…	…	PUNCT
eshr-8982	23	17	.	.	PUNCT
eshr-8982	24	1	75	75	NUM
eshr-8982	24	2	vol	vol	NOUN
eshr-8982	24	3	.	.	PROPN
eshr-8982	25	1	6	6	NUM
eshr-8982	25	2	,	,	PUNCT
eshr-8982	25	3	no	no	INTJ
eshr-8982	25	4	.	.	NOUN
eshr-8982	25	5	2	2	NUM
eshr-8982	25	6	,	,	PUNCT
eshr-8982	25	7	2024	2024	NUM
eshr-8982	25	8	,	,	PUNCT
eshr-8982	25	9	pp	pp	ADJ
eshr-8982	25	10	.	.	PUNCT
eshr-8982	26	1	74	74	NUM
eshr-8982	26	2	-	-	SYM
eshr-8982	26	3	86	86	NUM
eshr-8982	26	4	10.26555	10.26555	NUM
eshr-8982	26	5	/	/	SYM
eshr-8982	26	6	eshr.v6i2.8982	eshr.v6i2.8982	NUM
eshr-8982	26	7	introduction	introduction	NOUN
eshr-8982	26	8	diabetes	diabetes	NOUN
eshr-8982	26	9	mellitus	mellitus	NOUN
eshr-8982	26	10	is	be	AUX
eshr-8982	26	11	a	a	DET
eshr-8982	26	12	chronic	chronic	ADJ
eshr-8982	26	13	metabolic	metabolic	NOUN
eshr-8982	26	14	condition	condition	NOUN
eshr-8982	26	15	that	that	PRON
eshr-8982	26	16	causes	cause	VERB
eshr-8982	26	17	elevated	elevated	ADJ
eshr-8982	26	18	blood	blood	NOUN
eshr-8982	26	19	glucose	glucose	NOUN
eshr-8982	26	20	levels	level	NOUN
eshr-8982	26	21	over	over	ADP
eshr-8982	26	22	time	time	NOUN
eshr-8982	26	23	.	.	PUNCT
eshr-8982	27	1	this	this	DET
eshr-8982	27	2	tissue	tissue	NOUN
eshr-8982	27	3	damage	damage	NOUN
eshr-8982	27	4	can	can	AUX
eshr-8982	27	5	result	result	VERB
eshr-8982	27	6	in	in	ADP
eshr-8982	27	7	both	both	CCONJ
eshr-8982	27	8	microvascular	microvascular	ADJ
eshr-8982	27	9	and	and	CCONJ
eshr-8982	27	10	macrovascular	macrovascular	ADJ
eshr-8982	27	11	consequences	consequence	NOUN
eshr-8982	27	12	.	.	PUNCT
eshr-8982	28	1	small	small	ADJ
eshr-8982	28	2	blood	blood	NOUN
eshr-8982	28	3	vessels	vessel	NOUN
eshr-8982	28	4	are	be	AUX
eshr-8982	28	5	damaged	damage	VERB
eshr-8982	28	6	by	by	ADP
eshr-8982	28	7	microvascular	microvascular	ADJ
eshr-8982	28	8	problems	problem	NOUN
eshr-8982	28	9	,	,	PUNCT
eshr-8982	28	10	causing	cause	VERB
eshr-8982	28	11	retinopathy	retinopathy	ADJ
eshr-8982	28	12	,	,	PUNCT
eshr-8982	28	13	nephropathy	nephropathy	ADJ
eshr-8982	28	14	,	,	PUNCT
eshr-8982	28	15	and	and	CCONJ
eshr-8982	28	16	neuropathy	neuropathy	ADJ
eshr-8982	28	17	.	.	PUNCT
eshr-8982	29	1	large	large	ADJ
eshr-8982	29	2	blood	blood	NOUN
eshr-8982	29	3	arteries	artery	NOUN
eshr-8982	29	4	are	be	AUX
eshr-8982	29	5	damaged	damage	VERB
eshr-8982	29	6	by	by	ADP
eshr-8982	29	7	macrovascular	macrovascular	ADJ
eshr-8982	29	8	problems	problem	NOUN
eshr-8982	29	9	,	,	PUNCT
eshr-8982	29	10	which	which	PRON
eshr-8982	29	11	raises	raise	VERB
eshr-8982	29	12	the	the	DET
eshr-8982	29	13	risk	risk	NOUN
eshr-8982	29	14	of	of	ADP
eshr-8982	29	15	hypertension	hypertension	NOUN
eshr-8982	29	16	,	,	PUNCT
eshr-8982	29	17	heart	heart	NOUN
eshr-8982	29	18	attacks	attack	NOUN
eshr-8982	29	19	,	,	PUNCT
eshr-8982	29	20	strokes	stroke	NOUN
eshr-8982	29	21	,	,	PUNCT
eshr-8982	29	22	decreased	decrease	VERB
eshr-8982	29	23	blood	blood	NOUN
eshr-8982	29	24	flow	flow	NOUN
eshr-8982	29	25	(	(	PUNCT
eshr-8982	29	26	particularly	particularly	ADV
eshr-8982	29	27	in	in	ADP
eshr-8982	29	28	the	the	DET
eshr-8982	29	29	legs	leg	NOUN
eshr-8982	29	30	)	)	PUNCT
eshr-8982	29	31	,	,	PUNCT
eshr-8982	29	32	and	and	CCONJ
eshr-8982	29	33	postponed	postpone	VERB
eshr-8982	29	34	wound	wound	NOUN
eshr-8982	29	35	healing.1	healing.1	PROPN
eshr-8982	29	36	diabetes	diabetes	NOUN
eshr-8982	29	37	mellitus	mellitus	NOUN
eshr-8982	29	38	is	be	AUX
eshr-8982	29	39	becoming	become	VERB
eshr-8982	29	40	more	more	ADV
eshr-8982	29	41	common	common	ADJ
eshr-8982	29	42	all	all	ADV
eshr-8982	29	43	over	over	ADP
eshr-8982	29	44	the	the	DET
eshr-8982	29	45	world	world	NOUN
eshr-8982	29	46	.	.	PUNCT
eshr-8982	30	1	according	accord	VERB
eshr-8982	30	2	to	to	ADP
eshr-8982	30	3	the	the	DET
eshr-8982	30	4	diabetes	diabetes	NOUN
eshr-8982	30	5	atlas	atlas	PROPN
eshr-8982	30	6	2021	2021	NUM
eshr-8982	30	7	,	,	PUNCT
eshr-8982	30	8	people	people	NOUN
eshr-8982	30	9	with	with	ADP
eshr-8982	30	10	diabetes	diabetes	NOUN
eshr-8982	30	11	mellitus	mellitus	NOUN
eshr-8982	30	12	worldwide	worldwide	ADV
eshr-8982	30	13	reach	reach	VERB
eshr-8982	30	14	more	more	ADJ
eshr-8982	30	15	than	than	ADP
eshr-8982	30	16	500	500	NUM
eshr-8982	30	17	million	million	NUM
eshr-8982	30	18	.	.	PUNCT
eshr-8982	31	1	meanwhile	meanwhile	ADV
eshr-8982	31	2	,	,	PUNCT
eshr-8982	31	3	in	in	ADP
eshr-8982	31	4	indonesia	indonesia	PROPN
eshr-8982	31	5	,	,	PUNCT
eshr-8982	31	6	there	there	PRON
eshr-8982	31	7	are	be	VERB
eshr-8982	31	8	more	more	ADJ
eshr-8982	31	9	than	than	ADP
eshr-8982	31	10	19	19	NUM
eshr-8982	31	11	million	million	NUM
eshr-8982	31	12	people	people	NOUN
eshr-8982	31	13	with	with	ADP
eshr-8982	31	14	diabetes.2	diabetes.2	PROPN
eshr-8982	31	15	diabetes	diabetes	NOUN
eshr-8982	31	16	mellitus	mellitus	NOUN
eshr-8982	31	17	is	be	AUX
eshr-8982	31	18	a	a	DET
eshr-8982	31	19	leading	lead	VERB
eshr-8982	31	20	cause	cause	NOUN
eshr-8982	31	21	of	of	ADP
eshr-8982	31	22	end	end	NOUN
eshr-8982	31	23	-	-	PUNCT
eshr-8982	31	24	stage	stage	NOUN
eshr-8982	31	25	kidney	kidney	NOUN
eshr-8982	31	26	disease	disease	NOUN
eshr-8982	31	27	(	(	PUNCT
eshr-8982	31	28	eskd	eskd	PROPN
eshr-8982	31	29	)	)	PUNCT
eshr-8982	31	30	.	.	PUNCT
eshr-8982	32	1	many	many	ADJ
eshr-8982	32	2	multiethnic	multiethnic	ADJ
eshr-8982	32	3	studies	study	NOUN
eshr-8982	32	4	have	have	AUX
eshr-8982	32	5	found	find	VERB
eshr-8982	32	6	a	a	DET
eshr-8982	32	7	higher	high	ADJ
eshr-8982	32	8	prevalence	prevalence	NOUN
eshr-8982	32	9	of	of	ADP
eshr-8982	32	10	kidney	kidney	NOUN
eshr-8982	32	11	problems	problem	NOUN
eshr-8982	32	12	in	in	ADP
eshr-8982	32	13	asian	asian	ADJ
eshr-8982	32	14	individuals	individual	NOUN
eshr-8982	32	15	with	with	ADP
eshr-8982	32	16	type	type	NOUN
eshr-8982	32	17	2	2	NUM
eshr-8982	32	18	diabetes	diabetes	NOUN
eshr-8982	32	19	mellitus.3	mellitus.3	NOUN
eshr-8982	32	20	patients	patient	NOUN
eshr-8982	32	21	with	with	ADP
eshr-8982	32	22	type	type	NOUN
eshr-8982	32	23	2	2	NUM
eshr-8982	32	24	diabetes	diabetes	NOUN
eshr-8982	32	25	(	(	PUNCT
eshr-8982	32	26	t2d	t2d	NOUN
eshr-8982	32	27	)	)	PUNCT
eshr-8982	32	28	are	be	AUX
eshr-8982	32	29	more	more	ADV
eshr-8982	32	30	likely	likely	ADJ
eshr-8982	32	31	to	to	PART
eshr-8982	32	32	be	be	AUX
eshr-8982	32	33	diagnosed	diagnose	VERB
eshr-8982	32	34	with	with	ADP
eshr-8982	32	35	end	end	NOUN
eshr-8982	32	36	-	-	PUNCT
eshr-8982	32	37	stage	stage	NOUN
eshr-8982	32	38	renal	renal	ADJ
eshr-8982	32	39	disease	disease	NOUN
eshr-8982	32	40	(	(	PUNCT
eshr-8982	32	41	esrd	esrd	PROPN
eshr-8982	32	42	)	)	PUNCT
eshr-8982	32	43	.	.	PUNCT
eshr-8982	33	1	diabetes	diabetes	NOUN
eshr-8982	33	2	causes	cause	VERB
eshr-8982	33	3	diabetic	diabetic	ADJ
eshr-8982	33	4	nephropathy	nephropathy	NOUN
eshr-8982	33	5	,	,	PUNCT
eshr-8982	33	6	which	which	PRON
eshr-8982	33	7	is	be	AUX
eshr-8982	33	8	the	the	DET
eshr-8982	33	9	leading	lead	VERB
eshr-8982	33	10	cause	cause	NOUN
eshr-8982	33	11	of	of	ADP
eshr-8982	33	12	endstage	endstage	NOUN
eshr-8982	33	13	renal	renal	ADJ
eshr-8982	33	14	disease.4	disease.4	ADJ
eshr-8982	33	15	microvascular	microvascular	NOUN
eshr-8982	33	16	complications	complication	NOUN
eshr-8982	33	17	caused	cause	VERB
eshr-8982	33	18	by	by	ADP
eshr-8982	33	19	chronic	chronic	ADJ
eshr-8982	33	20	hyperglycemia	hyperglycemia	NOUN
eshr-8982	33	21	are	be	AUX
eshr-8982	33	22	the	the	DET
eshr-8982	33	23	leading	lead	VERB
eshr-8982	33	24	cause	cause	NOUN
eshr-8982	33	25	of	of	ADP
eshr-8982	33	26	diabetes	diabete	NOUN
eshr-8982	33	27	mellitus	mellitus	NOUN
eshr-8982	33	28	.	.	PUNCT
eshr-8982	34	1	albumin	albumin	ADJ
eshr-8982	34	2	excretion	excretion	NOUN
eshr-8982	34	3	of	of	ADP
eshr-8982	34	4	more	more	ADJ
eshr-8982	34	5	than	than	ADP
eshr-8982	34	6	30	30	NUM
eshr-8982	34	7	mg	mg	NOUN
eshr-8982	34	8	per	per	ADP
eshr-8982	34	9	day	day	NOUN
eshr-8982	34	10	is	be	AUX
eshr-8982	34	11	known	know	VERB
eshr-8982	34	12	as	as	ADP
eshr-8982	34	13	microalbuminuria	microalbuminuria	NOUN
eshr-8982	34	14	,	,	PUNCT
eshr-8982	34	15	which	which	PRON
eshr-8982	34	16	plays	play	VERB
eshr-8982	34	17	a	a	DET
eshr-8982	34	18	vital	vital	ADJ
eshr-8982	34	19	role	role	NOUN
eshr-8982	34	20	in	in	ADP
eshr-8982	34	21	the	the	DET
eshr-8982	34	22	onset	onset	NOUN
eshr-8982	34	23	of	of	ADP
eshr-8982	34	24	diabetic	diabetic	ADJ
eshr-8982	34	25	nephropathy	nephropathy	NOUN
eshr-8982	34	26	,	,	PUNCT
eshr-8982	34	27	which	which	PRON
eshr-8982	34	28	uncontrollably	uncontrollably	ADV
eshr-8982	34	29	develops	develop	VERB
eshr-8982	34	30	into	into	ADP
eshr-8982	34	31	clinical	clinical	ADJ
eshr-8982	34	32	proteinuria	proteinuria	NOUN
eshr-8982	34	33	and	and	CCONJ
eshr-8982	34	34	ends	end	VERB
eshr-8982	34	35	with	with	ADP
eshr-8982	34	36	a	a	DET
eshr-8982	34	37	decrease	decrease	NOUN
eshr-8982	34	38	in	in	ADP
eshr-8982	34	39	glomerular	glomerular	ADJ
eshr-8982	34	40	filtration	filtration	NOUN
eshr-8982	34	41	rate	rate	NOUN
eshr-8982	34	42	and	and	CCONJ
eshr-8982	34	43	kidney	kidney	NOUN
eshr-8982	34	44	failure.5	failure.5	VERB
eshr-8982	34	45	one	one	NUM
eshr-8982	34	46	of	of	ADP
eshr-8982	34	47	the	the	DET
eshr-8982	34	48	most	most	ADV
eshr-8982	34	49	common	common	ADJ
eshr-8982	34	50	complications	complication	NOUN
eshr-8982	34	51	of	of	ADP
eshr-8982	34	52	diabetes	diabetes	NOUN
eshr-8982	34	53	is	be	AUX
eshr-8982	34	54	diabetic	diabetic	ADJ
eshr-8982	34	55	nephropathy	nephropathy	NOUN
eshr-8982	34	56	.	.	PUNCT
eshr-8982	35	1	while	while	SCONJ
eshr-8982	35	2	metabolic	metabolic	NOUN
eshr-8982	35	3	syndrome	syndrome	NOUN
eshr-8982	35	4	is	be	AUX
eshr-8982	35	5	an	an	DET
eshr-8982	35	6	established	establish	VERB
eshr-8982	35	7	risk	risk	NOUN
eshr-8982	35	8	factor	factor	NOUN
eshr-8982	35	9	for	for	ADP
eshr-8982	35	10	albuminuria	albuminuria	NOUN
eshr-8982	35	11	and	and	CCONJ
eshr-8982	35	12	cardiovascular	cardiovascular	ADJ
eshr-8982	35	13	disease	disease	NOUN
eshr-8982	35	14	,	,	PUNCT
eshr-8982	35	15	it	it	PRON
eshr-8982	35	16	certainly	certainly	ADV
eshr-8982	35	17	is	be	AUX
eshr-8982	35	18	not	not	PART
eshr-8982	35	19	the	the	DET
eshr-8982	35	20	only	only	ADJ
eshr-8982	35	21	risk	risk	NOUN
eshr-8982	35	22	factor	factor	NOUN
eshr-8982	35	23	.	.	PUNCT
eshr-8982	36	1	furthermore	furthermore	ADV
eshr-8982	36	2	,	,	PUNCT
eshr-8982	36	3	in	in	ADP
eshr-8982	36	4	prediabetes	prediabete	NOUN
eshr-8982	36	5	patients	patient	NOUN
eshr-8982	36	6	,	,	PUNCT
eshr-8982	36	7	a	a	DET
eshr-8982	36	8	high	high	ADJ
eshr-8982	36	9	glomerular	glomerular	ADJ
eshr-8982	36	10	filtration	filtration	NOUN
eshr-8982	36	11	rate	rate	NOUN
eshr-8982	36	12	is	be	AUX
eshr-8982	36	13	related	relate	VERB
eshr-8982	36	14	to	to	ADP
eshr-8982	36	15	impaired	impair	VERB
eshr-8982	36	16	arterial	arterial	ADJ
eshr-8982	36	17	stiffness	stiffness	NOUN
eshr-8982	36	18	and	and	CCONJ
eshr-8982	36	19	cardiovascular	cardiovascular	ADJ
eshr-8982	36	20	disease	disease	NOUN
eshr-8982	36	21	.	.	PUNCT
eshr-8982	37	1	the	the	DET
eshr-8982	37	2	urinary	urinary	ADJ
eshr-8982	37	3	albumin	albumin	ADJ
eshr-8982	37	4	-	-	PUNCT
eshr-8982	37	5	tocreatinine	tocreatinine	NOUN
eshr-8982	37	6	ratio	ratio	NOUN
eshr-8982	37	7	(	(	PUNCT
eshr-8982	37	8	acr	acr	NOUN
eshr-8982	37	9	)	)	PUNCT
eshr-8982	37	10	is	be	AUX
eshr-8982	37	11	used	use	VERB
eshr-8982	37	12	clinically	clinically	ADV
eshr-8982	37	13	to	to	PART
eshr-8982	37	14	evaluate	evaluate	VERB
eshr-8982	37	15	albuminuria	albuminuria	NOUN
eshr-8982	37	16	while	while	SCONJ
eshr-8982	37	17	also	also	ADV
eshr-8982	37	18	serving	serve	VERB
eshr-8982	37	19	as	as	ADP
eshr-8982	37	20	a	a	DET
eshr-8982	37	21	regular	regular	ADJ
eshr-8982	37	22	practice	practice	NOUN
eshr-8982	37	23	for	for	ADP
eshr-8982	37	24	diabetes	diabetes	NOUN
eshr-8982	37	25	management	management	NOUN
eshr-8982	37	26	and	and	CCONJ
eshr-8982	37	27	intervention	intervention	NOUN
eshr-8982	37	28	to	to	PART
eshr-8982	37	29	detect	detect	VERB
eshr-8982	37	30	and	and	CCONJ
eshr-8982	37	31	prevent	prevent	VERB
eshr-8982	37	32	the	the	DET
eshr-8982	37	33	progression	progression	NOUN
eshr-8982	37	34	of	of	ADP
eshr-8982	37	35	diabetic	diabetic	ADJ
eshr-8982	37	36	nephropathy	nephropathy	NOUN
eshr-8982	37	37	.	.	PUNCT
eshr-8982	38	1	albuminuria	albuminuria	PROPN
eshr-8982	38	2	is	be	AUX
eshr-8982	38	3	a	a	DET
eshr-8982	38	4	warning	warning	NOUN
eshr-8982	38	5	sign	sign	NOUN
eshr-8982	38	6	of	of	ADP
eshr-8982	38	7	diabetes	diabetes	NOUN
eshr-8982	38	8	and	and	CCONJ
eshr-8982	38	9	shows	show	VERB
eshr-8982	38	10	the	the	DET
eshr-8982	38	11	existence	existence	NOUN
eshr-8982	38	12	of	of	ADP
eshr-8982	38	13	diabetic	diabetic	ADJ
eshr-8982	38	14	microvascular	microvascular	ADJ
eshr-8982	38	15	damage	damage	NOUN
eshr-8982	38	16	.	.	PUNCT
eshr-8982	39	1	previous	previous	ADJ
eshr-8982	39	2	research	research	NOUN
eshr-8982	39	3	has	have	AUX
eshr-8982	39	4	shown	show	VERB
eshr-8982	39	5	that	that	SCONJ
eshr-8982	39	6	acr	acr	PROPN
eshr-8982	39	7	is	be	AUX
eshr-8982	39	8	independently	independently	ADV
eshr-8982	39	9	related	relate	VERB
eshr-8982	39	10	to	to	ADP
eshr-8982	39	11	all	all	DET
eshr-8982	39	12	-	-	PUNCT
eshr-8982	39	13	cause	cause	NOUN
eshr-8982	39	14	and	and	CCONJ
eshr-8982	39	15	cardiovascular	cardiovascular	ADJ
eshr-8982	39	16	disease	disease	NOUN
eshr-8982	39	17	mortality	mortality	NOUN
eshr-8982	39	18	in	in	ADP
eshr-8982	39	19	diabetics.6	diabetics.6	PROPN
eshr-8982	39	20	the	the	DET
eshr-8982	39	21	detection	detection	NOUN
eshr-8982	39	22	of	of	ADP
eshr-8982	39	23	uacr	uacr	PROPN
eshr-8982	39	24	(	(	PUNCT
eshr-8982	39	25	urinary	urinary	ADJ
eshr-8982	39	26	albumin	albumin	ADJ
eshr-8982	39	27	creatinine	creatinine	NOUN
eshr-8982	39	28	ratio	ratio	NOUN
eshr-8982	39	29	)	)	PUNCT
eshr-8982	39	30	in	in	ADP
eshr-8982	39	31	diabetic	diabetic	ADJ
eshr-8982	39	32	individuals	individual	NOUN
eshr-8982	39	33	is	be	AUX
eshr-8982	39	34	a	a	DET
eshr-8982	39	35	standard	standard	ADJ
eshr-8982	39	36	approach	approach	NOUN
eshr-8982	39	37	for	for	ADP
eshr-8982	39	38	clinical	clinical	ADJ
eshr-8982	39	39	screening	screening	NOUN
eshr-8982	39	40	of	of	ADP
eshr-8982	39	41	kidney	kidney	NOUN
eshr-8982	39	42	damage	damage	NOUN
eshr-8982	39	43	in	in	ADP
eshr-8982	39	44	these	these	DET
eshr-8982	39	45	patients.7	patients.7	ADJ
eshr-8982	39	46	albumin	albumin	NOUN
eshr-8982	39	47	-	-	PUNCT
eshr-8982	39	48	to	to	ADP
eshr-8982	39	49	-	-	PUNCT
eshr-8982	39	50	creatinine	creatinine	NOUN
eshr-8982	39	51	ratio	ratio	NOUN
eshr-8982	39	52	(	(	PUNCT
eshr-8982	39	53	acr	acr	NOUN
eshr-8982	39	54	)	)	PUNCT
eshr-8982	39	55	measurements	measurement	NOUN
eshr-8982	39	56	of	of	ADP
eshr-8982	39	57	albuminuria	albuminuria	NOUN
eshr-8982	39	58	are	be	AUX
eshr-8982	39	59	common	common	ADJ
eshr-8982	39	60	in	in	ADP
eshr-8982	39	61	diabetics	diabetic	NOUN
eshr-8982	39	62	and	and	CCONJ
eshr-8982	39	63	are	be	AUX
eshr-8982	39	64	recognized	recognize	VERB
eshr-8982	39	65	as	as	ADP
eshr-8982	39	66	predictive	predictive	ADJ
eshr-8982	39	67	markers	marker	NOUN
eshr-8982	39	68	for	for	ADP
eshr-8982	39	69	renal	renal	ADJ
eshr-8982	39	70	outcomes	outcome	NOUN
eshr-8982	39	71	,	,	PUNCT
eshr-8982	39	72	cardiovascular	cardiovascular	ADJ
eshr-8982	39	73	outcomes	outcome	NOUN
eshr-8982	39	74	,	,	PUNCT
eshr-8982	39	75	and	and	CCONJ
eshr-8982	39	76	mortality.8	mortality.8	NOUN
eshr-8982	39	77	the	the	DET
eshr-8982	39	78	average	average	ADJ
eshr-8982	39	79	concentration	concentration	NOUN
eshr-8982	39	80	of	of	ADP
eshr-8982	39	81	uacr	uacr	NOUN
eshr-8982	39	82	in	in	ADP
eshr-8982	39	83	spot	spot	ADJ
eshr-8982	39	84	urine	urine	NOUN
eshr-8982	39	85	samples	sample	NOUN
eshr-8982	39	86	is	be	AUX
eshr-8982	39	87	less	less	ADJ
eshr-8982	39	88	than	than	ADP
eshr-8982	39	89	30	30	NUM
eshr-8982	39	90	mg	mg	NUM
eshr-8982	39	91	/	/	SYM
eshr-8982	39	92	g.	g.	PROPN
eshr-8982	39	93	men	man	NOUN
eshr-8982	39	94	's	's	PART
eshr-8982	39	95	average	average	ADJ
eshr-8982	39	96	uacr	uacr	NOUN
eshr-8982	39	97	values	value	NOUN
eshr-8982	39	98	range	range	VERB
eshr-8982	39	99	from	from	ADP
eshr-8982	39	100	less	less	ADJ
eshr-8982	39	101	than	than	ADP
eshr-8982	39	102	or	or	CCONJ
eshr-8982	39	103	equal	equal	ADJ
eshr-8982	39	104	to	to	ADP
eshr-8982	39	105	17	17	NUM
eshr-8982	39	106	mg	mg	PROPN
eshr-8982	39	107	/	/	SYM
eshr-8982	39	108	g	g	NOUN
eshr-8982	39	109	,	,	PUNCT
eshr-8982	39	110	but	but	CCONJ
eshr-8982	39	111	women	woman	NOUN
eshr-8982	39	112	's	's	PART
eshr-8982	39	113	levels	level	NOUN
eshr-8982	39	114	are	be	AUX
eshr-8982	39	115	often	often	ADV
eshr-8982	39	116	higher	high	ADJ
eshr-8982	39	117	,	,	PUNCT
eshr-8982	39	118	about	about	ADV
eshr-8982	39	119	25	25	NUM
eshr-8982	39	120	mg	mg	NUM
eshr-8982	39	121	/	/	SYM
eshr-8982	39	122	g.	g.	PROPN
eshr-8982	39	123	microalbuminuria	microalbuminuria	PROPN
eshr-8982	39	124	occurs	occur	VERB
eshr-8982	39	125	when	when	SCONJ
eshr-8982	39	126	the	the	DET
eshr-8982	39	127	spot	spot	NOUN
eshr-8982	39	128	pee	pee	NOUN
eshr-8982	39	129	contains	contain	VERB
eshr-8982	39	130	30	30	NUM
eshr-8982	39	131	to	to	PART
eshr-8982	39	132	300	300	NUM
eshr-8982	39	133	mg	mg	PROPN
eshr-8982	39	134	/	/	SYM
eshr-8982	39	135	g.	g.	NOUN
eshr-8982	39	136	in	in	ADP
eshr-8982	39	137	the	the	DET
eshr-8982	39	138	general	general	ADJ
eshr-8982	39	139	population	population	NOUN
eshr-8982	39	140	,	,	PUNCT
eshr-8982	39	141	microalbuminuria	microalbuminuria	PROPN
eshr-8982	39	142	is	be	AUX
eshr-8982	39	143	an	an	DET
eshr-8982	39	144	independent	independent	ADJ
eshr-8982	39	145	predictor	predictor	NOUN
eshr-8982	39	146	of	of	ADP
eshr-8982	39	147	coronary	coronary	ADJ
eshr-8982	39	148	artery	artery	NOUN
eshr-8982	39	149	disease	disease	NOUN
eshr-8982	39	150	,	,	PUNCT
eshr-8982	39	151	cardiovascular	cardiovascular	ADJ
eshr-8982	39	152	disease	disease	NOUN
eshr-8982	39	153	,	,	PUNCT
eshr-8982	39	154	and	and	CCONJ
eshr-8982	39	155	all	all	DET
eshr-8982	39	156	-	-	PUNCT
eshr-8982	39	157	cause	cause	NOUN
eshr-8982	39	158	mortality	mortality	NOUN
eshr-8982	39	159	.	.	PUNCT
eshr-8982	40	1	there	there	PRON
eshr-8982	40	2	is	be	VERB
eshr-8982	40	3	conflicting	conflicting	ADJ
eshr-8982	40	4	evidence	evidence	NOUN
eshr-8982	40	5	from	from	ADP
eshr-8982	40	6	several	several	ADJ
eshr-8982	40	7	observational	observational	ADJ
eshr-8982	40	8	studies	study	NOUN
eshr-8982	40	9	that	that	SCONJ
eshr-8982	40	10	there	there	PRON
eshr-8982	40	11	is	be	VERB
eshr-8982	40	12	a	a	DET
eshr-8982	40	13	link	link	NOUN
eshr-8982	40	14	between	between	ADP
eshr-8982	40	15	incident	incident	NOUN
eshr-8982	40	16	hypertension	hypertension	NOUN
eshr-8982	40	17	and	and	CCONJ
eshr-8982	40	18	a	a	DET
eshr-8982	40	19	slight	slight	ADJ
eshr-8982	40	20	increase	increase	NOUN
eshr-8982	40	21	in	in	ADP
eshr-8982	40	22	uacr	uacr	NOUN
eshr-8982	40	23	within	within	ADP
eshr-8982	40	24	the	the	DET
eshr-8982	40	25	normal	normal	ADJ
eshr-8982	40	26	range.9	range.9	NOUN
eshr-8982	40	27	a	a	DET
eshr-8982	40	28	systematic	systematic	ADJ
eshr-8982	40	29	review	review	NOUN
eshr-8982	40	30	is	be	AUX
eshr-8982	40	31	done	do	VERB
eshr-8982	40	32	to	to	PART
eshr-8982	40	33	determine	determine	VERB
eshr-8982	40	34	the	the	DET
eshr-8982	40	35	role	role	NOUN
eshr-8982	40	36	of	of	ADP
eshr-8982	40	37	acr	acr	NOUN
eshr-8982	40	38	urine	urine	NOUN
eshr-8982	40	39	in	in	ADP
eshr-8982	40	40	patients	patient	NOUN
eshr-8982	40	41	with	with	ADP
eshr-8982	40	42	dm	dm	PROPN
eshr-8982	40	43	type	type	NOUN
eshr-8982	40	44	2	2	NUM
eshr-8982	40	45	.	.	PUNCT
eshr-8982	41	1	https://doi.org/10.26555/eshr.v3i1.3629	https://doi.org/10.26555/eshr.v3i1.3629	PROPN
eshr-8982	41	2	https://doi.org/10.26555/eshr.v3i1.3629	https://doi.org/10.26555/eshr.v3i1.3629	PROPN
eshr-8982	41	3	purtaria	purtaria	PROPN
eshr-8982	41	4	et	et	PROPN
eshr-8982	41	5	al	al	PROPN
eshr-8982	41	6	.	.	PUNCT
eshr-8982	42	1	(	(	PUNCT
eshr-8982	42	2	the	the	DET
eshr-8982	42	3	importance	importance	NOUN
eshr-8982	42	4	of	of	ADP
eshr-8982	42	5	uacr	uacr	NOUN
eshr-8982	42	6	(	(	PUNCT
eshr-8982	42	7	urinary	urinary	ADJ
eshr-8982	42	8	albumin	albumin	ADJ
eshr-8982	42	9	creatinine	creatinine	NOUN
eshr-8982	42	10	ratio	ratio	NOUN
eshr-8982	42	11	)	)	PUNCT
eshr-8982	42	12	examination	examination	NOUN
eshr-8982	42	13	in	in	ADP
eshr-8982	42	14	patients	patient	NOUN
eshr-8982	42	15	)	)	PUNCT
eshr-8982	42	16	…	…	PUNCT
eshr-8982	42	17	.	.	PUNCT
eshr-8982	43	1	76	76	NUM
eshr-8982	43	2	vol	vol	NOUN
eshr-8982	43	3	.	.	PROPN
eshr-8982	44	1	6	6	NUM
eshr-8982	44	2	,	,	PUNCT
eshr-8982	44	3	no	no	INTJ
eshr-8982	44	4	.	.	NOUN
eshr-8982	44	5	2	2	NUM
eshr-8982	44	6	,	,	PUNCT
eshr-8982	44	7	2024	2024	NUM
eshr-8982	44	8	,	,	PUNCT
eshr-8982	44	9	pp	pp	ADJ
eshr-8982	44	10	.	.	PUNCT
eshr-8982	45	1	74	74	NUM
eshr-8982	45	2	-	-	SYM
eshr-8982	45	3	86	86	NUM
eshr-8982	45	4	10.26555	10.26555	NUM
eshr-8982	45	5	/	/	SYM
eshr-8982	45	6	eshr.v6i2.8982	eshr.v6i2.8982	PUNCT
eshr-8982	45	7	method	method	NOUN
eshr-8982	45	8	the	the	DET
eshr-8982	45	9	systematic	systematic	ADJ
eshr-8982	45	10	review	review	NOUN
eshr-8982	45	11	followed	follow	VERB
eshr-8982	45	12	recommendations	recommendation	NOUN
eshr-8982	45	13	of	of	ADP
eshr-8982	45	14	the	the	DET
eshr-8982	45	15	preferred	preferred	ADJ
eshr-8982	45	16	reporting	reporting	NOUN
eshr-8982	45	17	items	item	NOUN
eshr-8982	45	18	for	for	ADP
eshr-8982	45	19	systematic	systematic	ADJ
eshr-8982	45	20	reviews	review	NOUN
eshr-8982	45	21	and	and	CCONJ
eshr-8982	45	22	meta	meta	NOUN
eshr-8982	45	23	-	-	PUNCT
eshr-8982	45	24	analyses	analysis	NOUN
eshr-8982	45	25	(	(	PUNCT
eshr-8982	45	26	prisma	prisma	NOUN
eshr-8982	45	27	)	)	PUNCT
eshr-8982	45	28	guidelines	guideline	NOUN
eshr-8982	45	29	.	.	PUNCT
eshr-8982	46	1	the	the	DET
eshr-8982	46	2	research	research	NOUN
eshr-8982	46	3	articles	article	NOUN
eshr-8982	46	4	used	use	VERB
eshr-8982	46	5	in	in	ADP
eshr-8982	46	6	this	this	DET
eshr-8982	46	7	systematic	systematic	ADJ
eshr-8982	46	8	review	review	NOUN
eshr-8982	46	9	were	be	AUX
eshr-8982	46	10	obtained	obtain	VERB
eshr-8982	46	11	from	from	ADP
eshr-8982	46	12	some	some	DET
eshr-8982	46	13	databases	database	NOUN
eshr-8982	46	14	such	such	ADJ
eshr-8982	46	15	as	as	ADP
eshr-8982	46	16	sciencedirect	sciencedirect	PROPN
eshr-8982	46	17	,	,	PUNCT
eshr-8982	46	18	pubmed	pubmed	PROPN
eshr-8982	46	19	and	and	CCONJ
eshr-8982	46	20	sage	sage	NOUN
eshr-8982	46	21	.	.	PUNCT
eshr-8982	47	1	the	the	DET
eshr-8982	47	2	search	search	NOUN
eshr-8982	47	3	used	use	VERB
eshr-8982	47	4	keywords	keyword	NOUN
eshr-8982	47	5	:	:	PUNCT
eshr-8982	47	6	'	'	PUNCT
eshr-8982	47	7	urinary	urinary	ADJ
eshr-8982	47	8	albumin	albumin	ADJ
eshr-8982	47	9	creatinine	creatinine	NOUN
eshr-8982	47	10	ratio	ratio	NOUN
eshr-8982	47	11	in	in	ADP
eshr-8982	47	12	type	type	NOUN
eshr-8982	47	13	2	2	NUM
eshr-8982	47	14	diabetes	diabetes	NOUN
eshr-8982	47	15	mellitus	mellitus	NOUN
eshr-8982	47	16	’	'	PUNCT
eshr-8982	47	17	.	.	PUNCT
eshr-8982	48	1	the	the	DET
eshr-8982	48	2	next	next	ADJ
eshr-8982	48	3	stage	stage	NOUN
eshr-8982	48	4	was	be	AUX
eshr-8982	48	5	analysis	analysis	NOUN
eshr-8982	48	6	and	and	CCONJ
eshr-8982	48	7	synthesis	synthesis	NOUN
eshr-8982	48	8	,	,	PUNCT
eshr-8982	48	9	in	in	ADP
eshr-8982	48	10	which	which	PRON
eshr-8982	48	11	the	the	DET
eshr-8982	48	12	article	article	NOUN
eshr-8982	48	13	adjusted	adjust	VERB
eshr-8982	48	14	to	to	ADP
eshr-8982	48	15	the	the	DET
eshr-8982	48	16	inclusion	inclusion	NOUN
eshr-8982	48	17	and	and	CCONJ
eshr-8982	48	18	exclusion	exclusion	NOUN
eshr-8982	48	19	criteria	criterion	NOUN
eshr-8982	48	20	previously	previously	ADV
eshr-8982	48	21	defined	define	VERB
eshr-8982	48	22	.	.	PUNCT
eshr-8982	49	1	criteria	criterion	NOUN
eshr-8982	49	2	for	for	ADP
eshr-8982	49	3	inclusion	inclusion	NOUN
eshr-8982	49	4	in	in	ADP
eshr-8982	49	5	this	this	DET
eshr-8982	49	6	systematic	systematic	ADJ
eshr-8982	49	7	review	review	NOUN
eshr-8982	49	8	are	be	AUX
eshr-8982	49	9	(	(	PUNCT
eshr-8982	49	10	1	1	X
eshr-8982	49	11	)	)	PUNCT
eshr-8982	49	12	an	an	DET
eshr-8982	49	13	article	article	NOUN
eshr-8982	49	14	in	in	ADP
eshr-8982	49	15	english	english	PROPN
eshr-8982	49	16	,	,	PUNCT
eshr-8982	49	17	(	(	PUNCT
eshr-8982	49	18	2	2	X
eshr-8982	49	19	)	)	PUNCT
eshr-8982	49	20	free	free	ADJ
eshr-8982	49	21	full	full	ADJ
eshr-8982	49	22	text	text	NOUN
eshr-8982	49	23	,	,	PUNCT
eshr-8982	49	24	(	(	PUNCT
eshr-8982	49	25	3	3	X
eshr-8982	49	26	)	)	PUNCT
eshr-8982	49	27	discuss	discuss	VERB
eshr-8982	49	28	diabetes	diabetes	NOUN
eshr-8982	49	29	mellitus	mellitus	NOUN
eshr-8982	49	30	type	type	VERB
eshr-8982	49	31	2	2	NUM
eshr-8982	49	32	,	,	PUNCT
eshr-8982	49	33	(	(	PUNCT
eshr-8982	49	34	4	4	X
eshr-8982	49	35	)	)	PUNCT
eshr-8982	49	36	published	publish	VERB
eshr-8982	49	37	from	from	ADP
eshr-8982	49	38	2018	2018	NUM
eshr-8982	49	39	to	to	ADP
eshr-8982	49	40	may	may	PROPN
eshr-8982	49	41	2023	2023	NUM
eshr-8982	49	42	,	,	PUNCT
eshr-8982	49	43	and	and	CCONJ
eshr-8982	49	44	(	(	PUNCT
eshr-8982	49	45	5	5	NUM
eshr-8982	49	46	)	)	PUNCT
eshr-8982	49	47	based	base	VERB
eshr-8982	49	48	on	on	ADP
eshr-8982	49	49	experiment	experiment	NOUN
eshr-8982	49	50	or	or	CCONJ
eshr-8982	49	51	research	research	NOUN
eshr-8982	49	52	data	datum	NOUN
eshr-8982	49	53	.	.	PUNCT
eshr-8982	50	1	exclusion	exclusion	NOUN
eshr-8982	50	2	criteria	criterion	NOUN
eshr-8982	50	3	for	for	ADP
eshr-8982	50	4	a	a	DET
eshr-8982	50	5	systematic	systematic	ADJ
eshr-8982	50	6	review	review	NOUN
eshr-8982	50	7	are	be	AUX
eshr-8982	50	8	(	(	PUNCT
eshr-8982	50	9	1	1	X
eshr-8982	50	10	)	)	PUNCT
eshr-8982	50	11	full	full	ADJ
eshr-8982	50	12	text	text	NOUN
eshr-8982	50	13	not	not	PART
eshr-8982	50	14	available	available	ADJ
eshr-8982	50	15	,	,	PUNCT
eshr-8982	50	16	(	(	PUNCT
eshr-8982	50	17	2	2	X
eshr-8982	50	18	)	)	PUNCT
eshr-8982	50	19	the	the	DET
eshr-8982	50	20	title	title	NOUN
eshr-8982	50	21	of	of	ADP
eshr-8982	50	22	the	the	DET
eshr-8982	50	23	article	article	NOUN
eshr-8982	50	24	needs	need	VERB
eshr-8982	50	25	to	to	PART
eshr-8982	50	26	be	be	AUX
eshr-8982	50	27	more	more	ADV
eshr-8982	50	28	relevant	relevant	ADJ
eshr-8982	50	29	to	to	ADP
eshr-8982	50	30	the	the	DET
eshr-8982	50	31	topic	topic	NOUN
eshr-8982	50	32	(	(	PUNCT
eshr-8982	50	33	3	3	X
eshr-8982	50	34	)	)	PUNCT
eshr-8982	50	35	it	it	PRON
eshr-8982	50	36	does	do	AUX
eshr-8982	50	37	not	not	PART
eshr-8982	50	38	discuss	discuss	VERB
eshr-8982	50	39	the	the	DET
eshr-8982	50	40	role	role	NOUN
eshr-8982	50	41	of	of	ADP
eshr-8982	50	42	acr	acr	PROPN
eshr-8982	50	43	urine	urine	NOUN
eshr-8982	50	44	.	.	PUNCT
eshr-8982	51	1	results	result	VERB
eshr-8982	51	2	the	the	DET
eshr-8982	51	3	search	search	NOUN
eshr-8982	51	4	process	process	NOUN
eshr-8982	51	5	conducted	conduct	VERB
eshr-8982	51	6	is	be	AUX
eshr-8982	51	7	described	describe	VERB
eshr-8982	51	8	in	in	ADP
eshr-8982	51	9	figure	figure	NOUN
eshr-8982	51	10	1	1	NUM
eshr-8982	51	11	.	.	PUNCT
eshr-8982	51	12	based	base	VERB
eshr-8982	51	13	on	on	ADP
eshr-8982	51	14	the	the	DET
eshr-8982	51	15	search	search	NOUN
eshr-8982	51	16	results	result	NOUN
eshr-8982	51	17	from	from	ADP
eshr-8982	51	18	several	several	ADJ
eshr-8982	51	19	databases	database	NOUN
eshr-8982	51	20	using	use	VERB
eshr-8982	51	21	predefined	predefine	VERB
eshr-8982	51	22	keywords	keyword	NOUN
eshr-8982	51	23	,	,	PUNCT
eshr-8982	51	24	in	in	ADP
eshr-8982	51	25	total	total	ADJ
eshr-8982	51	26	22,629	22,629	NUM
eshr-8982	51	27	articles	article	NOUN
eshr-8982	51	28	were	be	AUX
eshr-8982	51	29	obtained	obtain	VERB
eshr-8982	51	30	.	.	PUNCT
eshr-8982	52	1	after	after	ADP
eshr-8982	52	2	the	the	DET
eshr-8982	52	3	screening	screening	NOUN
eshr-8982	52	4	according	accord	VERB
eshr-8982	52	5	to	to	ADP
eshr-8982	52	6	our	our	PRON
eshr-8982	52	7	criteria	criterion	NOUN
eshr-8982	52	8	,	,	PUNCT
eshr-8982	52	9	10	10	NUM
eshr-8982	52	10	articles	article	NOUN
eshr-8982	52	11	were	be	AUX
eshr-8982	52	12	met	meet	VERB
eshr-8982	52	13	the	the	DET
eshr-8982	52	14	criteria	criterion	NOUN
eshr-8982	52	15	and	and	CCONJ
eshr-8982	52	16	included	include	VERB
eshr-8982	52	17	to	to	ADP
eshr-8982	52	18	the	the	DET
eshr-8982	52	19	analysis	analysis	NOUN
eshr-8982	52	20	.	.	PUNCT
eshr-8982	53	1	figure	figure	NOUN
eshr-8982	53	2	1	1	NUM
eshr-8982	53	3	.	.	PUNCT
eshr-8982	54	1	diagram	diagram	NOUN
eshr-8982	54	2	of	of	ADP
eshr-8982	54	3	preferred	preferred	ADJ
eshr-8982	54	4	reporting	reporting	NOUN
eshr-8982	54	5	items	item	NOUN
eshr-8982	54	6	for	for	ADP
eshr-8982	54	7	systematic	systematic	ADJ
eshr-8982	54	8	review	review	NOUN
eshr-8982	54	9	and	and	CCONJ
eshr-8982	54	10	meta	meta	ADJ
eshr-8982	54	11	-	-	PUNCT
eshr-8982	54	12	analysis	analysis	NOUN
eshr-8982	54	13	(	(	PUNCT
eshr-8982	54	14	prisma	prisma	NOUN
eshr-8982	54	15	)	)	PUNCT
eshr-8982	54	16	https://doi.org/10.26555/eshr.v3i1.3629	https://doi.org/10.26555/eshr.v3i1.3629	PROPN
eshr-8982	54	17	https://doi.org/10.26555/eshr.v3i1.3629	https://doi.org/10.26555/eshr.v3i1.3629	PROPN
eshr-8982	54	18	purtaria	purtaria	NOUN
eshr-8982	54	19	et	et	PROPN
eshr-8982	54	20	al	al	PROPN
eshr-8982	54	21	.	.	PUNCT
eshr-8982	55	1	(	(	PUNCT
eshr-8982	55	2	the	the	DET
eshr-8982	55	3	importance	importance	NOUN
eshr-8982	55	4	of	of	ADP
eshr-8982	55	5	uacr	uacr	NOUN
eshr-8982	55	6	(	(	PUNCT
eshr-8982	55	7	urinary	urinary	ADJ
eshr-8982	55	8	albumin	albumin	ADJ
eshr-8982	55	9	creatinine	creatinine	NOUN
eshr-8982	55	10	ratio	ratio	NOUN
eshr-8982	55	11	)	)	PUNCT
eshr-8982	55	12	examination	examination	NOUN
eshr-8982	55	13	in	in	ADP
eshr-8982	55	14	patients	patient	NOUN
eshr-8982	55	15	)	)	PUNCT
eshr-8982	55	16	…	…	PUNCT
eshr-8982	55	17	.	.	PUNCT
eshr-8982	56	1	77	77	NUM
eshr-8982	56	2	vol	vol	NOUN
eshr-8982	56	3	.	.	PROPN
eshr-8982	56	4	6	6	NUM
eshr-8982	56	5	,	,	PUNCT
eshr-8982	56	6	no	no	INTJ
eshr-8982	56	7	.	.	NOUN
eshr-8982	56	8	2	2	NUM
eshr-8982	56	9	,	,	PUNCT
eshr-8982	56	10	2024	2024	NUM
eshr-8982	56	11	,	,	PUNCT
eshr-8982	56	12	pp	pp	ADJ
eshr-8982	56	13	.	.	PUNCT
eshr-8982	57	1	74	74	NUM
eshr-8982	57	2	-	-	SYM
eshr-8982	57	3	86	86	NUM
eshr-8982	57	4	10.26555	10.26555	NUM
eshr-8982	57	5	/	/	SYM
eshr-8982	57	6	eshr.v6i2.8982	eshr.v6i2.8982	NUM
eshr-8982	57	7	ten	ten	NUM
eshr-8982	57	8	articles	article	NOUN
eshr-8982	57	9	were	be	AUX
eshr-8982	57	10	included	include	VERB
eshr-8982	57	11	in	in	ADP
eshr-8982	57	12	the	the	DET
eshr-8982	57	13	analysis	analysis	NOUN
eshr-8982	57	14	,	,	PUNCT
eshr-8982	57	15	we	we	PRON
eshr-8982	57	16	synthesized	synthesize	VERB
eshr-8982	57	17	each	each	DET
eshr-8982	57	18	article	article	NOUN
eshr-8982	57	19	by	by	ADP
eshr-8982	57	20	looking	look	VERB
eshr-8982	57	21	at	at	ADP
eshr-8982	57	22	the	the	DET
eshr-8982	57	23	design	design	NOUN
eshr-8982	57	24	,	,	PUNCT
eshr-8982	57	25	sample	sample	NOUN
eshr-8982	57	26	,	,	PUNCT
eshr-8982	57	27	variables	variable	NOUN
eshr-8982	57	28	,	,	PUNCT
eshr-8982	57	29	instruments	instrument	NOUN
eshr-8982	57	30	and	and	CCONJ
eshr-8982	57	31	analysis	analysis	NOUN
eshr-8982	57	32	used	use	VERB
eshr-8982	57	33	(	(	PUNCT
eshr-8982	57	34	table	table	NOUN
eshr-8982	57	35	1	1	NUM
eshr-8982	57	36	)	)	PUNCT
eshr-8982	57	37	table	table	NOUN
eshr-8982	57	38	1	1	NUM
eshr-8982	57	39	.	.	PUNCT
eshr-8982	58	1	summary	summary	NOUN
eshr-8982	58	2	of	of	ADP
eshr-8982	58	3	findings	finding	NOUN
eshr-8982	58	4	from	from	ADP
eshr-8982	58	5	articles	article	NOUN
eshr-8982	58	6	included	include	VERB
eshr-8982	58	7	no	no	DET
eshr-8982	58	8	author	author	NOUN
eshr-8982	58	9	year	year	NOUN
eshr-8982	58	10	title	title	NOUN
eshr-8982	58	11	methods	method	NOUN
eshr-8982	58	12	(	(	PUNCT
eshr-8982	58	13	design	design	NOUN
eshr-8982	58	14	,	,	PUNCT
eshr-8982	58	15	samples	sample	NOUN
eshr-8982	58	16	,	,	PUNCT
eshr-8982	58	17	variables	variable	NOUN
eshr-8982	58	18	,	,	PUNCT
eshr-8982	58	19	instrument	instrument	NOUN
eshr-8982	58	20	,	,	PUNCT
eshr-8982	58	21	analysis	analysis	NOUN
eshr-8982	58	22	)	)	PUNCT
eshr-8982	58	23	results	result	VERB
eshr-8982	58	24	1	1	NUM
eshr-8982	58	25	hertzel	hertzel	ADJ
eshr-8982	58	26	c.	c.	PROPN
eshr-8982	58	27	gerstein	gerstein	PROPN
eshr-8982	58	28	et	et	PROPN
eshr-8982	58	29	al	al	PROPN
eshr-8982	58	30	.	.	PROPN
eshr-8982	58	31	2022	2022	NUM
eshr-8982	58	32	a	a	DET
eshr-8982	58	33	novel	novel	ADJ
eshr-8982	58	34	kidney	kidney	NOUN
eshr-8982	58	35	disease	disease	NOUN
eshr-8982	58	36	index	index	NOUN
eshr-8982	58	37	reflecting	reflect	VERB
eshr-8982	58	38	both	both	DET
eshr-8982	58	39	the	the	DET
eshr-8982	58	40	albumin	albumin	ADJ
eshr-8982	58	41	-	-	PUNCT
eshr-8982	58	42	tocreatinine	tocreatinine	NOUN
eshr-8982	58	43	ratio	ratio	NOUN
eshr-8982	58	44	and	and	CCONJ
eshr-8982	58	45	estimated	estimate	VERB
eshr-8982	58	46	glomerular	glomerular	ADJ
eshr-8982	58	47	filtration	filtration	NOUN
eshr-8982	58	48	rate	rate	NOUN
eshr-8982	58	49	predicted	predict	VERB
eshr-8982	58	50	cardiovascular	cardiovascular	ADJ
eshr-8982	58	51	and	and	CCONJ
eshr-8982	58	52	kidney	kidney	NOUN
eshr-8982	58	53	outcomes	outcome	NOUN
eshr-8982	58	54	in	in	ADP
eshr-8982	58	55	type	type	NOUN
eshr-8982	58	56	2	2	NUM
eshr-8982	58	57	diabetes	diabetes	NOUN
eshr-8982	58	58	.	.	PUNCT
eshr-8982	59	1	8	8	NUM
eshr-8982	59	2	d	d	NOUN
eshr-8982	59	3	comparative	comparative	ADJ
eshr-8982	59	4	design	design	NOUN
eshr-8982	59	5	study	study	NOUN
eshr-8982	59	6	the	the	DET
eshr-8982	59	7	kidney	kidney	NOUN
eshr-8982	59	8	disease	disease	NOUN
eshr-8982	59	9	index	index	NOUN
eshr-8982	59	10	combines	combine	VERB
eshr-8982	59	11	the	the	DET
eshr-8982	59	12	baseline	baseline	NOUN
eshr-8982	59	13	egfr	egfr	NOUN
eshr-8982	59	14	and	and	CCONJ
eshr-8982	59	15	acr	acr	NOUN
eshr-8982	59	16	into	into	ADP
eshr-8982	59	17	a	a	DET
eshr-8982	59	18	novel	novel	ADJ
eshr-8982	59	19	composite	composite	ADJ
eshr-8982	59	20	risk	risk	NOUN
eshr-8982	59	21	factor	factor	NOUN
eshr-8982	59	22	that	that	PRON
eshr-8982	59	23	has	have	VERB
eshr-8982	59	24	a	a	DET
eshr-8982	59	25	simple	simple	ADJ
eshr-8982	59	26	linear	linear	ADJ
eshr-8982	59	27	relationship	relationship	NOUN
eshr-8982	59	28	with	with	ADP
eshr-8982	59	29	incident	incident	NOUN
eshr-8982	59	30	serious	serious	ADJ
eshr-8982	59	31	outcomes	outcome	NOUN
eshr-8982	59	32	in	in	ADP
eshr-8982	59	33	people	people	NOUN
eshr-8982	59	34	with	with	ADP
eshr-8982	59	35	diabetes	diabetes	NOUN
eshr-8982	59	36	and	and	CCONJ
eshr-8982	59	37	additional	additional	ADJ
eshr-8982	59	38	cardiovascular	cardiovascular	ADJ
eshr-8982	59	39	risk	risk	NOUN
eshr-8982	59	40	factors	factor	NOUN
eshr-8982	59	41	.	.	PUNCT
eshr-8982	60	1	s	s	VERB
eshr-8982	60	2	purposive	purposive	ADJ
eshr-8982	60	3	sampling	sampling	NOUN
eshr-8982	60	4	;	;	PUNCT
eshr-8982	60	5	v	v	NUM
eshr-8982	60	6	people	people	NOUN
eshr-8982	60	7	aged	age	VERB
eshr-8982	60	8	50	50	NUM
eshr-8982	60	9	or	or	CCONJ
eshr-8982	60	10	older	old	ADJ
eshr-8982	60	11	with	with	ADP
eshr-8982	60	12	either	either	CCONJ
eshr-8982	60	13	newly	newly	ADV
eshr-8982	60	14	diagnosed	diagnose	VERB
eshr-8982	60	15	or	or	CCONJ
eshr-8982	60	16	established	establish	VERB
eshr-8982	60	17	type	type	NOUN
eshr-8982	60	18	2	2	NUM
eshr-8982	60	19	diabetes	diabete	NOUN
eshr-8982	60	20	whose	whose	DET
eshr-8982	60	21	body	body	NOUN
eshr-8982	60	22	mass	mass	NOUN
eshr-8982	60	23	index	index	NOUN
eshr-8982	60	24	was≥23	was≥23	PROPN
eshr-8982	60	25	kg	kg	PROPN
eshr-8982	60	26	/	/	SYM
eshr-8982	60	27	m2	m2	PROPN
eshr-8982	60	28	and	and	CCONJ
eshr-8982	60	29	whose	whose	DET
eshr-8982	60	30	hba1c	hba1c	NOUN
eshr-8982	60	31	was	be	AUX
eshr-8982	60	32	9.5	9.5	NUM
eshr-8982	60	33	%	%	NOUN
eshr-8982	60	34	or	or	CCONJ
eshr-8982	60	35	less	less	ADJ
eshr-8982	60	36	(	(	PUNCT
eshr-8982	60	37	with	with	ADP
eshr-8982	60	38	no	no	DET
eshr-8982	60	39	lower	low	ADJ
eshr-8982	60	40	limit	limit	NOUN
eshr-8982	60	41	)	)	PUNCT
eshr-8982	60	42	on	on	ADP
eshr-8982	60	43	stable	stable	ADJ
eshr-8982	60	44	doses	dose	NOUN
eshr-8982	60	45	of	of	ADP
eshr-8982	60	46	up	up	ADP
eshr-8982	60	47	to	to	PART
eshr-8982	60	48	2	2	NUM
eshr-8982	60	49	oral	oral	ADJ
eshr-8982	60	50	glucose	glucose	NOUN
eshr-8982	60	51	-	-	PUNCT
eshr-8982	60	52	lowering	lower	VERB
eshr-8982	60	53	drugs	drug	NOUN
eshr-8982	60	54	with	with	ADP
eshr-8982	60	55	or	or	CCONJ
eshr-8982	60	56	without	without	ADP
eshr-8982	60	57	basal	basal	ADJ
eshr-8982	60	58	insulin	insulin	NOUN
eshr-8982	60	59	between	between	ADP
eshr-8982	60	60	august	august	PROPN
eshr-8982	60	61	2011	2011	NUM
eshr-8982	60	62	and	and	CCONJ
eshr-8982	60	63	2013	2013	NUM
eshr-8982	60	64	i	i	PRON
eshr-8982	60	65	annual	annual	ADJ
eshr-8982	60	66	laboratory	laboratory	NOUN
eshr-8982	60	67	assessments	assessment	NOUN
eshr-8982	60	68	(	(	PUNCT
eshr-8982	60	69	measured	measure	VERB
eshr-8982	60	70	urine	urine	NOUN
eshr-8982	60	71	albumin	albumin	ADJ
eshr-8982	60	72	-	-	PUNCT
eshr-8982	60	73	tocreatinine	tocreatinine	NOUN
eshr-8982	60	74	ratio	ratio	NOUN
eshr-8982	60	75	(	(	PUNCT
eshr-8982	60	76	acr	acr	PROPN
eshr-8982	60	77	)	)	PUNCT
eshr-8982	60	78	and	and	CCONJ
eshr-8982	60	79	estimated	estimate	VERB
eshr-8982	60	80	glomerular	glomerular	ADJ
eshr-8982	60	81	filtration	filtration	NOUN
eshr-8982	60	82	rate	rate	NOUN
eshr-8982	60	83	a	a	DET
eshr-8982	60	84	chi	chi	ADJ
eshr-8982	60	85	-	-	PUNCT
eshr-8982	60	86	square	square	ADJ
eshr-8982	60	87	2	2	NUM
eshr-8982	60	88	wilailuck	wilailuck	NOUN
eshr-8982	60	89	tuntayothin	tuntayothin	NOUN
eshr-8982	60	90	et	et	PROPN
eshr-8982	60	91	al	al	PROPN
eshr-8982	60	92	.	.	PROPN
eshr-8982	60	93	2020	2020	NUM
eshr-8982	60	94	development	development	NOUN
eshr-8982	60	95	and	and	CCONJ
eshr-8982	60	96	validation	validation	NOUN
eshr-8982	60	97	of	of	ADP
eshr-8982	60	98	a	a	DET
eshr-8982	60	99	chronic	chronic	ADJ
eshr-8982	60	100	kidney	kidney	NOUN
eshr-8982	60	101	disease	disease	NOUN
eshr-8982	60	102	prediction	prediction	NOUN
eshr-8982	60	103	model	model	NOUN
eshr-8982	60	104	for	for	ADP
eshr-8982	60	105	type	type	NOUN
eshr-8982	60	106	2	2	NUM
eshr-8982	60	107	diabetes	diabetes	NOUN
eshr-8982	60	108	mellitus	mellitus	NOUN
eshr-8982	60	109	in	in	ADP
eshr-8982	60	110	thailand.10	thailand.10	NOUN
eshr-8982	60	111	d	d	ADP
eshr-8982	60	112	retrospective	retrospective	ADJ
eshr-8982	60	113	cohort	cohort	NOUN
eshr-8982	60	114	study	study	VERB
eshr-8982	60	115	older	old	ADJ
eshr-8982	60	116	age	age	NOUN
eshr-8982	60	117	,	,	PUNCT
eshr-8982	60	118	female	female	ADJ
eshr-8982	60	119	sex	sex	NOUN
eshr-8982	60	120	,	,	PUNCT
eshr-8982	60	121	lower	low	ADJ
eshr-8982	60	122	egfr	egfr	ADJ
eshr-8982	60	123	,	,	PUNCT
eshr-8982	60	124	higher	high	ADJ
eshr-8982	60	125	uacr	uacr	ADV
eshr-8982	60	126	,	,	PUNCT
eshr-8982	60	127	and	and	CCONJ
eshr-8982	60	128	higher	high	ADJ
eshr-8982	60	129	hba1c	hba1c	NOUN
eshr-8982	60	130	were	be	AUX
eshr-8982	60	131	associated	associate	VERB
eshr-8982	60	132	with	with	ADP
eshr-8982	60	133	an	an	DET
eshr-8982	60	134	increased	increase	VERB
eshr-8982	60	135	risk	risk	NOUN
eshr-8982	60	136	of	of	ADP
eshr-8982	60	137	developing	develop	VERB
eshr-8982	60	138	stage-3	stage-3	NUM
eshr-8982	60	139	ckd	ckd	NOUN
eshr-8982	60	140	in	in	ADP
eshr-8982	60	141	thai	thai	PROPN
eshr-8982	60	142	patients	patient	NOUN
eshr-8982	60	143	with	with	ADP
eshr-8982	60	144	type	type	NOUN
eshr-8982	60	145	2	2	NUM
eshr-8982	60	146	dm	dm	NOUN
eshr-8982	60	147	.	.	PUNCT
eshr-8982	60	148	higher	high	ADJ
eshr-8982	60	149	uacr	uacr	NOUN
eshr-8982	60	150	at	at	ADP
eshr-8982	60	151	baseline	baseline	NOUN
eshr-8982	60	152	reflects	reflect	VERB
eshr-8982	60	153	preexisting	preexist	VERB
eshr-8982	60	154	kidney	kidney	NOUN
eshr-8982	60	155	damage	damage	NOUN
eshr-8982	60	156	.	.	PUNCT
eshr-8982	61	1	s	s	VERB
eshr-8982	61	2	purposive	purposive	ADJ
eshr-8982	61	3	sampling	sampling	NOUN
eshr-8982	61	4	;	;	PUNCT
eshr-8982	61	5	v	v	X
eshr-8982	61	6	v	v	NOUN
eshr-8982	61	7	=	=	NOUN
eshr-8982	61	8	patients	patient	NOUN
eshr-8982	61	9	with	with	ADP
eshr-8982	61	10	type	type	NOUN
eshr-8982	61	11	2	2	NUM
eshr-8982	61	12	dm	dm	NUM
eshr-8982	61	13	treated	treat	VERB
eshr-8982	61	14	at	at	ADP
eshr-8982	61	15	the	the	DET
eshr-8982	61	16	diabetics	diabetic	NOUN
eshr-8982	61	17	clinic	clinic	NOUN
eshr-8982	61	18	centre	centre	NOUN
eshr-8982	61	19	at	at	ADP
eshr-8982	61	20	taksin	taksin	NOUN
eshr-8982	61	21	hospital	hospital	NOUN
eshr-8982	61	22	in	in	ADP
eshr-8982	61	23	bangkok	bangkok	PROPN
eshr-8982	61	24	,	,	PUNCT
eshr-8982	61	25	thailand	thailand	PROPN
eshr-8982	62	1	i	i	PROPN
eshr-8982	62	2	medical	medical	ADJ
eshr-8982	62	3	record	record	VERB
eshr-8982	62	4	a	a	DET
eshr-8982	62	5	baseline	baseline	ADJ
eshr-8982	62	6	characteristics	characteristic	NOUN
eshr-8982	62	7	of	of	ADP
eshr-8982	62	8	training	training	NOUN
eshr-8982	62	9	and	and	CCONJ
eshr-8982	62	10	validation	validation	NOUN
eshr-8982	62	11	data	datum	NOUN
eshr-8982	62	12	sets	set	NOUN
eshr-8982	62	13	were	be	AUX
eshr-8982	62	14	compared	compare	VERB
eshr-8982	62	15	using	use	VERB
eshr-8982	62	16	student	student	NOUN
eshr-8982	62	17	's	's	PART
eshr-8982	62	18	t	t	NOUN
eshr-8982	62	19	-	-	PUNCT
eshr-8982	62	20	test	test	NOUN
eshr-8982	62	21	or	or	CCONJ
eshr-8982	62	22	mann	mann	PROPN
eshr-8982	62	23	-	-	PUNCT
eshr-8982	62	24	whitney	whitney	PROPN
eshr-8982	62	25	.	.	PUNCT
eshr-8982	63	1	wilcoxon	wilcoxon	PROPN
eshr-8982	63	2	test	test	NOUN
eshr-8982	63	3	for	for	ADP
eshr-8982	63	4	continuous	continuous	ADJ
eshr-8982	63	5	variables	variable	NOUN
eshr-8982	63	6	and	and	CCONJ
eshr-8982	63	7	chi	chi	ADJ
eshr-8982	63	8	-	-	PUNCT
eshr-8982	63	9	square	square	ADJ
eshr-8982	63	10	test	test	NOUN
eshr-8982	63	11	for	for	ADP
eshr-8982	63	12	categorical	categorical	ADJ
eshr-8982	63	13	variables	variable	NOUN
eshr-8982	63	14	3	3	NUM
eshr-8982	63	15	austin	austin	PROPN
eshr-8982	63	16	g.	g.	PROPN
eshr-8982	63	17	stack	stack	VERB
eshr-8982	63	18	et	et	PROPN
eshr-8982	63	19	al	al	PROPN
eshr-8982	63	20	.	.	PROPN
eshr-8982	63	21	2021	2021	NUM
eshr-8982	63	22	effect	effect	NOUN
eshr-8982	63	23	of	of	ADP
eshr-8982	63	24	intensive	intensive	ADJ
eshr-8982	63	25	urate	urate	NOUN
eshr-8982	63	26	lowering	lower	VERB
eshr-8982	63	27	with	with	ADP
eshr-8982	63	28	combined	combined	ADJ
eshr-8982	63	29	d	d	PROPN
eshr-8982	63	30	multicenter	multicenter	NOUN
eshr-8982	63	31	,	,	PUNCT
eshr-8982	63	32	prospective	prospective	ADJ
eshr-8982	63	33	,	,	PUNCT
eshr-8982	63	34	randomized	randomize	VERB
eshr-8982	63	35	,	,	PUNCT
eshr-8982	63	36	doubleblinded	doubleblinde	VERB
eshr-8982	63	37	,	,	PUNCT
eshr-8982	63	38	parallel	parallel	NOUN
eshr-8982	63	39	-	-	PUNCT
eshr-8982	63	40	group	group	NOUN
eshr-8982	63	41	,	,	PUNCT
eshr-8982	63	42	placebo	placebo	NOUN
eshr-8982	63	43	-	-	PUNCT
eshr-8982	63	44	controlled	control	VERB
eshr-8982	63	45	trial	trial	NOUN
eshr-8982	63	46	the	the	DET
eshr-8982	63	47	study	study	NOUN
eshr-8982	63	48	met	meet	VERB
eshr-8982	63	49	the	the	DET
eshr-8982	63	50	primary	primary	ADJ
eshr-8982	63	51	objective	objective	NOUN
eshr-8982	63	52	with	with	ADP
eshr-8982	63	53	a	a	DET
eshr-8982	63	54	reduction	reduction	NOUN
eshr-8982	63	55	in	in	ADP
eshr-8982	63	56	uacr	uacr	NOUN
eshr-8982	63	57	from	from	ADP
eshr-8982	63	58	baseline	baseline	NOUN
eshr-8982	63	59	at	at	ADP
eshr-8982	63	60	12	12	NUM
eshr-8982	63	61	s	s	NOUN
eshr-8982	63	62	purposive	purposive	NOUN
eshr-8982	63	63	sampling	sampling	NOUN
eshr-8982	63	64	;	;	PUNCT
eshr-8982	63	65	https://doi.org/10.26555/eshr.v3i1.3629	https://doi.org/10.26555/eshr.v3i1.3629	PROPN
eshr-8982	63	66	https://doi.org/10.26555/eshr.v3i1.3629	https://doi.org/10.26555/eshr.v3i1.3629	PROPN
eshr-8982	63	67	purtaria	purtaria	PROPN
eshr-8982	63	68	et	et	PROPN
eshr-8982	63	69	al	al	PROPN
eshr-8982	63	70	.	.	PUNCT
eshr-8982	64	1	(	(	PUNCT
eshr-8982	64	2	the	the	DET
eshr-8982	64	3	importance	importance	NOUN
eshr-8982	64	4	of	of	ADP
eshr-8982	64	5	uacr	uacr	NOUN
eshr-8982	64	6	(	(	PUNCT
eshr-8982	64	7	urinary	urinary	ADJ
eshr-8982	64	8	albumin	albumin	ADJ
eshr-8982	64	9	creatinine	creatinine	NOUN
eshr-8982	64	10	ratio	ratio	NOUN
eshr-8982	64	11	)	)	PUNCT
eshr-8982	64	12	examination	examination	NOUN
eshr-8982	64	13	in	in	ADP
eshr-8982	64	14	patients	patient	NOUN
eshr-8982	64	15	)	)	PUNCT
eshr-8982	64	16	…	…	PUNCT
eshr-8982	64	17	.	.	PUNCT
eshr-8982	65	1	78	78	NUM
eshr-8982	65	2	vol	vol	NOUN
eshr-8982	65	3	.	.	PROPN
eshr-8982	66	1	6	6	NUM
eshr-8982	66	2	,	,	PUNCT
eshr-8982	66	3	no	no	INTJ
eshr-8982	66	4	.	.	NOUN
eshr-8982	66	5	2	2	NUM
eshr-8982	66	6	,	,	PUNCT
eshr-8982	66	7	2024	2024	NUM
eshr-8982	66	8	,	,	PUNCT
eshr-8982	66	9	pp	pp	ADJ
eshr-8982	66	10	.	.	PUNCT
eshr-8982	67	1	74	74	NUM
eshr-8982	67	2	-	-	SYM
eshr-8982	67	3	86	86	NUM
eshr-8982	67	4	10.26555	10.26555	NUM
eshr-8982	67	5	/	/	SYM
eshr-8982	67	6	eshr.v6i2.8982	eshr.v6i2.8982	PUNCT
eshr-8982	67	7	no	no	DET
eshr-8982	67	8	author	author	NOUN
eshr-8982	67	9	year	year	NOUN
eshr-8982	67	10	title	title	NOUN
eshr-8982	67	11	methods	method	NOUN
eshr-8982	67	12	(	(	PUNCT
eshr-8982	67	13	design	design	NOUN
eshr-8982	67	14	,	,	PUNCT
eshr-8982	67	15	samples	sample	NOUN
eshr-8982	67	16	,	,	PUNCT
eshr-8982	67	17	variables	variable	NOUN
eshr-8982	67	18	,	,	PUNCT
eshr-8982	67	19	instrument	instrument	NOUN
eshr-8982	67	20	,	,	PUNCT
eshr-8982	67	21	analysis	analysis	NOUN
eshr-8982	67	22	)	)	PUNCT
eshr-8982	67	23	results	result	VERB
eshr-8982	67	24	verinurad	verinurad	NOUN
eshr-8982	67	25	and	and	CCONJ
eshr-8982	67	26	febuxostat	febuxostat	NOUN
eshr-8982	67	27	on	on	ADP
eshr-8982	67	28	albuminuria	albuminuria	NOUN
eshr-8982	67	29	in	in	ADP
eshr-8982	67	30	patients	patient	NOUN
eshr-8982	67	31	with	with	ADP
eshr-8982	67	32	type	type	NOUN
eshr-8982	67	33	2	2	NUM
eshr-8982	67	34	diabetes	diabetes	NOUN
eshr-8982	67	35	:	:	PUNCT
eshr-8982	67	36	a	a	DET
eshr-8982	67	37	randomized	randomized	ADJ
eshr-8982	67	38	trial.11	trial.11	PROPN
eshr-8982	67	39	v	v	ADP
eshr-8982	67	40	adults	adult	NOUN
eshr-8982	67	41	18	18	NUM
eshr-8982	67	42	years	year	NOUN
eshr-8982	67	43	or	or	CCONJ
eshr-8982	67	44	older	old	ADJ
eshr-8982	67	45	with	with	ADP
eshr-8982	67	46	t2	t2	NOUN
eshr-8982	67	47	dm	dm	NUM
eshr-8982	67	48	weeks	week	NOUN
eshr-8982	67	49	for	for	ADP
eshr-8982	67	50	verinurad	verinurad	NOUN
eshr-8982	67	51	plus	plus	CCONJ
eshr-8982	67	52	febuxostat	febuxostat	NOUN
eshr-8982	67	53	versus	versus	ADP
eshr-8982	67	54	placebo	placebo	NOUN
eshr-8982	67	55	i	i	PRON
eshr-8982	67	56	medical	medical	ADJ
eshr-8982	67	57	record	record	VERB
eshr-8982	67	58	a	a	DET
eshr-8982	67	59	standard	standard	ADJ
eshr-8982	67	60	descriptive	descriptive	ADJ
eshr-8982	67	61	statistics	statistic	NOUN
eshr-8982	67	62	4	4	NUM
eshr-8982	67	63	yuxian	yuxian	ADJ
eshr-8982	67	64	xie	xie	PROPN
eshr-8982	67	65	et	et	PROPN
eshr-8982	67	66	al	al	PROPN
eshr-8982	67	67	.	.	PROPN
eshr-8982	67	68	2022	2022	NUM
eshr-8982	67	69	assessment	assessment	NOUN
eshr-8982	67	70	of	of	ADP
eshr-8982	67	71	urinary	urinary	ADJ
eshr-8982	67	72	podocalyxin	podocalyxin	NOUN
eshr-8982	67	73	as	as	ADP
eshr-8982	67	74	an	an	DET
eshr-8982	67	75	alternative	alternative	ADJ
eshr-8982	67	76	marker	marker	NOUN
eshr-8982	67	77	for	for	ADP
eshr-8982	67	78	urinary	urinary	ADJ
eshr-8982	67	79	albumin	albumin	ADJ
eshr-8982	67	80	creatinine	creatinine	NOUN
eshr-8982	67	81	ratio	ratio	NOUN
eshr-8982	67	82	in	in	ADP
eshr-8982	67	83	the	the	DET
eshr-8982	67	84	early	early	ADJ
eshr-8982	67	85	stage	stage	NOUN
eshr-8982	67	86	of	of	ADP
eshr-8982	67	87	diabetic	diabetic	ADJ
eshr-8982	67	88	kidney	kidney	NOUN
eshr-8982	67	89	disease	disease	NOUN
eshr-8982	67	90	in	in	ADP
eshr-8982	67	91	older	old	ADJ
eshr-8982	67	92	patients.12	patients.12	NOUN
eshr-8982	67	93	d	d	PROPN
eshr-8982	67	94	correlational	correlational	ADJ
eshr-8982	67	95	studies	study	NOUN
eshr-8982	67	96	the	the	DET
eshr-8982	67	97	correlation	correlation	NOUN
eshr-8982	67	98	coefficient	coefficient	NOUN
eshr-8982	67	99	between	between	ADP
eshr-8982	67	100	pcx	pcx	PROPN
eshr-8982	67	101	(	(	PUNCT
eshr-8982	67	102	podocaxin	podocaxin	NOUN
eshr-8982	67	103	)	)	PUNCT
eshr-8982	67	104	and	and	CCONJ
eshr-8982	67	105	acr	acr	PROPN
eshr-8982	67	106	(	(	PUNCT
eshr-8982	67	107	albumin	albumin	ADJ
eshr-8982	67	108	creatinine	creatinine	NOUN
eshr-8982	67	109	ratio	ratio	NOUN
eshr-8982	67	110	)	)	PUNCT
eshr-8982	67	111	is	be	AUX
eshr-8982	67	112	0.852	0.852	NUM
eshr-8982	67	113	.	.	PUNCT
eshr-8982	68	1	based	base	VERB
eshr-8982	68	2	on	on	ADP
eshr-8982	68	3	the	the	DET
eshr-8982	68	4	roc	roc	PROPN
eshr-8982	68	5	curve	curve	NOUN
eshr-8982	68	6	analysis	analysis	NOUN
eshr-8982	68	7	,	,	PUNCT
eshr-8982	68	8	pcx	pcx	PROPN
eshr-8982	68	9	's	's	PART
eshr-8982	68	10	area	area	NOUN
eshr-8982	68	11	under	under	ADP
eshr-8982	68	12	the	the	DET
eshr-8982	68	13	roc	roc	PROPN
eshr-8982	68	14	(	(	PUNCT
eshr-8982	68	15	receiving	receive	VERB
eshr-8982	68	16	operator	operator	NOUN
eshr-8982	68	17	characteristic	characteristic	NOUN
eshr-8982	68	18	)	)	PUNCT
eshr-8982	68	19	curve	curve	NOUN
eshr-8982	68	20	is	be	AUX
eshr-8982	68	21	0.946	0.946	NUM
eshr-8982	68	22	;	;	PUNCT
eshr-8982	68	23	the	the	DET
eshr-8982	68	24	cutoff	cutoff	NOUN
eshr-8982	68	25	is	be	AUX
eshr-8982	68	26	3.09	3.09	NUM
eshr-8982	68	27	.	.	PUNCT
eshr-8982	69	1	finally	finally	ADV
eshr-8982	69	2	,	,	PUNCT
eshr-8982	69	3	the	the	DET
eshr-8982	69	4	sensitivity	sensitivity	NOUN
eshr-8982	69	5	and	and	CCONJ
eshr-8982	69	6	specificity	specificity	NOUN
eshr-8982	69	7	are	be	AUX
eshr-8982	69	8	0.84	0.84	NUM
eshr-8982	69	9	and	and	CCONJ
eshr-8982	69	10	0.91	0.91	NUM
eshr-8982	69	11	,	,	PUNCT
eshr-8982	69	12	respectively	respectively	ADV
eshr-8982	69	13	.	.	PUNCT
eshr-8982	70	1	132	132	NUM
eshr-8982	70	2	cases	case	NOUN
eshr-8982	70	3	of	of	ADP
eshr-8982	70	4	dkd	dkd	ADJ
eshr-8982	70	5	(	(	PUNCT
eshr-8982	70	6	diabetic	diabetic	ADJ
eshr-8982	70	7	kidney	kidney	NOUN
eshr-8982	70	8	disease	disease	NOUN
eshr-8982	70	9	)	)	PUNCT
eshr-8982	70	10	diagnosed	diagnose	VERB
eshr-8982	70	11	with	with	ADP
eshr-8982	70	12	acr	acr	PROPN
eshr-8982	70	13	;	;	PUNCT
eshr-8982	70	14	among	among	ADP
eshr-8982	70	15	them	they	PRON
eshr-8982	70	16	,	,	PUNCT
eshr-8982	70	17	pcx	pcx	PROPN
eshr-8982	70	18	predicted	predict	VERB
eshr-8982	70	19	104	104	NUM
eshr-8982	70	20	cases	case	NOUN
eshr-8982	70	21	of	of	ADP
eshr-8982	70	22	dkd	dkd	ADJ
eshr-8982	70	23	.	.	PUNCT
eshr-8982	71	1	the	the	DET
eshr-8982	71	2	percentage	percentage	NOUN
eshr-8982	71	3	correction	correction	NOUN
eshr-8982	71	4	value	value	NOUN
eshr-8982	71	5	was	be	AUX
eshr-8982	71	6	78.8	78.8	NUM
eshr-8982	71	7	%	%	NOUN
eshr-8982	71	8	s	s	PART
eshr-8982	71	9	purposive	purposive	NOUN
eshr-8982	71	10	sampling	sampling	NOUN
eshr-8982	71	11	;	;	PUNCT
eshr-8982	71	12	v	v	X
eshr-8982	71	13	type	type	NOUN
eshr-8982	71	14	2	2	NUM
eshr-8982	71	15	dm	dm	NOUN
eshr-8982	71	16	with	with	ADP
eshr-8982	71	17	no	no	DET
eshr-8982	71	18	history	history	NOUN
eshr-8982	71	19	of	of	ADP
eshr-8982	71	20	diabetic	diabetic	ADJ
eshr-8982	71	21	kidney	kidney	NOUN
eshr-8982	71	22	diseases	disease	NOUN
eshr-8982	71	23	i	i	PRON
eshr-8982	71	24	medical	medical	ADJ
eshr-8982	71	25	record	record	VERB
eshr-8982	71	26	a	a	DET
eshr-8982	71	27	kruskal	kruskal	NOUN
eshr-8982	71	28	–	–	PUNCT
eshr-8982	71	29	wallis	wallis	PROPN
eshr-8982	71	30	,	,	PUNCT
eshr-8982	71	31	one	one	NUM
eshr-8982	71	32	-	-	PUNCT
eshr-8982	71	33	way	way	NOUN
eshr-8982	71	34	anova	anova	X
eshr-8982	71	35	and	and	CCONJ
eshr-8982	71	36	spearman	spearman	NOUN
eshr-8982	71	37	test	test	NOUN
eshr-8982	71	38	5	5	NUM
eshr-8982	71	39	natalia	natalia	PROPN
eshr-8982	71	40	nowak	nowak	PROPN
eshr-8982	71	41	et	et	PROPN
eshr-8982	71	42	al	al	PROPN
eshr-8982	71	43	.	.	PROPN
eshr-8982	71	44	2018	2018	NUM
eshr-8982	71	45	markers	marker	NOUN
eshr-8982	71	46	of	of	ADP
eshr-8982	71	47	early	early	ADJ
eshr-8982	71	48	progressive	progressive	ADJ
eshr-8982	71	49	renal	renal	ADJ
eshr-8982	71	50	decline	decline	NOUN
eshr-8982	71	51	in	in	ADP
eshr-8982	71	52	type	type	NOUN
eshr-8982	71	53	2	2	NUM
eshr-8982	71	54	diabetes	diabetes	NOUN
eshr-8982	71	55	suggest	suggest	VERB
eshr-8982	71	56	different	different	ADJ
eshr-8982	71	57	implications	implication	NOUN
eshr-8982	71	58	for	for	ADP
eshr-8982	71	59	etiological	etiological	ADJ
eshr-8982	71	60	studies	study	NOUN
eshr-8982	71	61	and	and	CCONJ
eshr-8982	71	62	prognostic	prognostic	ADJ
eshr-8982	71	63	test	test	NOUN
eshr-8982	71	64	development.13	development.13	NOUN
eshr-8982	71	65	d	d	SCONJ
eshr-8982	71	66	comparative	comparative	ADJ
eshr-8982	71	67	study	study	NOUN
eshr-8982	71	68	acr	acr	PROPN
eshr-8982	71	69	remained	remained	AUX
eshr-8982	71	70	independently	independently	ADV
eshr-8982	71	71	associated	associate	VERB
eshr-8982	71	72	with	with	ADP
eshr-8982	71	73	an	an	DET
eshr-8982	71	74	increased	increase	VERB
eshr-8982	71	75	risk	risk	NOUN
eshr-8982	71	76	of	of	ADP
eshr-8982	71	77	the	the	DET
eshr-8982	71	78	development	development	NOUN
eshr-8982	71	79	of	of	ADP
eshr-8982	71	80	early	early	ADJ
eshr-8982	71	81	renal	renal	ADJ
eshr-8982	71	82	decline	decline	NOUN
eshr-8982	71	83	.	.	PUNCT
eshr-8982	72	1	s	s	VERB
eshr-8982	72	2	purposive	purposive	ADJ
eshr-8982	72	3	sampling	sampling	NOUN
eshr-8982	72	4	;	;	PUNCT
eshr-8982	72	5	v	v	ADP
eshr-8982	72	6	1368	1368	NUM
eshr-8982	72	7	patients	patient	NOUN
eshr-8982	72	8	with	with	ADP
eshr-8982	72	9	t2d	t2d	CCONJ
eshr-8982	72	10	attending	attend	VERB
eshr-8982	72	11	the	the	DET
eshr-8982	72	12	joslin	joslin	PROPN
eshr-8982	72	13	clinic	clinic	NOUN
eshr-8982	72	14	between	between	ADP
eshr-8982	72	15	2003	2003	NUM
eshr-8982	72	16	and	and	CCONJ
eshr-8982	72	17	2009	2009	NUM
eshr-8982	72	18	i	i	PRON
eshr-8982	72	19	medical	medical	ADJ
eshr-8982	72	20	record	record	NOUN
eshr-8982	72	21	a	a	DET
eshr-8982	72	22	wilcoxon	wilcoxon	ADJ
eshr-8982	72	23	rank	rank	NOUN
eshr-8982	72	24	and	and	CCONJ
eshr-8982	72	25	regression	regression	VERB
eshr-8982	72	26	linear	linear	PROPN
eshr-8982	72	27	6	6	NUM
eshr-8982	72	28	takaya	takaya	NOUN
eshr-8982	72	29	sasaki	sasaki	PROPN
eshr-8982	72	30	et	et	PROPN
eshr-8982	72	31	al	al	PROPN
eshr-8982	72	32	.	.	PROPN
eshr-8982	72	33	2021	2021	NUM
eshr-8982	72	34	pathologic	pathologic	ADJ
eshr-8982	72	35	diabetic	diabetic	NOUN
eshr-8982	73	1	d	d	X
eshr-8982	73	2	longitudinal	longitudinal	ADJ
eshr-8982	73	3	study	study	VERB
eshr-8982	73	4	the	the	DET
eshr-8982	73	5	frequency	frequency	NOUN
eshr-8982	73	6	of	of	ADP
eshr-8982	73	7	the	the	DET
eshr-8982	73	8	duration	duration	NOUN
eshr-8982	73	9	of	of	ADP
eshr-8982	73	10	s	s	PRON
eshr-8982	73	11	purposive	purposive	NOUN
eshr-8982	73	12	sampling	sampling	NOUN
eshr-8982	73	13	;	;	PUNCT
eshr-8982	73	14	https://doi.org/10.26555/eshr.v3i1.3629	https://doi.org/10.26555/eshr.v3i1.3629	PROPN
eshr-8982	73	15	https://doi.org/10.26555/eshr.v3i1.3629	https://doi.org/10.26555/eshr.v3i1.3629	PROPN
eshr-8982	73	16	purtaria	purtaria	PROPN
eshr-8982	73	17	et	et	PROPN
eshr-8982	73	18	al	al	PROPN
eshr-8982	73	19	.	.	PUNCT
eshr-8982	74	1	(	(	PUNCT
eshr-8982	74	2	the	the	DET
eshr-8982	74	3	importance	importance	NOUN
eshr-8982	74	4	of	of	ADP
eshr-8982	74	5	uacr	uacr	NOUN
eshr-8982	74	6	(	(	PUNCT
eshr-8982	74	7	urinary	urinary	ADJ
eshr-8982	74	8	albumin	albumin	ADJ
eshr-8982	74	9	creatinine	creatinine	NOUN
eshr-8982	74	10	ratio	ratio	NOUN
eshr-8982	74	11	)	)	PUNCT
eshr-8982	74	12	examination	examination	NOUN
eshr-8982	74	13	in	in	ADP
eshr-8982	74	14	patients	patient	NOUN
eshr-8982	74	15	)	)	PUNCT
eshr-8982	74	16	…	…	PUNCT
eshr-8982	74	17	.	.	PUNCT
eshr-8982	75	1	79	79	NUM
eshr-8982	75	2	vol	vol	NOUN
eshr-8982	75	3	.	.	PROPN
eshr-8982	76	1	6	6	NUM
eshr-8982	76	2	,	,	PUNCT
eshr-8982	76	3	no	no	INTJ
eshr-8982	76	4	.	.	NOUN
eshr-8982	76	5	2	2	NUM
eshr-8982	76	6	,	,	PUNCT
eshr-8982	76	7	2024	2024	NUM
eshr-8982	76	8	,	,	PUNCT
eshr-8982	76	9	pp	pp	ADJ
eshr-8982	76	10	.	.	PUNCT
eshr-8982	77	1	74	74	NUM
eshr-8982	77	2	-	-	SYM
eshr-8982	77	3	86	86	NUM
eshr-8982	77	4	10.26555	10.26555	NUM
eshr-8982	77	5	/	/	SYM
eshr-8982	77	6	eshr.v6i2.8982	eshr.v6i2.8982	PUNCT
eshr-8982	77	7	no	no	DET
eshr-8982	77	8	author	author	NOUN
eshr-8982	77	9	year	year	NOUN
eshr-8982	77	10	title	title	NOUN
eshr-8982	77	11	methods	method	NOUN
eshr-8982	77	12	(	(	PUNCT
eshr-8982	77	13	design	design	NOUN
eshr-8982	77	14	,	,	PUNCT
eshr-8982	77	15	samples	sample	NOUN
eshr-8982	77	16	,	,	PUNCT
eshr-8982	77	17	variables	variable	NOUN
eshr-8982	77	18	,	,	PUNCT
eshr-8982	77	19	instrument	instrument	NOUN
eshr-8982	77	20	,	,	PUNCT
eshr-8982	77	21	analysis	analysis	NOUN
eshr-8982	77	22	)	)	PUNCT
eshr-8982	77	23	results	result	VERB
eshr-8982	77	24	nephropathy	nephropathy	NOUN
eshr-8982	77	25	in	in	ADP
eshr-8982	77	26	autopsied	autopsie	VERB
eshr-8982	77	27	diabetic	diabetic	ADJ
eshr-8982	77	28	cases	case	NOUN
eshr-8982	77	29	with	with	ADP
eshr-8982	77	30	normo	normo	NOUN
eshr-8982	77	31	albuminuria	albuminuria	NOUN
eshr-8982	77	32	from	from	ADP
eshr-8982	77	33	a	a	DET
eshr-8982	77	34	japanese	japanese	PROPN
eshr-8982	77	35	communitybased	communitybase	VERB
eshr-8982	77	36	study.14	study.14	PROPN
eshr-8982	77	37	v	v	ADP
eshr-8982	77	38	used	use	VERB
eshr-8982	77	39	autopsy	autopsy	ADJ
eshr-8982	77	40	specimens	specimen	NOUN
eshr-8982	77	41	obtained	obtain	VERB
eshr-8982	77	42	from	from	ADP
eshr-8982	77	43	deceased	deceased	ADJ
eshr-8982	77	44	people	people	NOUN
eshr-8982	77	45	in	in	ADP
eshr-8982	77	46	the	the	DET
eshr-8982	77	47	town	town	NOUN
eshr-8982	77	48	of	of	ADP
eshr-8982	77	49	hisayama	hisayama	NOUN
eshr-8982	77	50	from	from	ADP
eshr-8982	77	51	july	july	PROPN
eshr-8982	77	52	2002	2002	NUM
eshr-8982	77	53	to	to	ADP
eshr-8982	77	54	november	november	PROPN
eshr-8982	77	55	2017	2017	NUM
eshr-8982	77	56	diabetes	diabetes	NOUN
eshr-8982	77	57	mellitus	mellitus	NOUN
eshr-8982	77	58	is>5	is>5	PROPN
eshr-8982	77	59	years	year	NOUN
eshr-8982	77	60	,	,	PUNCT
eshr-8982	77	61	increasing	increase	VERB
eshr-8982	77	62	uacr	uacr	ADV
eshr-8982	77	63	(	(	PUNCT
eshr-8982	77	64	urinary	urinary	ADJ
eshr-8982	77	65	albumin	albumin	ADJ
eshr-8982	77	66	creatinine	creatinine	NOUN
eshr-8982	77	67	ratio	ratio	NOUN
eshr-8982	77	68	)	)	PUNCT
eshr-8982	77	69	levels	level	NOUN
eshr-8982	77	70	.	.	PUNCT
eshr-8982	78	1	diabetic	diabetic	ADJ
eshr-8982	78	2	cases	case	NOUN
eshr-8982	78	3	with	with	ADP
eshr-8982	78	4	class	class	NOUN
eshr-8982	78	5	iia	iia	NOUN
eshr-8982	78	6	or	or	CCONJ
eshr-8982	78	7	higher	high	ADJ
eshr-8982	78	8	glomerular	glomerular	ADJ
eshr-8982	78	9	dn	dn	PROPN
eshr-8982	78	10	(	(	PUNCT
eshr-8982	78	11	diabetic	diabetic	ADJ
eshr-8982	78	12	nephropathy	nephropathy	NOUN
eshr-8982	78	13	)	)	PUNCT
eshr-8982	78	14	lesions	lesion	NOUN
eshr-8982	78	15	increased	increase	VERB
eshr-8982	78	16	significantly	significantly	ADV
eshr-8982	78	17	with	with	ADP
eshr-8982	78	18	increasing	increase	VERB
eshr-8982	78	19	uacr	uacr	ADJ
eshr-8982	78	20	levels	level	NOUN
eshr-8982	78	21	i	i	PRON
eshr-8982	78	22	data	data	VERB
eshr-8982	78	23	autopsy	autopsy	VERB
eshr-8982	78	24	a	a	DET
eshr-8982	78	25	linear	linear	ADJ
eshr-8982	78	26	regression	regression	NOUN
eshr-8982	78	27	analysis	analysis	NOUN
eshr-8982	78	28	7	7	NUM
eshr-8982	78	29	ze	ze	NOUN
eshr-8982	78	30	wang	wang	PROPN
eshr-8982	78	31	et	et	PROPN
eshr-8982	78	32	al	al	PROPN
eshr-8982	78	33	.	.	PROPN
eshr-8982	78	34	2023	2023	NUM
eshr-8982	78	35	the	the	DET
eshr-8982	78	36	positive	positive	ADJ
eshr-8982	78	37	association	association	NOUN
eshr-8982	78	38	between	between	ADP
eshr-8982	78	39	urinary	urinary	ADJ
eshr-8982	78	40	albumincreatinine	albumincreatinine	NOUN
eshr-8982	78	41	ratio	ratio	NOUN
eshr-8982	78	42	and	and	CCONJ
eshr-8982	78	43	lower	low	ADJ
eshr-8982	78	44	extremity	extremity	NOUN
eshr-8982	78	45	peripheral	peripheral	ADJ
eshr-8982	78	46	arterial	arterial	ADJ
eshr-8982	78	47	disease	disease	NOUN
eshr-8982	78	48	in	in	ADP
eshr-8982	78	49	chinese	chinese	ADJ
eshr-8982	78	50	diabetes	diabetes	NOUN
eshr-8982	78	51	patients	patient	NOUN
eshr-8982	78	52	:	:	PUNCT
eshr-8982	78	53	a	a	DET
eshr-8982	78	54	crosssection	crosssection	NOUN
eshr-8982	78	55	study	study	NOUN
eshr-8982	78	56	with	with	ADP
eshr-8982	78	57	propensity	propensity	NOUN
eshr-8982	78	58	score	score	NOUN
eshr-8982	78	59	matching	match	VERB
eshr-8982	78	60	analysis.6	analysis.6	PROPN
eshr-8982	78	61	d	d	PROPN
eshr-8982	78	62	cross	cross	ADJ
eshr-8982	78	63	-	-	ADJ
eshr-8982	78	64	sectional	sectional	ADJ
eshr-8982	78	65	study	study	NOUN
eshr-8982	78	66	elevated	elevate	VERB
eshr-8982	78	67	urinary	urinary	ADJ
eshr-8982	78	68	acr	acr	NOUN
eshr-8982	78	69	level	level	NOUN
eshr-8982	78	70	was	be	AUX
eshr-8982	78	71	associated	associate	VERB
eshr-8982	78	72	with	with	ADP
eshr-8982	78	73	decreased	decrease	VERB
eshr-8982	78	74	abi	abi	PROPN
eshr-8982	78	75	(	(	PUNCT
eshr-8982	78	76	ankle	ankle	NOUN
eshr-8982	78	77	-	-	PUNCT
eshr-8982	78	78	brachial	brachial	ADJ
eshr-8982	78	79	index	index	NOUN
eshr-8982	78	80	)	)	PUNCT
eshr-8982	78	81	in	in	ADP
eshr-8982	78	82	patients	patient	NOUN
eshr-8982	78	83	with	with	ADP
eshr-8982	78	84	diabetes	diabetes	NOUN
eshr-8982	78	85	.	.	PUNCT
eshr-8982	79	1	therefore	therefore	ADV
eshr-8982	79	2	,	,	PUNCT
eshr-8982	79	3	elevated	elevated	ADJ
eshr-8982	79	4	urinary	urinary	ADJ
eshr-8982	79	5	acr	acr	PROPN
eshr-8982	79	6	was	be	AUX
eshr-8982	79	7	associated	associate	VERB
eshr-8982	79	8	with	with	ADP
eshr-8982	79	9	pad	pad	NOUN
eshr-8982	79	10	(	(	PUNCT
eshr-8982	79	11	peripheral	peripheral	ADJ
eshr-8982	79	12	arterial	arterial	ADJ
eshr-8982	79	13	disease	disease	NOUN
eshr-8982	79	14	)	)	PUNCT
eshr-8982	79	15	in	in	ADP
eshr-8982	79	16	chinese	chinese	ADJ
eshr-8982	79	17	patients	patient	NOUN
eshr-8982	79	18	with	with	ADP
eshr-8982	79	19	diabetes	diabetes	NOUN
eshr-8982	79	20	.	.	PUNCT
eshr-8982	80	1	s	s	VERB
eshr-8982	80	2	purposive	purposive	ADJ
eshr-8982	80	3	sampling	sampling	NOUN
eshr-8982	80	4	;	;	PUNCT
eshr-8982	80	5	v	v	NUM
eshr-8982	80	6	patients	patient	NOUN
eshr-8982	80	7	were	be	AUX
eshr-8982	80	8	diagnosed	diagnose	VERB
eshr-8982	80	9	with	with	ADP
eshr-8982	80	10	diabetes	diabete	NOUN
eshr-8982	80	11	according	accord	VERB
eshr-8982	80	12	to	to	ADP
eshr-8982	80	13	the	the	DET
eshr-8982	80	14	world	world	PROPN
eshr-8982	80	15	health	health	PROPN
eshr-8982	80	16	organization	organization	NOUN
eshr-8982	80	17	criteria	criterion	NOUN
eshr-8982	80	18	defined	define	VERB
eshr-8982	80	19	over	over	ADP
eshr-8982	80	20	18	18	NUM
eshr-8982	80	21	years	year	NOUN
eshr-8982	80	22	.	.	PUNCT
eshr-8982	81	1	i	i	PRON
eshr-8982	81	2	laboratory	laboratory	NOUN
eshr-8982	81	3	data	data	VERB
eshr-8982	81	4	a	a	DET
eshr-8982	81	5	fisher	fisher	NOUN
eshr-8982	81	6	's	's	PART
eshr-8982	81	7	exact	exact	ADJ
eshr-8982	81	8	tests	test	NOUN
eshr-8982	81	9	or	or	CCONJ
eshr-8982	81	10	chi	chi	ADJ
eshr-8982	81	11	-	-	PUNCT
eshr-8982	81	12	square	square	ADJ
eshr-8982	81	13	tests	test	NOUN
eshr-8982	81	14	,	,	PUNCT
eshr-8982	81	15	t	t	NOUN
eshr-8982	81	16	-	-	PUNCT
eshr-8982	81	17	tests	test	NOUN
eshr-8982	81	18	and	and	CCONJ
eshr-8982	81	19	one	one	NUM
eshr-8982	81	20	-	-	PUNCT
eshr-8982	81	21	way	way	NOUN
eshr-8982	81	22	anova	anova	PROPN
eshr-8982	81	23	analysis	analysis	NOUN
eshr-8982	81	24	,	,	PUNCT
eshr-8982	81	25	mann	mann	PROPN
eshr-8982	81	26	whitney	whitney	PROPN
eshr-8982	81	27	u	u	PROPN
eshr-8982	81	28	tests	test	VERB
eshr-8982	81	29	and	and	CCONJ
eshr-8982	81	30	kruskalwallis	kruskalwalli	VERB
eshr-8982	81	31	tests	test	NOUN
eshr-8982	81	32	,	,	PUNCT
eshr-8982	81	33	multivariate	multivariate	NOUN
eshr-8982	81	34	logistic	logistic	ADJ
eshr-8982	81	35	regression	regression	NOUN
eshr-8982	81	36	analysis	analysis	NOUN
eshr-8982	81	37	8	8	NUM
eshr-8982	81	38	wai	wai	PROPN
eshr-8982	81	39	kin	kin	PROPN
eshr-8982	81	40	chan	chan	PROPN
eshr-8982	81	41	et	et	PROPN
eshr-8982	81	42	al	al	PROPN
eshr-8982	81	43	.	.	PROPN
eshr-8982	81	44	2021	2021	NUM
eshr-8982	81	45	association	association	NOUN
eshr-8982	81	46	between	between	ADP
eshr-8982	81	47	serum	serum	NOUN
eshr-8982	81	48	bilirubin	bilirubin	NOUN
eshr-8982	81	49	levels	level	NOUN
eshr-8982	81	50	and	and	CCONJ
eshr-8982	81	51	progression	progression	NOUN
eshr-8982	81	52	of	of	ADP
eshr-8982	81	53	albuminuria	albuminuria	PROPN
eshr-8982	81	54	in	in	ADP
eshr-8982	81	55	taiwanese	taiwanese	PROPN
eshr-8982	81	56	with	with	ADP
eshr-8982	81	57	type	type	NOUN
eshr-8982	81	58	2	2	NUM
eshr-8982	81	59	diabetes	diabetes	NOUN
eshr-8982	81	60	mellitus.15	mellitus.15	NOUN
eshr-8982	81	61	d	d	ADP
eshr-8982	81	62	longitudinal	longitudinal	ADJ
eshr-8982	81	63	study	study	VERB
eshr-8982	81	64	a	a	DET
eshr-8982	81	65	significant	significant	ADJ
eshr-8982	81	66	association	association	NOUN
eshr-8982	81	67	was	be	AUX
eshr-8982	81	68	observed	observe	VERB
eshr-8982	81	69	between	between	ADP
eshr-8982	81	70	the	the	DET
eshr-8982	81	71	uacrs	uacr	NOUN
eshr-8982	81	72	at	at	ADP
eshr-8982	81	73	baseline	baseline	NOUN
eshr-8982	81	74	and	and	CCONJ
eshr-8982	81	75	the	the	DET
eshr-8982	81	76	serum	serum	NOUN
eshr-8982	81	77	bil	bil	NUM
eshr-8982	81	78	groups	group	NOUN
eshr-8982	81	79	(	(	PUNCT
eshr-8982	81	80	p	p	X
eshr-8982	81	81	<	<	X
eshr-8982	81	82	0.001	0.001	NUM
eshr-8982	81	83	)	)	PUNCT
eshr-8982	81	84	s	s	VERB
eshr-8982	81	85	purposive	purposive	ADJ
eshr-8982	81	86	sampling	sampling	NOUN
eshr-8982	81	87	;	;	PUNCT
eshr-8982	81	88	v	v	X
eshr-8982	81	89	patients	patient	NOUN
eshr-8982	81	90	diagnosed	diagnose	VERB
eshr-8982	81	91	with	with	ADP
eshr-8982	81	92	type	type	NOUN
eshr-8982	81	93	2	2	NUM
eshr-8982	81	94	diabetes	diabete	NOUN
eshr-8982	81	95	,	,	PUNCT
eshr-8982	81	96	according	accord	VERB
eshr-8982	81	97	to	to	ADP
eshr-8982	81	98	the	the	DET
eshr-8982	81	99	9th	9th	ADJ
eshr-8982	81	100	version	version	NOUN
eshr-8982	81	101	of	of	ADP
eshr-8982	81	102	the	the	DET
eshr-8982	81	103	international	international	ADJ
eshr-8982	81	104	classification	classification	NOUN
eshr-8982	81	105	of	of	ADP
eshr-8982	81	106	diseases	disease	NOUN
eshr-8982	81	107	,	,	PUNCT
eshr-8982	81	108	clinical	clinical	ADJ
eshr-8982	81	109	modification	modification	NOUN
eshr-8982	81	110	i	i	PRON
eshr-8982	81	111	database	database	VERB
eshr-8982	81	112	medical	medical	ADJ
eshr-8982	81	113	records	record	NOUN
eshr-8982	81	114	from	from	ADP
eshr-8982	81	115	chang	chang	PROPN
eshr-8982	81	116	gung	gung	PROPN
eshr-8982	81	117	memorial	memorial	ADJ
eshr-8982	81	118	hospital	hospital	NOUN
eshr-8982	81	119	(	(	PUNCT
eshr-8982	81	120	cgmh	cgmh	PROPN
eshr-8982	81	121	)	)	PUNCT
eshr-8982	81	122	a	a	DET
eshr-8982	81	123	anova	anova	PROPN
eshr-8982	81	124	9	9	NUM
eshr-8982	81	125	lin	lin	PROPN
eshr-8982	81	126	hou	hou	PROPN
eshr-8982	81	127	et	et	PROPN
eshr-8982	81	128	al	al	PROPN
eshr-8982	81	129	.	.	PROPN
eshr-8982	81	130	2020	2020	NUM
eshr-8982	81	131	associations	association	NOUN
eshr-8982	81	132	of	of	ADP
eshr-8982	81	133	serum	serum	NOUN
eshr-8982	81	134	uric	uric	ADJ
eshr-8982	81	135	acid	acid	NOUN
eshr-8982	81	136	level	level	NOUN
eshr-8982	81	137	with	with	ADP
eshr-8982	81	138	diabetic	diabetic	ADJ
eshr-8982	81	139	d	d	ADP
eshr-8982	81	140	retrospective	retrospective	ADJ
eshr-8982	81	141	analysis	analysis	NOUN
eshr-8982	81	142	study	study	NOUN
eshr-8982	81	143	uacr	uacr	PROPN
eshr-8982	81	144	identified	identify	VERB
eshr-8982	81	145	as	as	ADP
eshr-8982	81	146	a	a	DET
eshr-8982	81	147	risk	risk	NOUN
eshr-8982	81	148	factor	factor	NOUN
eshr-8982	81	149	for	for	ADP
eshr-8982	81	150	s	s	NOUN
eshr-8982	81	151	purposive	purposive	ADJ
eshr-8982	81	152	sampling	sampling	NOUN
eshr-8982	81	153	;	;	PUNCT
eshr-8982	81	154	https://doi.org/10.26555/eshr.v3i1.3629	https://doi.org/10.26555/eshr.v3i1.3629	PROPN
eshr-8982	81	155	https://doi.org/10.26555/eshr.v3i1.3629	https://doi.org/10.26555/eshr.v3i1.3629	PROPN
eshr-8982	81	156	purtaria	purtaria	PROPN
eshr-8982	81	157	et	et	PROPN
eshr-8982	81	158	al	al	PROPN
eshr-8982	81	159	.	.	PUNCT
eshr-8982	82	1	(	(	PUNCT
eshr-8982	82	2	the	the	DET
eshr-8982	82	3	importance	importance	NOUN
eshr-8982	82	4	of	of	ADP
eshr-8982	82	5	uacr	uacr	NOUN
eshr-8982	82	6	(	(	PUNCT
eshr-8982	82	7	urinary	urinary	ADJ
eshr-8982	82	8	albumin	albumin	ADJ
eshr-8982	82	9	creatinine	creatinine	NOUN
eshr-8982	82	10	ratio	ratio	NOUN
eshr-8982	82	11	)	)	PUNCT
eshr-8982	82	12	examination	examination	NOUN
eshr-8982	82	13	in	in	ADP
eshr-8982	82	14	patients	patient	NOUN
eshr-8982	82	15	)	)	PUNCT
eshr-8982	82	16	…	…	PUNCT
eshr-8982	82	17	.	.	PUNCT
eshr-8982	83	1	80	80	NUM
eshr-8982	83	2	vol	vol	NOUN
eshr-8982	83	3	.	.	PROPN
eshr-8982	84	1	6	6	NUM
eshr-8982	84	2	,	,	PUNCT
eshr-8982	84	3	no	no	INTJ
eshr-8982	84	4	.	.	NOUN
eshr-8982	84	5	2	2	NUM
eshr-8982	84	6	,	,	PUNCT
eshr-8982	84	7	2024	2024	NUM
eshr-8982	84	8	,	,	PUNCT
eshr-8982	84	9	pp	pp	ADJ
eshr-8982	84	10	.	.	PUNCT
eshr-8982	85	1	74	74	NUM
eshr-8982	85	2	-	-	SYM
eshr-8982	85	3	86	86	NUM
eshr-8982	85	4	10.26555	10.26555	NUM
eshr-8982	85	5	/	/	SYM
eshr-8982	85	6	eshr.v6i2.8982	eshr.v6i2.8982	PUNCT
eshr-8982	85	7	no	no	DET
eshr-8982	85	8	author	author	NOUN
eshr-8982	85	9	year	year	NOUN
eshr-8982	85	10	title	title	NOUN
eshr-8982	85	11	methods	method	NOUN
eshr-8982	85	12	(	(	PUNCT
eshr-8982	85	13	design	design	NOUN
eshr-8982	85	14	,	,	PUNCT
eshr-8982	85	15	samples	sample	NOUN
eshr-8982	85	16	,	,	PUNCT
eshr-8982	85	17	variables	variable	NOUN
eshr-8982	85	18	,	,	PUNCT
eshr-8982	85	19	instrument	instrument	NOUN
eshr-8982	85	20	,	,	PUNCT
eshr-8982	85	21	analysis	analysis	NOUN
eshr-8982	85	22	)	)	PUNCT
eshr-8982	85	23	results	result	VERB
eshr-8982	85	24	retinopathy	retinopathy	ADJ
eshr-8982	85	25	and	and	CCONJ
eshr-8982	85	26	albuminuria	albuminuria	NOUN
eshr-8982	85	27	in	in	ADP
eshr-8982	85	28	patients	patient	NOUN
eshr-8982	85	29	with	with	ADP
eshr-8982	85	30	type	type	NOUN
eshr-8982	85	31	2	2	NUM
eshr-8982	85	32	diabetes	diabetes	NOUN
eshr-8982	85	33	mellitus.7	mellitus.7	NOUN
eshr-8982	85	34	v	v	ADP
eshr-8982	85	35	patients	patient	NOUN
eshr-8982	85	36	with	with	ADP
eshr-8982	85	37	type	type	NOUN
eshr-8982	85	38	2	2	NUM
eshr-8982	85	39	dm	dm	NOUN
eshr-8982	85	40	(	(	PUNCT
eshr-8982	85	41	aged	aged	ADJ
eshr-8982	85	42	21	21	NUM
eshr-8982	85	43	to	to	PART
eshr-8982	85	44	85	85	NUM
eshr-8982	85	45	years	year	NOUN
eshr-8982	85	46	)	)	PUNCT
eshr-8982	85	47	who	who	PRON
eshr-8982	85	48	underwent	undergo	VERB
eshr-8982	85	49	treatment	treatment	NOUN
eshr-8982	85	50	from	from	ADP
eshr-8982	85	51	march	march	PROPN
eshr-8982	85	52	2017	2017	NUM
eshr-8982	85	53	to	to	ADP
eshr-8982	85	54	september	september	PROPN
eshr-8982	85	55	2017	2017	NUM
eshr-8982	85	56	at	at	ADP
eshr-8982	85	57	the	the	DET
eshr-8982	85	58	department	department	NOUN
eshr-8982	85	59	of	of	ADP
eshr-8982	85	60	endocrinology	endocrinology	NOUN
eshr-8982	85	61	,	,	PUNCT
eshr-8982	85	62	shandong	shandong	PROPN
eshr-8982	85	63	provincial	provincial	ADJ
eshr-8982	85	64	hospital	hospital	NOUN
eshr-8982	85	65	affiliated	affiliate	VERB
eshr-8982	85	66	with	with	ADP
eshr-8982	85	67	shandong	shandong	PROPN
eshr-8982	85	68	university	university	PROPN
eshr-8982	85	69	.	.	PUNCT
eshr-8982	86	1	diabetic	diabetic	ADJ
eshr-8982	86	2	retinopathy	retinopathy	ADJ
eshr-8982	86	3	(	(	PUNCT
eshr-8982	86	4	dr	dr	PROPN
eshr-8982	86	5	)	)	PUNCT
eshr-8982	86	6	i	i	PRON
eshr-8982	86	7	clinical	clinical	ADJ
eshr-8982	86	8	record	record	NOUN
eshr-8982	86	9	data	datum	NOUN
eshr-8982	86	10	a	a	DET
eshr-8982	86	11	multivariate	multivariate	NOUN
eshr-8982	86	12	logistic	logistic	ADJ
eshr-8982	86	13	regression	regression	NOUN
eshr-8982	86	14	analysis	analysis	NOUN
eshr-8982	86	15	10	10	NUM
eshr-8982	86	16	kazuo	kazuo	PROPN
eshr-8982	86	17	kobayashi	kobayashi	PROPN
eshr-8982	86	18	et	et	PROPN
eshr-8982	86	19	al	al	PROPN
eshr-8982	86	20	.	.	PROPN
eshr-8982	87	1	2019	2019	NUM
eshr-8982	87	2	retrospective	retrospective	ADJ
eshr-8982	87	3	analysis	analysis	NOUN
eshr-8982	87	4	of	of	ADP
eshr-8982	87	5	effects	effect	NOUN
eshr-8982	87	6	of	of	ADP
eshr-8982	87	7	sodium	sodium	NOUN
eshr-8982	87	8	-	-	PUNCT
eshr-8982	87	9	glucose	glucose	NOUN
eshr-8982	87	10	co	co	NOUN
eshr-8982	87	11	-	-	NOUN
eshr-8982	87	12	transporter	transporter	ADJ
eshr-8982	87	13	2	2	NUM
eshr-8982	87	14	inhibitors	inhibitor	NOUN
eshr-8982	87	15	in	in	ADP
eshr-8982	87	16	japanese	japanese	ADJ
eshr-8982	87	17	type	type	NOUN
eshr-8982	87	18	2	2	NUM
eshr-8982	87	19	diabetes	diabetes	NOUN
eshr-8982	87	20	mellitus	mellitus	NOUN
eshr-8982	87	21	patients	patient	NOUN
eshr-8982	87	22	with	with	ADP
eshr-8982	87	23	chronic	chronic	ADJ
eshr-8982	87	24	kidney	kidney	NOUN
eshr-8982	87	25	disease.16	disease.16	PROPN
eshr-8982	87	26	d	d	NOUN
eshr-8982	87	27	retrospective	retrospective	ADJ
eshr-8982	87	28	study	study	NOUN
eshr-8982	87	29	acr	acr	PROPN
eshr-8982	87	30	correlated	correlate	VERB
eshr-8982	87	31	significantly	significantly	ADV
eshr-8982	87	32	with	with	ADP
eshr-8982	87	33	age	age	NOUN
eshr-8982	87	34	and	and	CCONJ
eshr-8982	87	35	bp	bp	PROPN
eshr-8982	87	36	s	s	PART
eshr-8982	87	37	purposive	purposive	ADJ
eshr-8982	87	38	sampling	sampling	NOUN
eshr-8982	87	39	;	;	PUNCT
eshr-8982	87	40	v	v	ADP
eshr-8982	87	41	935	935	NUM
eshr-8982	87	42	t2	t2	NOUN
eshr-8982	87	43	dm	dm	NOUN
eshr-8982	87	44	patients	patient	NOUN
eshr-8982	87	45	who	who	PRON
eshr-8982	87	46	were	be	AUX
eshr-8982	87	47	registered	register	VERB
eshr-8982	87	48	and	and	CCONJ
eshr-8982	87	49	visited	visit	VERB
eshr-8982	87	50	the	the	DET
eshr-8982	87	51	clinics	clinic	NOUN
eshr-8982	87	52	of	of	ADP
eshr-8982	87	53	members	member	NOUN
eshr-8982	87	54	of	of	ADP
eshr-8982	87	55	the	the	DET
eshr-8982	87	56	kanagawa	kanagawa	PROPN
eshr-8982	87	57	physicians	physicians	PROPN
eshr-8982	87	58	association	association	PROPN
eshr-8982	87	59	between	between	ADP
eshr-8982	87	60	november	november	PROPN
eshr-8982	87	61	2016	2016	NUM
eshr-8982	87	62	and	and	CCONJ
eshr-8982	87	63	march	march	PROPN
eshr-8982	87	64	2017	2017	NUM
eshr-8982	87	65	i	i	PRON
eshr-8982	87	66	clinical	clinical	ADJ
eshr-8982	87	67	record	record	NOUN
eshr-8982	87	68	data	datum	NOUN
eshr-8982	87	69	a	a	DET
eshr-8982	87	70	multiple	multiple	ADJ
eshr-8982	87	71	linear	linear	ADJ
eshr-8982	87	72	regression	regression	NOUN
eshr-8982	87	73	analysis	analysis	NOUN
eshr-8982	87	74	note	note	NOUN
eshr-8982	87	75	:	:	PUNCT
eshr-8982	87	76	d	d	X
eshr-8982	87	77	for	for	ADP
eshr-8982	87	78	desain	desain	NOUN
eshr-8982	87	79	;	;	PUNCT
eshr-8982	87	80	s	s	X
eshr-8982	87	81	for	for	ADP
eshr-8982	87	82	sampel	sampel	NOUN
eshr-8982	87	83	;	;	PUNCT
eshr-8982	87	84	v	v	NOUN
eshr-8982	87	85	for	for	ADP
eshr-8982	87	86	variables	variable	NOUN
eshr-8982	87	87	;	;	PUNCT
eshr-8982	87	88	i	i	PRON
eshr-8982	87	89	for	for	ADP
eshr-8982	87	90	instrument	instrument	NOUN
eshr-8982	87	91	;	;	PUNCT
eshr-8982	87	92	a	a	PRON
eshr-8982	87	93	for	for	ADP
eshr-8982	87	94	analysis	analysis	NOUN
eshr-8982	87	95	.	.	PUNCT
eshr-8982	88	1	based	base	VERB
eshr-8982	88	2	on	on	ADP
eshr-8982	88	3	the	the	DET
eshr-8982	88	4	article	article	NOUN
eshr-8982	88	5	included	include	VERB
eshr-8982	88	6	(	(	PUNCT
eshr-8982	88	7	n=10	n=10	NOUN
eshr-8982	88	8	)	)	PUNCT
eshr-8982	88	9	,	,	PUNCT
eshr-8982	88	10	it	it	PRON
eshr-8982	88	11	was	be	AUX
eshr-8982	88	12	found	find	VERB
eshr-8982	88	13	that	that	SCONJ
eshr-8982	88	14	acr	acr	PROPN
eshr-8982	88	15	levels	level	NOUN
eshr-8982	88	16	were	be	AUX
eshr-8982	88	17	associated	associate	VERB
eshr-8982	88	18	with	with	ADP
eshr-8982	88	19	cardiovascular	cardiovascular	ADJ
eshr-8982	88	20	risk	risk	NOUN
eshr-8982	88	21	in	in	ADP
eshr-8982	88	22	people	people	NOUN
eshr-8982	88	23	with	with	ADP
eshr-8982	88	24	dm	dm	PROPN
eshr-8982	88	25	.	.	PUNCT
eshr-8982	88	26	high	high	ADJ
eshr-8982	88	27	levels	level	NOUN
eshr-8982	88	28	of	of	ADP
eshr-8982	88	29	uacr	uacr	PROPN
eshr-8982	88	30	are	be	AUX
eshr-8982	88	31	also	also	ADV
eshr-8982	88	32	associated	associate	VERB
eshr-8982	88	33	with	with	ADP
eshr-8982	88	34	an	an	DET
eshr-8982	88	35	increased	increase	VERB
eshr-8982	88	36	risk	risk	NOUN
eshr-8982	88	37	of	of	ADP
eshr-8982	88	38	ckd	ckd	PROPN
eshr-8982	88	39	.	.	PUNCT
eshr-8982	89	1	acr	acr	PROPN
eshr-8982	89	2	levels	level	NOUN
eshr-8982	89	3	are	be	AUX
eshr-8982	89	4	also	also	ADV
eshr-8982	89	5	influenced	influence	VERB
eshr-8982	89	6	by	by	ADP
eshr-8982	89	7	the	the	DET
eshr-8982	89	8	time	time	NOUN
eshr-8982	89	9	the	the	DET
eshr-8982	89	10	patient	patient	NOUN
eshr-8982	89	11	has	have	VERB
eshr-8982	89	12	diabetes	diabetes	NOUN
eshr-8982	89	13	.	.	PUNCT
eshr-8982	90	1	therefore	therefore	ADV
eshr-8982	90	2	,	,	PUNCT
eshr-8982	90	3	an	an	DET
eshr-8982	90	4	acr	acr	NOUN
eshr-8982	90	5	examination	examination	NOUN
eshr-8982	90	6	is	be	AUX
eshr-8982	90	7	essential	essential	ADJ
eshr-8982	90	8	for	for	ADP
eshr-8982	90	9	diabetic	diabetic	ADJ
eshr-8982	90	10	patients	patient	NOUN
eshr-8982	90	11	.	.	PUNCT
eshr-8982	91	1	chronic	chronic	ADJ
eshr-8982	91	2	kidney	kidney	NOUN
eshr-8982	91	3	disease	disease	NOUN
eshr-8982	91	4	(	(	PUNCT
eshr-8982	91	5	ckd	ckd	NOUN
eshr-8982	91	6	)	)	PUNCT
eshr-8982	91	7	is	be	AUX
eshr-8982	91	8	a	a	DET
eshr-8982	91	9	clinical	clinical	ADJ
eshr-8982	91	10	illness	illness	NOUN
eshr-8982	91	11	indicated	indicate	VERB
eshr-8982	91	12	by	by	ADP
eshr-8982	91	13	long	long	ADJ
eshr-8982	91	14	-	-	PUNCT
eshr-8982	91	15	term	term	NOUN
eshr-8982	91	16	changes	change	NOUN
eshr-8982	91	17	in	in	ADP
eshr-8982	91	18	renal	renal	ADJ
eshr-8982	91	19	structure	structure	NOUN
eshr-8982	91	20	or	or	CCONJ
eshr-8982	91	21	function	function	NOUN
eshr-8982	91	22	,	,	PUNCT
eshr-8982	91	23	as	as	ADV
eshr-8982	91	24	well	well	ADV
eshr-8982	91	25	as	as	ADP
eshr-8982	91	26	a	a	DET
eshr-8982	91	27	persistent	persistent	ADJ
eshr-8982	91	28	deterioration	deterioration	NOUN
eshr-8982	91	29	in	in	ADP
eshr-8982	91	30	glomerular	glomerular	ADJ
eshr-8982	91	31	filtration	filtration	NOUN
eshr-8982	91	32	.	.	PUNCT
eshr-8982	92	1	suppose	suppose	VERB
eshr-8982	92	2	the	the	DET
eshr-8982	92	3	underlying	underlie	VERB
eshr-8982	92	4	condition	condition	NOUN
eshr-8982	92	5	needs	need	VERB
eshr-8982	92	6	to	to	PART
eshr-8982	92	7	be	be	AUX
eshr-8982	92	8	addressed	address	VERB
eshr-8982	92	9	promptly	promptly	ADV
eshr-8982	92	10	.	.	PUNCT
eshr-8982	93	1	in	in	ADP
eshr-8982	93	2	that	that	DET
eshr-8982	93	3	case	case	NOUN
eshr-8982	93	4	,	,	PUNCT
eshr-8982	93	5	it	it	PRON
eshr-8982	93	6	advances	advance	VERB
eshr-8982	93	7	to	to	ADP
eshr-8982	93	8	end	end	VERB
eshr-8982	93	9	-	-	PUNCT
eshr-8982	93	10	stage	stage	NOUN
eshr-8982	93	11	renal	renal	ADJ
eshr-8982	93	12	disease	disease	NOUN
eshr-8982	93	13	(	(	PUNCT
eshr-8982	93	14	esrd	esrd	PROPN
eshr-8982	93	15	)	)	PUNCT
eshr-8982	93	16	,	,	PUNCT
eshr-8982	93	17	which	which	PRON
eshr-8982	93	18	imposes	impose	VERB
eshr-8982	93	19	a	a	DET
eshr-8982	93	20	significant	significant	ADJ
eshr-8982	93	21	healthcare	healthcare	NOUN
eshr-8982	93	22	cost	cost	NOUN
eshr-8982	93	23	on	on	ADP
eshr-8982	93	24	the	the	DET
eshr-8982	93	25	patient	patient	NOUN
eshr-8982	93	26	and	and	CCONJ
eshr-8982	93	27	family	family	NOUN
eshr-8982	93	28	,	,	PUNCT
eshr-8982	93	29	as	as	ADV
eshr-8982	93	30	well	well	ADV
eshr-8982	93	31	as	as	ADP
eshr-8982	93	32	a	a	DET
eshr-8982	93	33	financial	financial	ADJ
eshr-8982	93	34	burden	burden	NOUN
eshr-8982	93	35	on	on	ADP
eshr-8982	93	36	the	the	DET
eshr-8982	93	37	country.17	country.17	NOUN
eshr-8982	93	38	the	the	DET
eshr-8982	93	39	egfr	egfr	NOUN
eshr-8982	93	40	and	and	CCONJ
eshr-8982	93	41	acr	acr	PROPN
eshr-8982	93	42	are	be	AUX
eshr-8982	93	43	frequently	frequently	ADV
eshr-8982	93	44	tested	test	VERB
eshr-8982	93	45	risk	risk	NOUN
eshr-8982	93	46	factors	factor	NOUN
eshr-8982	93	47	for	for	ADP
eshr-8982	93	48	renal	renal	ADJ
eshr-8982	93	49	and	and	CCONJ
eshr-8982	93	50	cardiovascular	cardiovascular	ADJ
eshr-8982	93	51	outcomes	outcome	NOUN
eshr-8982	93	52	.	.	PUNCT
eshr-8982	94	1	the	the	DET
eshr-8982	94	2	finding	finding	NOUN
eshr-8982	94	3	that	that	SCONJ
eshr-8982	94	4	these	these	DET
eshr-8982	94	5	risk	risk	NOUN
eshr-8982	94	6	variables	variable	NOUN
eshr-8982	94	7	were	be	AUX
eshr-8982	94	8	not	not	PART
eshr-8982	94	9	linearly	linearly	ADV
eshr-8982	94	10	associated	associate	VERB
eshr-8982	94	11	with	with	ADP
eshr-8982	94	12	these	these	DET
eshr-8982	94	13	outcomes	outcome	NOUN
eshr-8982	94	14	and	and	CCONJ
eshr-8982	94	15	were	be	AUX
eshr-8982	94	16	not	not	PART
eshr-8982	94	17	independent	independent	ADJ
eshr-8982	94	18	of	of	ADP
eshr-8982	94	19	one	one	NUM
eshr-8982	94	20	another	another	DET
eshr-8982	94	21	in	in	ADP
eshr-8982	94	22	predicting	predict	VERB
eshr-8982	94	23	mace	mace	NOUN
eshr-8982	94	24	and	and	CCONJ
eshr-8982	94	25	mortality	mortality	NOUN
eshr-8982	94	26	stresses	stress	VERB
eshr-8982	94	27	their	their	PRON
eshr-8982	94	28	complicated	complicated	ADJ
eshr-8982	94	29	connection	connection	NOUN
eshr-8982	94	30	with	with	ADP
eshr-8982	94	31	each	each	DET
eshr-8982	94	32	other	other	ADJ
eshr-8982	94	33	else	else	ADV
eshr-8982	94	34	and	and	CCONJ
eshr-8982	94	35	to	to	ADP
eshr-8982	94	36	these	these	DET
eshr-8982	94	37	outcomes	outcome	NOUN
eshr-8982	94	38	.	.	PUNCT
eshr-8982	95	1	the	the	DET
eshr-8982	95	2	kdi	kdi	PROPN
eshr-8982	95	3	is	be	AUX
eshr-8982	95	4	a	a	DET
eshr-8982	95	5	combination	combination	NOUN
eshr-8982	95	6	of	of	ADP
eshr-8982	95	7	these	these	DET
eshr-8982	95	8	two	two	NUM
eshr-8982	95	9	risk	risk	NOUN
eshr-8982	95	10	variables	variable	NOUN
eshr-8982	95	11	.	.	PUNCT
eshr-8982	96	1	it	it	PRON
eshr-8982	96	2	incorporates	incorporate	VERB
eshr-8982	96	3	data	datum	NOUN
eshr-8982	96	4	from	from	ADP
eshr-8982	96	5	both	both	DET
eshr-8982	96	6	risk	risk	NOUN
eshr-8982	96	7	variables	variable	NOUN
eshr-8982	96	8	and	and	CCONJ
eshr-8982	96	9	has	have	VERB
eshr-8982	96	10	a	a	DET
eshr-8982	96	11	straightforward	straightforward	ADJ
eshr-8982	96	12	linear	linear	NOUN
eshr-8982	96	13	association	association	NOUN
eshr-8982	96	14	with	with	ADP
eshr-8982	96	15	all	all	DET
eshr-8982	96	16	three	three	NUM
eshr-8982	96	17	outcomes	outcome	NOUN
eshr-8982	96	18	.	.	PUNCT
eshr-8982	97	1	furthermore	furthermore	ADV
eshr-8982	97	2	,	,	PUNCT
eshr-8982	97	3	its	its	PRON
eshr-8982	97	4	ability	ability	NOUN
eshr-8982	97	5	to	to	PART
eshr-8982	97	6	predict	predict	VERB
eshr-8982	97	7	these	these	DET
eshr-8982	97	8	three	three	NUM
eshr-8982	97	9	outcomes	outcome	NOUN
eshr-8982	97	10	was	be	AUX
eshr-8982	97	11	comparable	comparable	ADJ
eshr-8982	97	12	to	to	ADP
eshr-8982	97	13	complicated	complicated	ADJ
eshr-8982	97	14	models	model	NOUN
eshr-8982	97	15	that	that	PRON
eshr-8982	97	16	contained	contain	VERB
eshr-8982	97	17	the	the	DET
eshr-8982	97	18	egfr	egfr	NOUN
eshr-8982	97	19	and	and	CCONJ
eshr-8982	97	20	acr	acr	PROPN
eshr-8982	97	21	,	,	PUNCT
eshr-8982	97	22	nonlinear	nonlinear	ADJ
eshr-8982	97	23	variables	variable	NOUN
eshr-8982	97	24	,	,	PUNCT
eshr-8982	97	25	and	and	CCONJ
eshr-8982	97	26	interaction	interaction	NOUN
eshr-8982	97	27	terms	term	NOUN
eshr-8982	97	28	.	.	PUNCT
eshr-8982	98	1	as	as	ADP
eshr-8982	98	2	a	a	DET
eshr-8982	98	3	result	result	NOUN
eshr-8982	98	4	,	,	PUNCT
eshr-8982	98	5	the	the	DET
eshr-8982	98	6	kdi	kdi	PROPN
eshr-8982	98	7	may	may	AUX
eshr-8982	98	8	make	make	VERB
eshr-8982	98	9	it	it	PRON
eshr-8982	98	10	easier	easy	ADJ
eshr-8982	98	11	to	to	PART
eshr-8982	98	12	identify	identify	VERB
eshr-8982	98	13	high	high	ADJ
eshr-8982	98	14	-	-	PUNCT
eshr-8982	98	15	risk	risk	NOUN
eshr-8982	98	16	patients	patient	NOUN
eshr-8982	98	17	who	who	PRON
eshr-8982	98	18	will	will	AUX
eshr-8982	98	19	benefit	benefit	VERB
eshr-8982	98	20	most	most	ADV
eshr-8982	98	21	from	from	ADP
eshr-8982	98	22	preventative	preventative	ADJ
eshr-8982	98	23	medicines	medicine	NOUN
eshr-8982	98	24	.	.	PUNCT
eshr-8982	99	1	future	future	ADJ
eshr-8982	99	2	https://doi.org/10.26555/eshr.v3i1.3629	https://doi.org/10.26555/eshr.v3i1.3629	PROPN
eshr-8982	99	3	https://doi.org/10.26555/eshr.v3i1.3629	https://doi.org/10.26555/eshr.v3i1.3629	PROPN
eshr-8982	99	4	purtaria	purtaria	PROPN
eshr-8982	99	5	et	et	PROPN
eshr-8982	99	6	al	al	PROPN
eshr-8982	99	7	.	.	PUNCT
eshr-8982	100	1	(	(	PUNCT
eshr-8982	100	2	the	the	DET
eshr-8982	100	3	importance	importance	NOUN
eshr-8982	100	4	of	of	ADP
eshr-8982	100	5	uacr	uacr	NOUN
eshr-8982	100	6	(	(	PUNCT
eshr-8982	100	7	urinary	urinary	ADJ
eshr-8982	100	8	albumin	albumin	ADJ
eshr-8982	100	9	creatinine	creatinine	NOUN
eshr-8982	100	10	ratio	ratio	NOUN
eshr-8982	100	11	)	)	PUNCT
eshr-8982	100	12	examination	examination	NOUN
eshr-8982	100	13	in	in	ADP
eshr-8982	100	14	patients	patient	NOUN
eshr-8982	100	15	)	)	PUNCT
eshr-8982	100	16	…	…	PUNCT
eshr-8982	100	17	.	.	PUNCT
eshr-8982	101	1	81	81	NUM
eshr-8982	101	2	vol	vol	NOUN
eshr-8982	101	3	.	.	PROPN
eshr-8982	102	1	6	6	NUM
eshr-8982	102	2	,	,	PUNCT
eshr-8982	102	3	no	no	INTJ
eshr-8982	102	4	.	.	NOUN
eshr-8982	102	5	2	2	NUM
eshr-8982	102	6	,	,	PUNCT
eshr-8982	102	7	2024	2024	NUM
eshr-8982	102	8	,	,	PUNCT
eshr-8982	102	9	pp	pp	ADJ
eshr-8982	102	10	.	.	PUNCT
eshr-8982	103	1	74	74	NUM
eshr-8982	103	2	-	-	SYM
eshr-8982	103	3	86	86	NUM
eshr-8982	103	4	10.26555	10.26555	NUM
eshr-8982	103	5	/	/	SYM
eshr-8982	103	6	eshr.v6i2.8982	eshr.v6i2.8982	NUM
eshr-8982	103	7	epidemiologic	epidemiologic	ADJ
eshr-8982	103	8	research	research	NOUN
eshr-8982	103	9	and	and	CCONJ
eshr-8982	103	10	clinical	clinical	ADJ
eshr-8982	103	11	trials	trial	NOUN
eshr-8982	103	12	should	should	AUX
eshr-8982	103	13	test	test	VERB
eshr-8982	103	14	and	and	CCONJ
eshr-8982	103	15	confirm	confirm	VERB
eshr-8982	103	16	its	its	PRON
eshr-8982	103	17	effectiveness	effectiveness	NOUN
eshr-8982	103	18	as	as	ADP
eshr-8982	103	19	a	a	DET
eshr-8982	103	20	risk	risk	NOUN
eshr-8982	103	21	stratification	stratification	NOUN
eshr-8982	103	22	tool.8	tool.8	DET
eshr-8982	103	23	patients	patient	NOUN
eshr-8982	103	24	should	should	AUX
eshr-8982	103	25	be	be	AUX
eshr-8982	103	26	educated	educate	VERB
eshr-8982	103	27	on	on	ADP
eshr-8982	103	28	how	how	SCONJ
eshr-8982	103	29	improved	improve	VERB
eshr-8982	103	30	blood	blood	NOUN
eshr-8982	103	31	glucose	glucose	NOUN
eshr-8982	103	32	and	and	CCONJ
eshr-8982	103	33	albuminuria	albuminuria	NOUN
eshr-8982	103	34	management	management	NOUN
eshr-8982	103	35	can	can	AUX
eshr-8982	103	36	help	help	VERB
eshr-8982	103	37	postpone	postpone	VERB
eshr-8982	103	38	the	the	DET
eshr-8982	103	39	development	development	NOUN
eshr-8982	103	40	of	of	ADP
eshr-8982	103	41	ckd	ckd	PROPN
eshr-8982	103	42	.	.	PUNCT
eshr-8982	104	1	empirical	empirical	ADJ
eshr-8982	104	2	data	datum	NOUN
eshr-8982	104	3	shows	show	VERB
eshr-8982	104	4	that	that	SCONJ
eshr-8982	104	5	estrogen	estrogen	NOUN
eshr-8982	104	6	has	have	VERB
eshr-8982	104	7	a	a	DET
eshr-8982	104	8	renoprotective	renoprotective	ADJ
eshr-8982	104	9	impact	impact	NOUN
eshr-8982	104	10	via	via	ADP
eshr-8982	104	11	lowering	lower	VERB
eshr-8982	104	12	albuminuria	albuminuria	PROPN
eshr-8982	104	13	.	.	PUNCT
eshr-8982	105	1	however	however	ADV
eshr-8982	105	2	,	,	PUNCT
eshr-8982	105	3	our	our	PRON
eshr-8982	105	4	investigation	investigation	NOUN
eshr-8982	105	5	found	find	VERB
eshr-8982	105	6	that	that	SCONJ
eshr-8982	105	7	the	the	DET
eshr-8982	105	8	male	male	ADJ
eshr-8982	105	9	sex	sex	NOUN
eshr-8982	105	10	had	have	VERB
eshr-8982	105	11	a	a	DET
eshr-8982	105	12	protective	protective	ADJ
eshr-8982	105	13	effect	effect	NOUN
eshr-8982	105	14	.	.	PUNCT
eshr-8982	106	1	our	our	PRON
eshr-8982	106	2	data	data	PROPN
eshr-8982	106	3	subgroup	subgroup	NOUN
eshr-8982	106	4	analysis	analysis	NOUN
eshr-8982	106	5	revealed	reveal	VERB
eshr-8982	106	6	that	that	SCONJ
eshr-8982	106	7	77	77	NUM
eshr-8982	106	8	%	%	NOUN
eshr-8982	106	9	of	of	ADP
eshr-8982	106	10	women	woman	NOUN
eshr-8982	106	11	were	be	AUX
eshr-8982	106	12	over	over	ADP
eshr-8982	106	13	50	50	NUM
eshr-8982	106	14	,	,	PUNCT
eshr-8982	106	15	compared	compare	VERB
eshr-8982	106	16	to	to	ADP
eshr-8982	106	17	65	65	NUM
eshr-8982	106	18	%	%	NOUN
eshr-8982	106	19	of	of	ADP
eshr-8982	106	20	men	man	NOUN
eshr-8982	106	21	(	(	PUNCT
eshr-8982	106	22	p	p	X
eshr-8982	106	23	,	,	PUNCT
eshr-8982	106	24	0.001	0.001	NUM
eshr-8982	106	25	)	)	PUNCT
eshr-8982	106	26	.	.	PUNCT
eshr-8982	107	1	this	this	PRON
eshr-8982	107	2	means	mean	VERB
eshr-8982	107	3	that	that	SCONJ
eshr-8982	107	4	most	most	ADJ
eshr-8982	107	5	female	female	ADJ
eshr-8982	107	6	patients	patient	NOUN
eshr-8982	107	7	were	be	AUX
eshr-8982	107	8	postmenopausal	postmenopausal	ADJ
eshr-8982	107	9	with	with	ADP
eshr-8982	107	10	low	low	ADJ
eshr-8982	107	11	estrogen	estrogen	NOUN
eshr-8982	107	12	levels	level	NOUN
eshr-8982	107	13	,	,	PUNCT
eshr-8982	107	14	negating	negate	VERB
eshr-8982	107	15	the	the	DET
eshr-8982	107	16	possible	possible	ADJ
eshr-8982	107	17	renoprotective	renoprotective	ADJ
eshr-8982	107	18	benefit	benefit	NOUN
eshr-8982	107	19	.	.	PUNCT
eshr-8982	108	1	uacr	uacr	PROPN
eshr-8982	108	2	examination	examination	NOUN
eshr-8982	108	3	can	can	AUX
eshr-8982	108	4	be	be	AUX
eshr-8982	108	5	done	do	VERB
eshr-8982	108	6	using	use	VERB
eshr-8982	108	7	dipsticks	dipstick	NOUN
eshr-8982	108	8	,	,	PUNCT
eshr-8982	108	9	making	make	VERB
eshr-8982	108	10	it	it	PRON
eshr-8982	108	11	easier	easy	ADJ
eshr-8982	108	12	for	for	ADP
eshr-8982	108	13	laboratories	laboratory	NOUN
eshr-8982	108	14	with	with	ADP
eshr-8982	108	15	limited	limited	ADJ
eshr-8982	108	16	equipment	equipment	NOUN
eshr-8982	108	17	.	.	PUNCT
eshr-8982	109	1	two	two	NUM
eshr-8982	109	2	stage-3	stage-3	NUM
eshr-8982	109	3	ckd	ckd	NOUN
eshr-8982	109	4	risk	risk	NOUN
eshr-8982	109	5	prediction	prediction	NOUN
eshr-8982	109	6	models	model	NOUN
eshr-8982	109	7	that	that	PRON
eshr-8982	109	8	used	use	VERB
eshr-8982	109	9	demographic	demographic	ADJ
eshr-8982	109	10	and	and	CCONJ
eshr-8982	109	11	laboratory	laboratory	NOUN
eshr-8982	109	12	characteristics	characteristic	NOUN
eshr-8982	109	13	as	as	SCONJ
eshr-8982	109	14	predictors	predictor	NOUN
eshr-8982	109	15	demonstrated	demonstrate	VERB
eshr-8982	109	16	intense	intense	ADJ
eshr-8982	109	17	discrimination	discrimination	NOUN
eshr-8982	109	18	and	and	CCONJ
eshr-8982	109	19	calibration	calibration	NOUN
eshr-8982	109	20	and	and	CCONJ
eshr-8982	109	21	were	be	AUX
eshr-8982	109	22	able	able	ADJ
eshr-8982	109	23	to	to	PART
eshr-8982	109	24	predict	predict	VERB
eshr-8982	109	25	the	the	DET
eshr-8982	109	26	3	3	NUM
eshr-8982	109	27	-	-	PUNCT
eshr-8982	109	28	year	year	NOUN
eshr-8982	109	29	risk	risk	NOUN
eshr-8982	109	30	of	of	ADP
eshr-8982	109	31	stage-3	stage-3	NUM
eshr-8982	109	32	ckd	ckd	NOUN
eshr-8982	109	33	in	in	ADP
eshr-8982	109	34	individuals	individual	NOUN
eshr-8982	109	35	with	with	ADP
eshr-8982	109	36	type	type	NOUN
eshr-8982	109	37	2	2	NUM
eshr-8982	109	38	diabetes	diabetes	NOUN
eshr-8982	109	39	.	.	PUNCT
eshr-8982	110	1	the	the	DET
eshr-8982	110	2	comprehensive	comprehensive	ADJ
eshr-8982	110	3	model	model	NOUN
eshr-8982	110	4	is	be	AUX
eshr-8982	110	5	appropriate	appropriate	ADJ
eshr-8982	110	6	for	for	ADP
eshr-8982	110	7	healthcare	healthcare	NOUN
eshr-8982	110	8	settings	setting	NOUN
eshr-8982	110	9	with	with	ADP
eshr-8982	110	10	extensive	extensive	ADJ
eshr-8982	110	11	laboratory	laboratory	NOUN
eshr-8982	110	12	testing	testing	NOUN
eshr-8982	110	13	,	,	PUNCT
eshr-8982	110	14	whereas	whereas	SCONJ
eshr-8982	110	15	the	the	DET
eshr-8982	110	16	simplified	simplified	ADJ
eshr-8982	110	17	model	model	NOUN
eshr-8982	110	18	is	be	AUX
eshr-8982	110	19	appropriate	appropriate	ADJ
eshr-8982	110	20	for	for	ADP
eshr-8982	110	21	primary	primary	ADJ
eshr-8982	110	22	care	care	NOUN
eshr-8982	110	23	settings	setting	NOUN
eshr-8982	110	24	with	with	ADP
eshr-8982	110	25	less	less	ADJ
eshr-8982	110	26	laboratory	laboratory	NOUN
eshr-8982	110	27	testing	testing	NOUN
eshr-8982	110	28	,	,	PUNCT
eshr-8982	110	29	including	include	VERB
eshr-8982	110	30	uacr	uacr	PROPN
eshr-8982	110	31	testing	testing	NOUN
eshr-8982	110	32	.	.	PUNCT
eshr-8982	111	1	these	these	DET
eshr-8982	111	2	stage-3	stage-3	NUM
eshr-8982	111	3	ckd	ckd	NOUN
eshr-8982	111	4	risk	risk	NOUN
eshr-8982	111	5	prediction	prediction	NOUN
eshr-8982	111	6	models	model	NOUN
eshr-8982	111	7	provide	provide	VERB
eshr-8982	111	8	tools	tool	NOUN
eshr-8982	111	9	for	for	SCONJ
eshr-8982	111	10	healthcare	healthcare	NOUN
eshr-8982	111	11	professionals	professional	NOUN
eshr-8982	111	12	to	to	PART
eshr-8982	111	13	screen	screen	VERB
eshr-8982	111	14	for	for	ADP
eshr-8982	111	15	the	the	DET
eshr-8982	111	16	risk	risk	NOUN
eshr-8982	111	17	of	of	ADP
eshr-8982	111	18	developing	develop	VERB
eshr-8982	111	19	stage-3	stage-3	NUM
eshr-8982	111	20	ckd	ckd	PROPN
eshr-8982	111	21	,	,	PUNCT
eshr-8982	111	22	allowing	allow	VERB
eshr-8982	111	23	for	for	ADP
eshr-8982	111	24	earlier	early	ADJ
eshr-8982	111	25	identification	identification	NOUN
eshr-8982	111	26	,	,	PUNCT
eshr-8982	111	27	and	and	CCONJ
eshr-8982	111	28	they	they	PRON
eshr-8982	111	29	assist	assist	VERB
eshr-8982	111	30	healthcare	healthcare	NOUN
eshr-8982	111	31	providers	provider	NOUN
eshr-8982	111	32	in	in	ADP
eshr-8982	111	33	adopting	adopt	VERB
eshr-8982	111	34	treatments	treatment	NOUN
eshr-8982	111	35	to	to	PART
eshr-8982	111	36	slow	slow	VERB
eshr-8982	111	37	ckd	ckd	PROPN
eshr-8982	111	38	development.10	development.10	PROPN
eshr-8982	111	39	previous	previous	ADJ
eshr-8982	111	40	research	research	NOUN
eshr-8982	111	41	also	also	ADV
eshr-8982	111	42	found	find	VERB
eshr-8982	111	43	that	that	SCONJ
eshr-8982	111	44	acr	acr	PROPN
eshr-8982	111	45	can	can	AUX
eshr-8982	111	46	improve	improve	VERB
eshr-8982	111	47	the	the	DET
eshr-8982	111	48	prediction	prediction	NOUN
eshr-8982	111	49	of	of	ADP
eshr-8982	111	50	early	early	ADJ
eshr-8982	111	51	symptoms	symptom	NOUN
eshr-8982	111	52	of	of	ADP
eshr-8982	111	53	dkd	dkd	ADJ
eshr-8982	111	54	(	(	PUNCT
eshr-8982	111	55	diabetic	diabetic	ADJ
eshr-8982	111	56	kidney	kidney	NOUN
eshr-8982	111	57	disease	disease	NOUN
eshr-8982	111	58	)	)	PUNCT
eshr-8982	111	59	.	.	PUNCT
eshr-8982	112	1	18	18	NUM
eshr-8982	112	2	this	this	PRON
eshr-8982	112	3	aligns	align	VERB
eshr-8982	112	4	with	with	ADP
eshr-8982	112	5	another	another	DET
eshr-8982	112	6	research	research	NOUN
eshr-8982	112	7	,	,	PUNCT
eshr-8982	112	8	which	which	PRON
eshr-8982	112	9	states	state	VERB
eshr-8982	112	10	that	that	SCONJ
eshr-8982	112	11	uacr	uacr	PROPN
eshr-8982	112	12	levels	level	NOUN
eshr-8982	112	13	can	can	AUX
eshr-8982	112	14	predict	predict	VERB
eshr-8982	112	15	a	a	DET
eshr-8982	112	16	decrease	decrease	NOUN
eshr-8982	112	17	in	in	ADP
eshr-8982	112	18	kidney	kidney	NOUN
eshr-8982	112	19	function	function	VERB
eshr-8982	112	20	early	early	ADV
eshr-8982	112	21	on	on	ADV
eshr-8982	112	22	in	in	ADP
eshr-8982	112	23	diabetics	diabetic	NOUN
eshr-8982	112	24	.	.	PUNCT
eshr-8982	113	1	13	13	NUM
eshr-8982	113	2	another	another	DET
eshr-8982	113	3	observable	observable	ADJ
eshr-8982	113	4	marker	marker	NOUN
eshr-8982	113	5	besides	besides	SCONJ
eshr-8982	113	6	uacr	uacr	NOUN
eshr-8982	113	7	is	be	AUX
eshr-8982	113	8	blood	blood	NOUN
eshr-8982	113	9	pressure	pressure	NOUN
eshr-8982	113	10	,	,	PUNCT
eshr-8982	113	11	where	where	SCONJ
eshr-8982	113	12	blood	blood	NOUN
eshr-8982	113	13	pressure	pressure	NOUN
eshr-8982	113	14	and	and	CCONJ
eshr-8982	113	15	uacr	uacr	AUX
eshr-8982	113	16	correlate	correlate	VERB
eshr-8982	113	17	with	with	ADP
eshr-8982	113	18	early	early	ADJ
eshr-8982	113	19	decline	decline	NOUN
eshr-8982	113	20	in	in	ADP
eshr-8982	113	21	kidney	kidney	NOUN
eshr-8982	113	22	function	function	NOUN
eshr-8982	113	23	.	.	PUNCT
eshr-8982	114	1	in	in	ADP
eshr-8982	114	2	many	many	ADJ
eshr-8982	114	3	countries	country	NOUN
eshr-8982	114	4	,	,	PUNCT
eshr-8982	114	5	dn	dn	PROPN
eshr-8982	114	6	accounts	account	VERB
eshr-8982	114	7	for	for	ADP
eshr-8982	114	8	around	around	ADP
eshr-8982	114	9	half	half	NOUN
eshr-8982	114	10	of	of	ADP
eshr-8982	114	11	all	all	DET
eshr-8982	114	12	instances	instance	NOUN
eshr-8982	114	13	of	of	ADP
eshr-8982	114	14	end	end	NOUN
eshr-8982	114	15	-	-	PUNCT
eshr-8982	114	16	stage	stage	NOUN
eshr-8982	114	17	renal	renal	ADJ
eshr-8982	114	18	disease	disease	NOUN
eshr-8982	114	19	.	.	PUNCT
eshr-8982	115	1	the	the	DET
eshr-8982	115	2	normal	normal	ADJ
eshr-8982	115	3	clinical	clinical	ADJ
eshr-8982	115	4	course	course	NOUN
eshr-8982	115	5	of	of	ADP
eshr-8982	115	6	dn	dn	NOUN
eshr-8982	115	7	is	be	AUX
eshr-8982	115	8	microalbuminuria	microalbuminuria	PROPN
eshr-8982	115	9	followed	follow	VERB
eshr-8982	115	10	by	by	ADP
eshr-8982	115	11	overt	overt	ADJ
eshr-8982	115	12	albuminuria	albuminuria	NOUN
eshr-8982	115	13	and	and	CCONJ
eshr-8982	115	14	eventually	eventually	ADV
eshr-8982	115	15	a	a	DET
eshr-8982	115	16	loss	loss	NOUN
eshr-8982	115	17	in	in	ADP
eshr-8982	115	18	kidney	kidney	NOUN
eshr-8982	115	19	function	function	NOUN
eshr-8982	115	20	,	,	PUNCT
eshr-8982	115	21	with	with	ADP
eshr-8982	115	22	pathologic	pathologic	ADJ
eshr-8982	115	23	dn	dn	PROPN
eshr-8982	115	24	lesions	lesion	NOUN
eshr-8982	115	25	progressing	progress	VERB
eshr-8982	115	26	with	with	ADP
eshr-8982	115	27	increasing	increase	VERB
eshr-8982	115	28	albuminuria	albuminuria	NOUN
eshr-8982	115	29	.	.	PUNCT
eshr-8982	116	1	as	as	ADP
eshr-8982	116	2	a	a	DET
eshr-8982	116	3	result	result	NOUN
eshr-8982	116	4	,	,	PUNCT
eshr-8982	116	5	albuminuria	albuminuria	PROPN
eshr-8982	116	6	is	be	AUX
eshr-8982	116	7	a	a	DET
eshr-8982	116	8	clinical	clinical	ADJ
eshr-8982	116	9	feature	feature	NOUN
eshr-8982	116	10	of	of	ADP
eshr-8982	116	11	dn	dn	PROPN
eshr-8982	116	12	.	.	PROPN
eshr-8982	117	1	on	on	ADP
eshr-8982	117	2	the	the	DET
eshr-8982	117	3	other	other	ADJ
eshr-8982	117	4	hand	hand	NOUN
eshr-8982	117	5	,	,	PUNCT
eshr-8982	117	6	some	some	DET
eshr-8982	117	7	diabetic	diabetic	ADJ
eshr-8982	117	8	individuals	individual	NOUN
eshr-8982	117	9	have	have	AUX
eshr-8982	117	10	reported	report	VERB
eshr-8982	117	11	a	a	DET
eshr-8982	117	12	fast	fast	ADJ
eshr-8982	117	13	deterioration	deterioration	NOUN
eshr-8982	117	14	in	in	ADP
eshr-8982	117	15	kidney	kidney	NOUN
eshr-8982	117	16	function	function	NOUN
eshr-8982	117	17	without	without	ADP
eshr-8982	117	18	overt	overt	ADJ
eshr-8982	117	19	albuminuria	albuminuria	PROPN
eshr-8982	117	20	.	.	PUNCT
eshr-8982	118	1	acr	acr	PROPN
eshr-8982	118	2	levels	level	NOUN
eshr-8982	118	3	also	also	ADV
eshr-8982	118	4	increase	increase	VERB
eshr-8982	118	5	with	with	ADP
eshr-8982	118	6	the	the	DET
eshr-8982	118	7	duration	duration	NOUN
eshr-8982	118	8	of	of	ADP
eshr-8982	118	9	diabetes.14	diabetes.14	PROPN
eshr-8982	118	10	increased	increase	VERB
eshr-8982	118	11	urine	urine	NOUN
eshr-8982	118	12	acr	acr	NOUN
eshr-8982	118	13	levels	level	NOUN
eshr-8982	118	14	were	be	AUX
eshr-8982	118	15	independently	independently	ADV
eshr-8982	118	16	linked	link	VERB
eshr-8982	118	17	with	with	ADP
eshr-8982	118	18	lower	low	ADJ
eshr-8982	118	19	abi	abi	NOUN
eshr-8982	118	20	in	in	ADP
eshr-8982	118	21	diabetic	diabetic	ADJ
eshr-8982	118	22	patients	patient	NOUN
eshr-8982	118	23	,	,	PUNCT
eshr-8982	118	24	and	and	CCONJ
eshr-8982	118	25	the	the	DET
eshr-8982	118	26	risk	risk	NOUN
eshr-8982	118	27	of	of	ADP
eshr-8982	118	28	low	low	ADJ
eshr-8982	118	29	abi	abi	PROPN
eshr-8982	118	30	(	(	PUNCT
eshr-8982	118	31	pad	pad	NOUN
eshr-8982	118	32	)	)	PUNCT
eshr-8982	118	33	was	be	AUX
eshr-8982	118	34	obvious	obvious	ADJ
eshr-8982	118	35	in	in	ADP
eshr-8982	118	36	all	all	DET
eshr-8982	118	37	subgroups	subgroup	NOUN
eshr-8982	118	38	investigated	investigate	VERB
eshr-8982	118	39	and	and	CCONJ
eshr-8982	118	40	after	after	ADP
eshr-8982	118	41	thorough	thorough	ADJ
eshr-8982	118	42	adjustments	adjustment	NOUN
eshr-8982	118	43	.	.	PUNCT
eshr-8982	119	1	as	as	ADP
eshr-8982	119	2	a	a	DET
eshr-8982	119	3	result	result	NOUN
eshr-8982	119	4	,	,	PUNCT
eshr-8982	119	5	our	our	PRON
eshr-8982	119	6	findings	finding	NOUN
eshr-8982	119	7	indicated	indicate	VERB
eshr-8982	119	8	that	that	SCONJ
eshr-8982	119	9	higher	high	ADJ
eshr-8982	119	10	urine	urine	NOUN
eshr-8982	119	11	acr	acr	PROPN
eshr-8982	119	12	was	be	AUX
eshr-8982	119	13	related	relate	VERB
eshr-8982	119	14	to	to	PART
eshr-8982	119	15	pad	pad	VERB
eshr-8982	119	16	in	in	ADP
eshr-8982	119	17	diabetic	diabetic	ADJ
eshr-8982	119	18	individuals.6	individuals.6	NOUN
eshr-8982	119	19	there	there	PRON
eshr-8982	119	20	was	be	VERB
eshr-8982	119	21	a	a	DET
eshr-8982	119	22	significant	significant	ADJ
eshr-8982	119	23	association	association	NOUN
eshr-8982	119	24	between	between	ADP
eshr-8982	119	25	the	the	DET
eshr-8982	119	26	uacrs	uacr	NOUN
eshr-8982	119	27	at	at	ADP
eshr-8982	119	28	baseline	baseline	NOUN
eshr-8982	119	29	and	and	CCONJ
eshr-8982	119	30	the	the	DET
eshr-8982	119	31	serum	serum	NOUN
eshr-8982	119	32	bilirubin	bilirubin	NOUN
eshr-8982	119	33	groups	group	NOUN
eshr-8982	119	34	.	.	PUNCT
eshr-8982	120	1	however	however	ADV
eshr-8982	120	2	,	,	PUNCT
eshr-8982	120	3	there	there	PRON
eshr-8982	120	4	was	be	VERB
eshr-8982	120	5	a	a	DET
eshr-8982	120	6	substantial	substantial	ADJ
eshr-8982	120	7	association	association	NOUN
eshr-8982	120	8	between	between	ADP
eshr-8982	120	9	bilirubin	bilirubin	NOUN
eshr-8982	120	10	levels	level	NOUN
eshr-8982	120	11	and	and	CCONJ
eshr-8982	120	12	baseline	baseline	VERB
eshr-8982	120	13	uacr	uacr	ADJ
eshr-8982	120	14	.	.	PUNCT
eshr-8982	121	1	higher	high	ADJ
eshr-8982	121	2	bilirubin	bilirubin	NOUN
eshr-8982	121	3	levels	level	NOUN
eshr-8982	121	4	are	be	AUX
eshr-8982	121	5	related	relate	VERB
eshr-8982	121	6	to	to	ADP
eshr-8982	121	7	a	a	DET
eshr-8982	121	8	decreased	decrease	VERB
eshr-8982	121	9	likelihood	likelihood	NOUN
eshr-8982	121	10	of	of	ADP
eshr-8982	121	11	albuminuria	albuminuria	PROPN
eshr-8982	121	12	advancement	advancement	NOUN
eshr-8982	121	13	in	in	ADP
eshr-8982	121	14	type	type	NOUN
eshr-8982	121	15	2	2	NUM
eshr-8982	121	16	diabetes	diabetes	NOUN
eshr-8982	121	17	patients	patient	NOUN
eshr-8982	121	18	,	,	PUNCT
eshr-8982	121	19	implying	imply	VERB
eshr-8982	121	20	that	that	SCONJ
eshr-8982	121	21	serum	serum	NOUN
eshr-8982	121	22	bilirubin	bilirubin	NOUN
eshr-8982	121	23	levels	level	NOUN
eshr-8982	121	24	may	may	AUX
eshr-8982	121	25	be	be	AUX
eshr-8982	121	26	a	a	DET
eshr-8982	121	27	surrogate	surrogate	ADJ
eshr-8982	121	28	indication	indication	NOUN
eshr-8982	121	29	of	of	ADP
eshr-8982	121	30	diabetic	diabetic	ADJ
eshr-8982	121	31	nephropathy	nephropathy	ADJ
eshr-8982	121	32	progression.15	progression.15	NOUN
eshr-8982	121	33	compared	compare	VERB
eshr-8982	121	34	to	to	ADP
eshr-8982	121	35	individuals	individual	NOUN
eshr-8982	121	36	with	with	ADP
eshr-8982	121	37	a	a	DET
eshr-8982	121	38	low	low	ADJ
eshr-8982	121	39	sua	sua	NOUN
eshr-8982	121	40	(	(	PUNCT
eshr-8982	121	41	serum	serum	X
eshr-8982	121	42	uric	uric	ADJ
eshr-8982	121	43	acid	acid	NOUN
eshr-8982	121	44	)	)	PUNCT
eshr-8982	121	45	level	level	NOUN
eshr-8982	121	46	,	,	PUNCT
eshr-8982	121	47	those	those	PRON
eshr-8982	121	48	with	with	ADP
eshr-8982	121	49	a	a	DET
eshr-8982	121	50	raised	raise	VERB
eshr-8982	121	51	sua	sua	NOUN
eshr-8982	121	52	level	level	NOUN
eshr-8982	121	53	showed	show	VERB
eshr-8982	121	54	a	a	DET
eshr-8982	121	55	higher	high	ADJ
eshr-8982	121	56	frequency	frequency	NOUN
eshr-8982	121	57	of	of	ADP
eshr-8982	121	58	dr	dr	PROPN
eshr-8982	121	59	and	and	CCONJ
eshr-8982	121	60	albuminuria	albuminuria	PROPN
eshr-8982	121	61	.	.	PUNCT
eshr-8982	122	1	as	as	ADP
eshr-8982	122	2	a	a	DET
eshr-8982	122	3	result	result	NOUN
eshr-8982	122	4	,	,	PUNCT
eshr-8982	122	5	even	even	ADV
eshr-8982	122	6	within	within	ADP
eshr-8982	122	7	the	the	DET
eshr-8982	122	8	normal	normal	ADJ
eshr-8982	122	9	range	range	NOUN
eshr-8982	122	10	of	of	ADP
eshr-8982	122	11	sua	sua	NOUN
eshr-8982	122	12	,	,	PUNCT
eshr-8982	122	13	people	people	NOUN
eshr-8982	122	14	with	with	ADP
eshr-8982	122	15	somewhat	somewhat	ADV
eshr-8982	122	16	high	high	ADJ
eshr-8982	122	17	sua	sua	PROPN
eshr-8982	122	18	levels	level	NOUN
eshr-8982	122	19	may	may	AUX
eshr-8982	122	20	be	be	AUX
eshr-8982	122	21	predisposed	predispose	VERB
eshr-8982	122	22	to	to	ADP
eshr-8982	122	23	diabetic	diabetic	ADJ
eshr-8982	122	24	retinopathy	retinopathy	ADJ
eshr-8982	122	25	(	(	PUNCT
eshr-8982	122	26	dr	dr	PROPN
eshr-8982	122	27	)	)	PUNCT
eshr-8982	122	28	and	and	CCONJ
eshr-8982	122	29	diabetic	diabetic	ADJ
eshr-8982	122	30	nephropathy	nephropathy	NOUN
eshr-8982	122	31	(	(	PUNCT
eshr-8982	122	32	dn	dn	NOUN
eshr-8982	122	33	)	)	PUNCT
eshr-8982	122	34	.	.	PUNCT
eshr-8982	123	1	as	as	ADP
eshr-8982	123	2	a	a	DET
eshr-8982	123	3	result	result	NOUN
eshr-8982	123	4	,	,	PUNCT
eshr-8982	123	5	sua	sua	PROPN
eshr-8982	123	6	levels	level	NOUN
eshr-8982	123	7	in	in	ADP
eshr-8982	123	8	individuals	individual	NOUN
eshr-8982	123	9	with	with	ADP
eshr-8982	123	10	type	type	NOUN
eshr-8982	123	11	2	2	NUM
eshr-8982	123	12	diabetes	diabetes	NOUN
eshr-8982	123	13	should	should	AUX
eshr-8982	123	14	be	be	AUX
eshr-8982	123	15	closely	closely	ADV
eshr-8982	123	16	monitored	monitor	VERB
eshr-8982	123	17	.	.	PUNCT
eshr-8982	124	1	several	several	ADJ
eshr-8982	124	2	diseases	disease	NOUN
eshr-8982	124	3	of	of	ADP
eshr-8982	124	4	the	the	DET
eshr-8982	124	5	kidneys	kidney	NOUN
eshr-8982	124	6	cause	cause	VERB
eshr-8982	124	7	elevated	elevated	ADJ
eshr-8982	124	8	sua	sua	NOUN
eshr-8982	124	9	levels	level	NOUN
eshr-8982	124	10	.	.	PUNCT
eshr-8982	125	1	a	a	DET
eshr-8982	125	2	decrease	decrease	NOUN
eshr-8982	125	3	in	in	ADP
eshr-8982	125	4	the	the	DET
eshr-8982	125	5	estimated	estimate	VERB
eshr-8982	125	6	glomerular	glomerular	ADJ
eshr-8982	125	7	filtration	filtration	NOUN
eshr-8982	125	8	rate	rate	NOUN
eshr-8982	125	9	or	or	CCONJ
eshr-8982	125	10	improper	improper	ADJ
eshr-8982	125	11	handling	handling	NOUN
eshr-8982	125	12	of	of	ADP
eshr-8982	125	13	filtered	filter	VERB
eshr-8982	125	14	uric	uric	ADJ
eshr-8982	125	15	acid	acid	NOUN
eshr-8982	125	16	are	be	AUX
eshr-8982	125	17	two	two	NUM
eshr-8982	125	18	possible	possible	ADJ
eshr-8982	125	19	causes	cause	NOUN
eshr-8982	125	20	of	of	ADP
eshr-8982	125	21	increased	increase	VERB
eshr-8982	125	22	sua	sua	NOUN
eshr-8982	125	23	over	over	ADP
eshr-8982	125	24	the	the	DET
eshr-8982	125	25	proximal	proximal	ADJ
eshr-8982	125	26	tubules	tubule	NOUN
eshr-8982	125	27	.	.	PUNCT
eshr-8982	126	1	the	the	DET
eshr-8982	126	2	substance	substance	NOUN
eshr-8982	126	3	uric	uric	ADJ
eshr-8982	126	4	acid	acid	NOUN
eshr-8982	126	5	https://doi.org/10.26555/eshr.v3i1.3629	https://doi.org/10.26555/eshr.v3i1.3629	PROPN
eshr-8982	126	6	https://doi.org/10.26555/eshr.v3i1.3629	https://doi.org/10.26555/eshr.v3i1.3629	PROPN
eshr-8982	126	7	purtaria	purtaria	NOUN
eshr-8982	126	8	et	et	PROPN
eshr-8982	126	9	al	al	PROPN
eshr-8982	126	10	.	.	PUNCT
eshr-8982	127	1	(	(	PUNCT
eshr-8982	127	2	the	the	DET
eshr-8982	127	3	importance	importance	NOUN
eshr-8982	127	4	of	of	ADP
eshr-8982	127	5	uacr	uacr	NOUN
eshr-8982	127	6	(	(	PUNCT
eshr-8982	127	7	urinary	urinary	ADJ
eshr-8982	127	8	albumin	albumin	ADJ
eshr-8982	127	9	creatinine	creatinine	NOUN
eshr-8982	127	10	ratio	ratio	NOUN
eshr-8982	127	11	)	)	PUNCT
eshr-8982	127	12	examination	examination	NOUN
eshr-8982	127	13	in	in	ADP
eshr-8982	127	14	patients	patient	NOUN
eshr-8982	127	15	)	)	PUNCT
eshr-8982	127	16	…	…	PUNCT
eshr-8982	127	17	.	.	PUNCT
eshr-8982	128	1	82	82	NUM
eshr-8982	128	2	vol	vol	NOUN
eshr-8982	128	3	.	.	PROPN
eshr-8982	129	1	6	6	NUM
eshr-8982	129	2	,	,	PUNCT
eshr-8982	129	3	no	no	INTJ
eshr-8982	129	4	.	.	NOUN
eshr-8982	129	5	2	2	NUM
eshr-8982	129	6	,	,	PUNCT
eshr-8982	129	7	2024	2024	NUM
eshr-8982	129	8	,	,	PUNCT
eshr-8982	129	9	pp	pp	ADJ
eshr-8982	129	10	.	.	PUNCT
eshr-8982	130	1	74	74	NUM
eshr-8982	130	2	-	-	SYM
eshr-8982	130	3	86	86	NUM
eshr-8982	130	4	10.26555	10.26555	NUM
eshr-8982	130	5	/	/	SYM
eshr-8982	130	6	eshr.v6i2.8982	eshr.v6i2.8982	PROPN
eshr-8982	130	7	is	be	AUX
eshr-8982	130	8	an	an	DET
eshr-8982	130	9	essential	essential	ADJ
eshr-8982	130	10	component	component	NOUN
eshr-8982	130	11	in	in	ADP
eshr-8982	130	12	the	the	DET
eshr-8982	130	13	development	development	NOUN
eshr-8982	130	14	of	of	ADP
eshr-8982	130	15	kidney	kidney	NOUN
eshr-8982	130	16	diseases	disease	NOUN
eshr-8982	130	17	.	.	PUNCT
eshr-8982	131	1	the	the	DET
eshr-8982	131	2	leading	lead	VERB
eshr-8982	131	3	cause	cause	NOUN
eshr-8982	131	4	is	be	AUX
eshr-8982	131	5	dn	dn	ADJ
eshr-8982	131	6	,	,	PUNCT
eshr-8982	131	7	several	several	ADJ
eshr-8982	131	8	research	research	NOUN
eshr-8982	131	9	have	have	AUX
eshr-8982	131	10	also	also	ADV
eshr-8982	131	11	concentrated	concentrate	VERB
eshr-8982	131	12	on	on	ADP
eshr-8982	131	13	the	the	DET
eshr-8982	131	14	connection	connection	NOUN
eshr-8982	131	15	between	between	ADP
eshr-8982	131	16	sua	sua	PROPN
eshr-8982	131	17	level	level	NOUN
eshr-8982	131	18	and	and	CCONJ
eshr-8982	131	19	dn.7	dn.7	PROPN
eshr-8982	131	20	acr	acr	PROPN
eshr-8982	131	21	was	be	AUX
eshr-8982	131	22	reduced	reduce	VERB
eshr-8982	131	23	in	in	ADP
eshr-8982	131	24	individuals	individual	NOUN
eshr-8982	131	25	with	with	ADP
eshr-8982	131	26	microalbuminuria	microalbuminuria	PROPN
eshr-8982	131	27	and	and	CCONJ
eshr-8982	131	28	macroalbuminuria	macroalbuminuria	PROPN
eshr-8982	131	29	but	but	CCONJ
eshr-8982	131	30	rose	rise	VERB
eshr-8982	131	31	dramatically	dramatically	ADV
eshr-8982	131	32	in	in	ADP
eshr-8982	131	33	those	those	PRON
eshr-8982	131	34	with	with	ADP
eshr-8982	131	35	normo	normo	PROPN
eshr-8982	131	36	albuminuria	albuminuria	PROPN
eshr-8982	131	37	.	.	PUNCT
eshr-8982	132	1	other	other	ADJ
eshr-8982	132	2	studies	study	NOUN
eshr-8982	132	3	found	find	VERB
eshr-8982	132	4	various	various	ADJ
eshr-8982	132	5	levels	level	NOUN
eshr-8982	132	6	of	of	ADP
eshr-8982	132	7	improvement	improvement	NOUN
eshr-8982	132	8	in	in	ADP
eshr-8982	132	9	acr	acr	PROPN
eshr-8982	132	10	.	.	PUNCT
eshr-8982	133	1	acr	acr	PROPN
eshr-8982	133	2	was	be	AUX
eshr-8982	133	3	reduced	reduce	VERB
eshr-8982	133	4	in	in	ADP
eshr-8982	133	5	individuals	individual	NOUN
eshr-8982	133	6	with	with	ADP
eshr-8982	133	7	microalbuminuria	microalbuminuria	PROPN
eshr-8982	133	8	and	and	CCONJ
eshr-8982	133	9	macroalbuminuria	macroalbuminuria	PROPN
eshr-8982	133	10	but	but	CCONJ
eshr-8982	133	11	rose	rise	VERB
eshr-8982	133	12	dramatically	dramatically	ADV
eshr-8982	133	13	in	in	ADP
eshr-8982	133	14	those	those	PRON
eshr-8982	133	15	with	with	ADP
eshr-8982	133	16	normo	normo	PROPN
eshr-8982	133	17	albuminuria	albuminuria	PROPN
eshr-8982	133	18	.	.	PUNCT
eshr-8982	134	1	other	other	ADJ
eshr-8982	134	2	studies	study	NOUN
eshr-8982	134	3	found	find	VERB
eshr-8982	134	4	varying	vary	VERB
eshr-8982	134	5	degrees	degree	NOUN
eshr-8982	134	6	of	of	ADP
eshr-8982	134	7	acr	acr	PROPN
eshr-8982	134	8	improvement	improvement	NOUN
eshr-8982	134	9	.	.	PUNCT
eshr-8982	135	1	acr	acr	PROPN
eshr-8982	135	2	was	be	AUX
eshr-8982	135	3	highly	highly	ADV
eshr-8982	135	4	associated	associate	VERB
eshr-8982	135	5	with	with	ADP
eshr-8982	135	6	age	age	NOUN
eshr-8982	135	7	and	and	CCONJ
eshr-8982	135	8	blood	blood	NOUN
eshr-8982	135	9	pressure	pressure	NOUN
eshr-8982	135	10	.	.	PUNCT
eshr-8982	136	1	the	the	DET
eshr-8982	136	2	effect	effect	NOUN
eshr-8982	136	3	of	of	ADP
eshr-8982	136	4	sglt2i	sglt2i	NOUN
eshr-8982	136	5	on	on	ADP
eshr-8982	136	6	acr	acr	PROPN
eshr-8982	136	7	was	be	AUX
eshr-8982	136	8	independent	independent	ADJ
eshr-8982	136	9	of	of	ADP
eshr-8982	136	10	age	age	NOUN
eshr-8982	136	11	,	,	PUNCT
eshr-8982	136	12	and	and	CCONJ
eshr-8982	136	13	the	the	DET
eshr-8982	136	14	use	use	NOUN
eshr-8982	136	15	of	of	ADP
eshr-8982	136	16	sglt2i	sglt2i	PROPN
eshr-8982	136	17	appears	appear	VERB
eshr-8982	136	18	to	to	PART
eshr-8982	136	19	be	be	AUX
eshr-8982	136	20	an	an	DET
eshr-8982	136	21	effective	effective	ADJ
eshr-8982	136	22	method	method	NOUN
eshr-8982	136	23	for	for	ADP
eshr-8982	136	24	treating	treat	VERB
eshr-8982	136	25	diabetes	diabetes	NOUN
eshr-8982	136	26	in	in	ADP
eshr-8982	136	27	advanced	advanced	ADJ
eshr-8982	136	28	age	age	NOUN
eshr-8982	136	29	.	.	PUNCT
eshr-8982	137	1	however	however	ADV
eshr-8982	137	2	,	,	PUNCT
eshr-8982	137	3	caution	caution	NOUN
eshr-8982	137	4	should	should	AUX
eshr-8982	137	5	be	be	AUX
eshr-8982	137	6	used	use	VERB
eshr-8982	137	7	in	in	ADP
eshr-8982	137	8	individuals	individual	NOUN
eshr-8982	137	9	with	with	ADP
eshr-8982	137	10	normal	normal	ADJ
eshr-8982	137	11	albuminuria	albuminuria	NOUN
eshr-8982	137	12	or	or	CCONJ
eshr-8982	137	13	increasingly	increasingly	ADV
eshr-8982	137	14	poor	poor	ADJ
eshr-8982	137	15	renal	renal	ADJ
eshr-8982	137	16	function	function	NOUN
eshr-8982	137	17	.	.	PUNCT
eshr-8982	138	1	in	in	ADP
eshr-8982	138	2	addition	addition	NOUN
eshr-8982	138	3	to	to	ADP
eshr-8982	138	4	their	their	PRON
eshr-8982	138	5	direct	direct	ADJ
eshr-8982	138	6	influence	influence	NOUN
eshr-8982	138	7	on	on	ADP
eshr-8982	138	8	blood	blood	NOUN
eshr-8982	138	9	glucose	glucose	NOUN
eshr-8982	138	10	levels	level	NOUN
eshr-8982	138	11	,	,	PUNCT
eshr-8982	138	12	sodium	sodium	NOUN
eshr-8982	138	13	-	-	PUNCT
eshr-8982	138	14	glucose	glucose	NOUN
eshr-8982	138	15	co	co	NOUN
eshr-8982	138	16	-	-	NOUN
eshr-8982	138	17	transporter	transporter	ADJ
eshr-8982	138	18	2	2	NUM
eshr-8982	138	19	inhibitors	inhibitor	NOUN
eshr-8982	138	20	(	(	PUNCT
eshr-8982	138	21	sglt2i	sglt2i	PROPN
eshr-8982	138	22	)	)	PUNCT
eshr-8982	138	23	have	have	VERB
eshr-8982	138	24	numerous	numerous	ADJ
eshr-8982	138	25	indirect	indirect	ADJ
eshr-8982	138	26	benefits	benefit	NOUN
eshr-8982	138	27	,	,	PUNCT
eshr-8982	138	28	such	such	ADJ
eshr-8982	138	29	as	as	ADP
eshr-8982	138	30	lowering	lower	VERB
eshr-8982	138	31	blood	blood	NOUN
eshr-8982	138	32	pressure	pressure	NOUN
eshr-8982	138	33	(	(	PUNCT
eshr-8982	138	34	bp	bp	PROPN
eshr-8982	138	35	)	)	PUNCT
eshr-8982	138	36	and	and	CCONJ
eshr-8982	138	37	improving	improve	VERB
eshr-8982	138	38	dyslipidemia	dyslipidemia	NOUN
eshr-8982	138	39	and	and	CCONJ
eshr-8982	138	40	liver	liver	NOUN
eshr-8982	138	41	function.16	function.16	NOUN
eshr-8982	138	42	reduction	reduction	NOUN
eshr-8982	138	43	of	of	ADP
eshr-8982	138	44	uacr	uacr	PROPN
eshr-8982	138	45	levels	level	NOUN
eshr-8982	138	46	can	can	AUX
eshr-8982	138	47	slow	slow	VERB
eshr-8982	138	48	kidney	kidney	NOUN
eshr-8982	138	49	damage	damage	NOUN
eshr-8982	138	50	and	and	CCONJ
eshr-8982	138	51	cardiovascular	cardiovascular	ADJ
eshr-8982	138	52	disease	disease	NOUN
eshr-8982	138	53	—	—	PUNCT
eshr-8982	138	54	a	a	DET
eshr-8982	138	55	reduction	reduction	NOUN
eshr-8982	138	56	of	of	ADP
eshr-8982	138	57	uacr	uacr	NOUN
eshr-8982	138	58	from	from	ADP
eshr-8982	138	59	baseline	baseline	NOUN
eshr-8982	138	60	at	at	ADP
eshr-8982	138	61	12	12	NUM
eshr-8982	138	62	weeks	week	NOUN
eshr-8982	138	63	for	for	ADP
eshr-8982	138	64	verinurad	verinurad	NOUN
eshr-8982	138	65	plus	plus	CCONJ
eshr-8982	138	66	febuxostat.11	febuxostat.11	ADJ
eshr-8982	138	67	diabetes	diabetes	NOUN
eshr-8982	138	68	kidney	kidney	NOUN
eshr-8982	138	69	disease	disease	NOUN
eshr-8982	138	70	is	be	AUX
eshr-8982	138	71	one	one	NUM
eshr-8982	138	72	of	of	ADP
eshr-8982	138	73	the	the	DET
eshr-8982	138	74	leading	lead	VERB
eshr-8982	138	75	causes	cause	NOUN
eshr-8982	138	76	of	of	ADP
eshr-8982	138	77	morbidity	morbidity	NOUN
eshr-8982	138	78	and	and	CCONJ
eshr-8982	138	79	death	death	NOUN
eshr-8982	138	80	in	in	ADP
eshr-8982	138	81	people	people	NOUN
eshr-8982	138	82	with	with	ADP
eshr-8982	138	83	diabetes	diabetes	NOUN
eshr-8982	138	84	.	.	PUNCT
eshr-8982	139	1	diabetic	diabetic	ADJ
eshr-8982	139	2	kidney	kidney	NOUN
eshr-8982	139	3	disease	disease	NOUN
eshr-8982	139	4	affects	affect	VERB
eshr-8982	139	5	20%-40	20%-40	NUM
eshr-8982	139	6	%	%	NOUN
eshr-8982	139	7	of	of	ADP
eshr-8982	139	8	persons	person	NOUN
eshr-8982	139	9	with	with	ADP
eshr-8982	139	10	diabetes	diabetes	NOUN
eshr-8982	139	11	,	,	PUNCT
eshr-8982	139	12	both	both	DET
eshr-8982	139	13	types	type	NOUN
eshr-8982	139	14	1	1	NUM
eshr-8982	139	15	and	and	CCONJ
eshr-8982	139	16	2	2	NUM
eshr-8982	139	17	.	.	X
eshr-8982	140	1	if	if	SCONJ
eshr-8982	140	2	not	not	PART
eshr-8982	140	3	treated	treat	VERB
eshr-8982	140	4	effectively	effectively	ADV
eshr-8982	140	5	,	,	PUNCT
eshr-8982	140	6	this	this	DET
eshr-8982	140	7	condition	condition	NOUN
eshr-8982	140	8	will	will	AUX
eshr-8982	140	9	progress	progress	VERB
eshr-8982	140	10	to	to	PART
eshr-8982	140	11	end	end	VERB
eshr-8982	140	12	-	-	PUNCT
eshr-8982	140	13	stage	stage	NOUN
eshr-8982	140	14	renal	renal	ADJ
eshr-8982	140	15	disease	disease	NOUN
eshr-8982	140	16	(	(	PUNCT
eshr-8982	140	17	esrd).19	esrd).19	NOUN
eshr-8982	140	18	discussion	discussion	NOUN
eshr-8982	140	19	the	the	DET
eshr-8982	140	20	article	article	NOUN
eshr-8982	140	21	that	that	PRON
eshr-8982	140	22	has	have	AUX
eshr-8982	140	23	been	be	AUX
eshr-8982	140	24	reviewed	review	VERB
eshr-8982	140	25	found	find	VERB
eshr-8982	140	26	that	that	SCONJ
eshr-8982	140	27	acr	acr	PROPN
eshr-8982	140	28	examination	examination	NOUN
eshr-8982	140	29	is	be	AUX
eshr-8982	140	30	critical	critical	ADJ
eshr-8982	140	31	to	to	PART
eshr-8982	140	32	monitor	monitor	VERB
eshr-8982	140	33	kidney	kidney	NOUN
eshr-8982	140	34	damage	damage	NOUN
eshr-8982	140	35	in	in	ADP
eshr-8982	140	36	patients	patient	NOUN
eshr-8982	140	37	with	with	ADP
eshr-8982	140	38	type	type	NOUN
eshr-8982	140	39	2	2	NUM
eshr-8982	140	40	diabetes	diabetes	NOUN
eshr-8982	140	41	.	.	PUNCT
eshr-8982	141	1	acr	acr	PROPN
eshr-8982	141	2	can	can	AUX
eshr-8982	141	3	also	also	ADV
eshr-8982	141	4	be	be	AUX
eshr-8982	141	5	used	use	VERB
eshr-8982	141	6	as	as	ADP
eshr-8982	141	7	a	a	DET
eshr-8982	141	8	marker	marker	NOUN
eshr-8982	141	9	of	of	ADP
eshr-8982	141	10	dn	dn	PROPN
eshr-8982	141	11	.	.	PUNCT
eshr-8982	142	1	acr	acr	PROPN
eshr-8982	142	2	levels	level	NOUN
eshr-8982	142	3	correlate	correlate	VERB
eshr-8982	142	4	with	with	ADP
eshr-8982	142	5	uric	uric	ADJ
eshr-8982	142	6	acid	acid	NOUN
eshr-8982	142	7	levels	level	NOUN
eshr-8982	142	8	and	and	CCONJ
eshr-8982	142	9	bilirubin	bilirubin	NOUN
eshr-8982	142	10	levels	level	NOUN
eshr-8982	142	11	in	in	ADP
eshr-8982	142	12	patients	patient	NOUN
eshr-8982	142	13	.	.	PUNCT
eshr-8982	143	1	dm	dm	NOUN
eshr-8982	143	2	sufferers	sufferer	NOUN
eshr-8982	143	3	should	should	AUX
eshr-8982	143	4	be	be	AUX
eshr-8982	143	5	educated	educate	VERB
eshr-8982	143	6	about	about	ADP
eshr-8982	143	7	maintaining	maintain	VERB
eshr-8982	143	8	blood	blood	NOUN
eshr-8982	143	9	sugar	sugar	NOUN
eshr-8982	143	10	levels	level	NOUN
eshr-8982	143	11	to	to	PART
eshr-8982	143	12	maintain	maintain	VERB
eshr-8982	143	13	kidney	kidney	NOUN
eshr-8982	143	14	conditions	condition	NOUN
eshr-8982	143	15	.	.	PUNCT
eshr-8982	144	1	prolonged	prolonged	ADJ
eshr-8982	144	2	suffering	suffering	NOUN
eshr-8982	144	3	from	from	ADP
eshr-8982	144	4	dm	dm	PROPN
eshr-8982	144	5	is	be	AUX
eshr-8982	144	6	also	also	ADV
eshr-8982	144	7	associated	associate	VERB
eshr-8982	144	8	with	with	ADP
eshr-8982	144	9	acr	acr	PROPN
eshr-8982	144	10	levels.10	levels.10	NOUN
eshr-8982	144	11	the	the	DET
eshr-8982	144	12	formation	formation	NOUN
eshr-8982	144	13	of	of	ADP
eshr-8982	144	14	advanced	advanced	ADJ
eshr-8982	144	15	glycation	glycation	NOUN
eshr-8982	144	16	end	end	NOUN
eshr-8982	144	17	products	product	NOUN
eshr-8982	144	18	(	(	PUNCT
eshr-8982	144	19	ages	age	NOUN
eshr-8982	144	20	)	)	PUNCT
eshr-8982	144	21	from	from	ADP
eshr-8982	144	22	glucose	glucose	NOUN
eshr-8982	144	23	with	with	ADP
eshr-8982	144	24	amino	amino	NOUN
eshr-8982	144	25	acid	acid	NOUN
eshr-8982	144	26	residues	residue	NOUN
eshr-8982	144	27	in	in	ADP
eshr-8982	144	28	body	body	NOUN
eshr-8982	144	29	tissues	tissue	NOUN
eshr-8982	144	30	is	be	AUX
eshr-8982	144	31	caused	cause	VERB
eshr-8982	144	32	by	by	ADP
eshr-8982	144	33	high	high	ADJ
eshr-8982	144	34	and	and	CCONJ
eshr-8982	144	35	prolonged	prolonged	ADJ
eshr-8982	144	36	blood	blood	NOUN
eshr-8982	144	37	glucose	glucose	NOUN
eshr-8982	144	38	levels	level	NOUN
eshr-8982	144	39	.	.	PUNCT
eshr-8982	145	1	the	the	DET
eshr-8982	145	2	kidneys	kidney	NOUN
eshr-8982	145	3	eliminate	eliminate	VERB
eshr-8982	145	4	ages	age	NOUN
eshr-8982	145	5	in	in	ADP
eshr-8982	145	6	small	small	ADJ
eshr-8982	145	7	quantities	quantity	NOUN
eshr-8982	145	8	,	,	PUNCT
eshr-8982	145	9	but	but	CCONJ
eshr-8982	145	10	in	in	ADP
eshr-8982	145	11	people	people	NOUN
eshr-8982	145	12	with	with	ADP
eshr-8982	145	13	diabetes	diabetes	NOUN
eshr-8982	145	14	mellitus	mellitus	NOUN
eshr-8982	145	15	,	,	PUNCT
eshr-8982	145	16	the	the	DET
eshr-8982	145	17	number	number	NOUN
eshr-8982	145	18	of	of	ADP
eshr-8982	145	19	ages	age	NOUN
eshr-8982	145	20	is	be	AUX
eshr-8982	145	21	very	very	ADV
eshr-8982	145	22	high	high	ADJ
eshr-8982	145	23	in	in	ADP
eshr-8982	145	24	the	the	DET
eshr-8982	145	25	plasma	plasma	NOUN
eshr-8982	145	26	,	,	PUNCT
eshr-8982	145	27	which	which	PRON
eshr-8982	145	28	makes	make	VERB
eshr-8982	145	29	kidney	kidney	NOUN
eshr-8982	145	30	work	work	VERB
eshr-8982	145	31	more	more	ADJ
eshr-8982	145	32	difficult.5	difficult.5	NOUN
eshr-8982	145	33	chronic	chronic	ADJ
eshr-8982	145	34	diabetes	diabetes	NOUN
eshr-8982	145	35	relates	relate	VERB
eshr-8982	145	36	to	to	PART
eshr-8982	145	37	organ	organ	NOUN
eshr-8982	145	38	damage	damage	NOUN
eshr-8982	145	39	,	,	PUNCT
eshr-8982	145	40	malfunction	malfunction	NOUN
eshr-8982	145	41	,	,	PUNCT
eshr-8982	145	42	and	and	CCONJ
eshr-8982	145	43	failure	failure	NOUN
eshr-8982	145	44	,	,	PUNCT
eshr-8982	145	45	particularly	particularly	ADV
eshr-8982	145	46	of	of	ADP
eshr-8982	145	47	the	the	DET
eshr-8982	145	48	eyes	eye	NOUN
eshr-8982	145	49	,	,	PUNCT
eshr-8982	145	50	nerves	nerve	NOUN
eshr-8982	145	51	,	,	PUNCT
eshr-8982	145	52	feet	foot	NOUN
eshr-8982	145	53	,	,	PUNCT
eshr-8982	145	54	blood	blood	NOUN
eshr-8982	145	55	vessels	vessel	NOUN
eshr-8982	145	56	,	,	PUNCT
eshr-8982	145	57	kidneys	kidney	NOUN
eshr-8982	145	58	,	,	PUNCT
eshr-8982	145	59	and	and	CCONJ
eshr-8982	145	60	heart	heart	NOUN
eshr-8982	145	61	.	.	PUNCT
eshr-8982	146	1	diabetes	diabetes	NOUN
eshr-8982	146	2	has	have	AUX
eshr-8982	146	3	been	be	AUX
eshr-8982	146	4	linked	link	VERB
eshr-8982	146	5	to	to	ADP
eshr-8982	146	6	microvascular	microvascular	ADJ
eshr-8982	146	7	problems	problem	NOUN
eshr-8982	146	8	,	,	PUNCT
eshr-8982	146	9	including	include	VERB
eshr-8982	146	10	retinopathy	retinopathy	ADJ
eshr-8982	146	11	,	,	PUNCT
eshr-8982	146	12	neuropathy	neuropathy	ADJ
eshr-8982	146	13	,	,	PUNCT
eshr-8982	146	14	and	and	CCONJ
eshr-8982	146	15	nephropathy	nephropathy	NOUN
eshr-8982	146	16	.	.	PUNCT
eshr-8982	147	1	diabetes	diabetes	NOUN
eshr-8982	147	2	microvascular	microvascular	NOUN
eshr-8982	147	3	problems	problem	NOUN
eshr-8982	147	4	include	include	VERB
eshr-8982	147	5	kidney	kidney	NOUN
eshr-8982	147	6	damage	damage	NOUN
eshr-8982	147	7	known	know	VERB
eshr-8982	147	8	as	as	ADP
eshr-8982	147	9	diabetic	diabetic	ADJ
eshr-8982	147	10	nephropathy	nephropathy	NOUN
eshr-8982	147	11	(	(	PUNCT
eshr-8982	147	12	dn	dn	NOUN
eshr-8982	147	13	)	)	PUNCT
eshr-8982	147	14	,	,	PUNCT
eshr-8982	147	15	which	which	PRON
eshr-8982	147	16	is	be	AUX
eshr-8982	147	17	the	the	DET
eshr-8982	147	18	most	most	ADV
eshr-8982	147	19	prevalent	prevalent	ADJ
eshr-8982	147	20	consequence	consequence	NOUN
eshr-8982	147	21	of	of	ADP
eshr-8982	147	22	type	type	NOUN
eshr-8982	147	23	2	2	NUM
eshr-8982	147	24	diabetes	diabetes	NOUN
eshr-8982	147	25	mellitus	mellitus	NOUN
eshr-8982	147	26	and	and	CCONJ
eshr-8982	147	27	the	the	DET
eshr-8982	147	28	leading	lead	VERB
eshr-8982	147	29	cause	cause	NOUN
eshr-8982	147	30	of	of	ADP
eshr-8982	147	31	end	end	NOUN
eshr-8982	147	32	-	-	PUNCT
eshr-8982	147	33	stage	stage	NOUN
eshr-8982	147	34	renal	renal	ADJ
eshr-8982	147	35	disease	disease	NOUN
eshr-8982	147	36	globally	globally	ADV
eshr-8982	147	37	,	,	PUNCT
eshr-8982	147	38	with	with	ADP
eshr-8982	147	39	substantial	substantial	ADJ
eshr-8982	147	40	morbidity	morbidity	NOUN
eshr-8982	147	41	and	and	CCONJ
eshr-8982	147	42	death	death	NOUN
eshr-8982	147	43	.	.	PUNCT
eshr-8982	148	1	it	it	PRON
eshr-8982	148	2	occurs	occur	VERB
eshr-8982	148	3	in	in	ADP
eshr-8982	148	4	around	around	ADV
eshr-8982	148	5	40	40	NUM
eshr-8982	148	6	%	%	NOUN
eshr-8982	148	7	of	of	ADP
eshr-8982	148	8	diabetic	diabetic	ADJ
eshr-8982	148	9	individuals	individual	NOUN
eshr-8982	148	10	after	after	ADP
eshr-8982	148	11	10	10	NUM
eshr-8982	148	12	years	year	NOUN
eshr-8982	148	13	of	of	ADP
eshr-8982	148	14	type	type	NOUN
eshr-8982	148	15	2	2	NUM
eshr-8982	148	16	diabetes	diabetes	NOUN
eshr-8982	148	17	mellitus	mellitus	NOUN
eshr-8982	148	18	diagnosis.20	diagnosis.20	PROPN
eshr-8982	148	19	diabetic	diabetic	ADJ
eshr-8982	148	20	kidney	kidney	NOUN
eshr-8982	148	21	disease	disease	NOUN
eshr-8982	148	22	(	(	PUNCT
eshr-8982	148	23	dkd	dkd	ADJ
eshr-8982	148	24	)	)	PUNCT
eshr-8982	148	25	is	be	AUX
eshr-8982	148	26	uncontrollably	uncontrollably	ADV
eshr-8982	148	27	managed	manage	VERB
eshr-8982	148	28	due	due	ADP
eshr-8982	148	29	to	to	ADP
eshr-8982	148	30	the	the	DET
eshr-8982	148	31	involvement	involvement	NOUN
eshr-8982	148	32	of	of	ADP
eshr-8982	148	33	complex	complex	ADJ
eshr-8982	148	34	pathophysiological	pathophysiological	ADJ
eshr-8982	148	35	pathways	pathway	NOUN
eshr-8982	148	36	that	that	PRON
eshr-8982	148	37	impact	impact	VERB
eshr-8982	148	38	practically	practically	ADV
eshr-8982	148	39	all	all	PRON
eshr-8982	148	40	renal	renal	ADJ
eshr-8982	148	41	tissues	tissue	NOUN
eshr-8982	148	42	,	,	PUNCT
eshr-8982	148	43	including	include	VERB
eshr-8982	148	44	glomeruli	glomeruli	NOUN
eshr-8982	148	45	,	,	PUNCT
eshr-8982	148	46	tubules	tubule	NOUN
eshr-8982	148	47	,	,	PUNCT
eshr-8982	148	48	interstitial	interstitial	ADJ
eshr-8982	148	49	,	,	PUNCT
eshr-8982	148	50	and	and	CCONJ
eshr-8982	148	51	blood	blood	NOUN
eshr-8982	148	52	vessels	vessel	NOUN
eshr-8982	148	53	.	.	PUNCT
eshr-8982	149	1	following	follow	VERB
eshr-8982	149	2	hyperfiltration	hyperfiltration	NOUN
eshr-8982	149	3	,	,	PUNCT
eshr-8982	149	4	microalbuminuria	microalbuminuria	PROPN
eshr-8982	149	5	develops	develop	VERB
eshr-8982	149	6	,	,	PUNCT
eshr-8982	149	7	followed	follow	VERB
eshr-8982	149	8	by	by	ADP
eshr-8982	149	9	proteinuria	proteinuria	NOUN
eshr-8982	149	10	and	and	CCONJ
eshr-8982	149	11	a	a	DET
eshr-8982	149	12	low	low	ADJ
eshr-8982	149	13	estimated	estimate	VERB
eshr-8982	149	14	glomerular	glomerular	ADJ
eshr-8982	149	15	filtration	filtration	NOUN
eshr-8982	149	16	rate	rate	NOUN
eshr-8982	149	17	(	(	PUNCT
eshr-8982	149	18	egfr	egfr	NOUN
eshr-8982	149	19	)	)	PUNCT
eshr-8982	149	20	.	.	PUNCT
eshr-8982	150	1	early	early	ADJ
eshr-8982	150	2	glycemic	glycemic	ADJ
eshr-8982	150	3	variability	variability	NOUN
eshr-8982	150	4	reduction	reduction	NOUN
eshr-8982	150	5	(	(	PUNCT
eshr-8982	150	6	before	before	ADP
eshr-8982	150	7	macro	macro	ADJ
eshr-8982	150	8	albuminuria	albuminuria	PROPN
eshr-8982	150	9	)	)	PUNCT
eshr-8982	150	10	can	can	AUX
eshr-8982	150	11	prevent	prevent	VERB
eshr-8982	150	12	renal	renal	ADJ
eshr-8982	150	13	function	function	NOUN
eshr-8982	150	14	degradation.21	degradation.21	NOUN
eshr-8982	150	15	hyperglycemia	hyperglycemia	NOUN
eshr-8982	150	16	in	in	ADP
eshr-8982	150	17	patients	patient	NOUN
eshr-8982	150	18	with	with	ADP
eshr-8982	150	19	diabetes	diabetes	NOUN
eshr-8982	150	20	mellitus	mellitus	NOUN
eshr-8982	150	21	causes	cause	VERB
eshr-8982	150	22	microalbuminuria	microalbuminuria	NOUN
eshr-8982	150	23	,	,	PUNCT
eshr-8982	150	24	which	which	PRON
eshr-8982	150	25	can	can	AUX
eshr-8982	150	26	increase	increase	VERB
eshr-8982	150	27	intraglomerular	intraglomerular	ADJ
eshr-8982	150	28	pressure	pressure	NOUN
eshr-8982	150	29	.	.	PUNCT
eshr-8982	151	1	a	a	DET
eshr-8982	151	2	glomerular	glomerular	ADJ
eshr-8982	151	3	capillary	capillary	NOUN
eshr-8982	151	4	that	that	PRON
eshr-8982	151	5	can	can	AUX
eshr-8982	151	6	increase	increase	VERB
eshr-8982	151	7	permeability	permeability	NOUN
eshr-8982	151	8	.	.	PUNCT
eshr-8982	152	1	if	if	SCONJ
eshr-8982	152	2	the	the	DET
eshr-8982	152	3	albumin	albumin	ADJ
eshr-8982	152	4	filtration	filtration	NOUN
eshr-8982	152	5	is	be	AUX
eshr-8982	152	6	increased	increase	VERB
eshr-8982	152	7	in	in	ADP
eshr-8982	152	8	the	the	DET
eshr-8982	152	9	glomerulus	glomerulus	NOUN
eshr-8982	152	10	,	,	PUNCT
eshr-8982	152	11	exceeding	exceed	VERB
eshr-8982	152	12	the	the	DET
eshr-8982	152	13	reabsorption	reabsorption	NOUN
eshr-8982	152	14	capacity	capacity	NOUN
eshr-8982	152	15	of	of	ADP
eshr-8982	152	16	the	the	DET
eshr-8982	152	17	tubules	tubule	NOUN
eshr-8982	152	18	,	,	PUNCT
eshr-8982	152	19	then	then	ADV
eshr-8982	152	20	there	there	PRON
eshr-8982	152	21	will	will	AUX
eshr-8982	152	22	be	be	AUX
eshr-8982	152	23	an	an	DET
eshr-8982	152	24	increase	increase	NOUN
eshr-8982	152	25	in	in	ADP
eshr-8982	152	26	the	the	DET
eshr-8982	152	27	excretion	excretion	NOUN
eshr-8982	152	28	of	of	ADP
eshr-8982	152	29	albumin	albumin	NOUN
eshr-8982	152	30	in	in	ADP
eshr-8982	152	31	the	the	DET
eshr-8982	152	32	urine	urine	NOUN
eshr-8982	152	33	.	.	PUNCT
eshr-8982	153	1	creatinine	creatinine	NOUN
eshr-8982	153	2	is	be	AUX
eshr-8982	153	3	released	release	VERB
eshr-8982	153	4	https://doi.org/10.26555/eshr.v3i1.3629	https://doi.org/10.26555/eshr.v3i1.3629	PROPN
eshr-8982	153	5	https://doi.org/10.26555/eshr.v3i1.3629	https://doi.org/10.26555/eshr.v3i1.3629	PROPN
eshr-8982	153	6	purtaria	purtaria	PROPN
eshr-8982	153	7	et	et	PROPN
eshr-8982	153	8	al	al	PROPN
eshr-8982	153	9	.	.	PUNCT
eshr-8982	154	1	(	(	PUNCT
eshr-8982	154	2	the	the	DET
eshr-8982	154	3	importance	importance	NOUN
eshr-8982	154	4	of	of	ADP
eshr-8982	154	5	uacr	uacr	NOUN
eshr-8982	154	6	(	(	PUNCT
eshr-8982	154	7	urinary	urinary	ADJ
eshr-8982	154	8	albumin	albumin	ADJ
eshr-8982	154	9	creatinine	creatinine	NOUN
eshr-8982	154	10	ratio	ratio	NOUN
eshr-8982	154	11	)	)	PUNCT
eshr-8982	154	12	examination	examination	NOUN
eshr-8982	154	13	in	in	ADP
eshr-8982	154	14	patients	patient	NOUN
eshr-8982	154	15	)	)	PUNCT
eshr-8982	154	16	…	…	PUNCT
eshr-8982	154	17	.	.	PUNCT
eshr-8982	155	1	83	83	NUM
eshr-8982	155	2	vol	vol	NOUN
eshr-8982	155	3	.	.	PROPN
eshr-8982	156	1	6	6	NUM
eshr-8982	156	2	,	,	PUNCT
eshr-8982	156	3	no	no	INTJ
eshr-8982	156	4	.	.	NOUN
eshr-8982	156	5	2	2	NUM
eshr-8982	156	6	,	,	PUNCT
eshr-8982	156	7	2024	2024	NUM
eshr-8982	156	8	,	,	PUNCT
eshr-8982	156	9	pp	pp	ADJ
eshr-8982	156	10	.	.	PUNCT
eshr-8982	157	1	74	74	NUM
eshr-8982	157	2	-	-	SYM
eshr-8982	157	3	86	86	NUM
eshr-8982	157	4	10.26555	10.26555	NUM
eshr-8982	157	5	/	/	SYM
eshr-8982	157	6	eshr.v6i2.8982	eshr.v6i2.8982	NUM
eshr-8982	157	7	from	from	ADP
eshr-8982	157	8	the	the	DET
eshr-8982	157	9	kidneys	kidney	NOUN
eshr-8982	157	10	relatively	relatively	ADV
eshr-8982	157	11	constantly	constantly	ADV
eshr-8982	157	12	in	in	ADP
eshr-8982	157	13	the	the	DET
eshr-8982	157	14	plasma	plasma	NOUN
eshr-8982	157	15	daily	daily	ADV
eshr-8982	157	16	through	through	ADP
eshr-8982	157	17	filtration	filtration	NOUN
eshr-8982	157	18	and	and	CCONJ
eshr-8982	157	19	secretion	secretion	NOUN
eshr-8982	157	20	.	.	PUNCT
eshr-8982	158	1	since	since	SCONJ
eshr-8982	158	2	almost	almost	ADV
eshr-8982	158	3	all	all	DET
eshr-8982	158	4	the	the	DET
eshr-8982	158	5	skeleton	skeleton	NOUN
eshr-8982	158	6	muscles	muscle	NOUN
eshr-8982	158	7	produce	produce	VERB
eshr-8982	158	8	creatinine	creatinine	NOUN
eshr-8982	158	9	,	,	PUNCT
eshr-8982	158	10	individuals	individual	NOUN
eshr-8982	158	11	with	with	ADP
eshr-8982	158	12	larger	large	ADJ
eshr-8982	158	13	muscles	muscle	NOUN
eshr-8982	158	14	may	may	AUX
eshr-8982	158	15	have	have	VERB
eshr-8982	158	16	higher	high	ADJ
eshr-8982	158	17	creatinine	creatinine	NOUN
eshr-8982	158	18	levels	level	NOUN
eshr-8982	158	19	.	.	PUNCT
eshr-8982	159	1	blood	blood	NOUN
eshr-8982	159	2	creatinine	creatinine	NOUN
eshr-8982	159	3	tests	test	VERB
eshr-8982	159	4	with	with	ADP
eshr-8982	159	5	urine	urine	NOUN
eshr-8982	159	6	creatinine	creatinine	NOUN
eshr-8982	159	7	usually	usually	ADV
eshr-8982	159	8	assess	assess	VERB
eshr-8982	159	9	the	the	DET
eshr-8982	159	10	speed	speed	NOUN
eshr-8982	159	11	of	of	ADP
eshr-8982	159	12	glomerular	glomerular	ADJ
eshr-8982	159	13	filtration	filtration	NOUN
eshr-8982	159	14	.	.	PUNCT
eshr-8982	160	1	a	a	DET
eshr-8982	160	2	doubling	doubling	NOUN
eshr-8982	160	3	of	of	ADP
eshr-8982	160	4	creatinine	creatinine	NOUN
eshr-8982	160	5	levels	level	NOUN
eshr-8982	160	6	indicates	indicate	VERB
eshr-8982	160	7	a	a	DET
eshr-8982	160	8	decrease	decrease	NOUN
eshr-8982	160	9	in	in	ADP
eshr-8982	160	10	kidney	kidney	NOUN
eshr-8982	160	11	function	function	NOUN
eshr-8982	160	12	by	by	ADP
eshr-8982	160	13	50	50	NUM
eshr-8982	160	14	%	%	NOUN
eshr-8982	160	15	.5	.5	NUM
eshr-8982	160	16	prolonged	prolonged	ADJ
eshr-8982	160	17	hyperglycemia	hyperglycemia	NOUN
eshr-8982	160	18	in	in	ADP
eshr-8982	160	19	patients	patient	NOUN
eshr-8982	160	20	can	can	AUX
eshr-8982	160	21	produce	produce	VERB
eshr-8982	160	22	alterations	alteration	NOUN
eshr-8982	160	23	in	in	ADP
eshr-8982	160	24	the	the	DET
eshr-8982	160	25	basal	basal	ADJ
eshr-8982	160	26	membrane	membrane	NOUN
eshr-8982	160	27	of	of	ADP
eshr-8982	160	28	the	the	DET
eshr-8982	160	29	glomerulus	glomerulus	NOUN
eshr-8982	160	30	,	,	PUNCT
eshr-8982	160	31	including	include	VERB
eshr-8982	160	32	the	the	DET
eshr-8982	160	33	proliferation	proliferation	NOUN
eshr-8982	160	34	of	of	ADP
eshr-8982	160	35	mesangium	mesangium	NOUN
eshr-8982	160	36	cells	cell	NOUN
eshr-8982	160	37	.	.	PUNCT
eshr-8982	161	1	high	high	ADJ
eshr-8982	161	2	blood	blood	NOUN
eshr-8982	161	3	sugar	sugar	NOUN
eshr-8982	161	4	interacts	interact	VERB
eshr-8982	161	5	with	with	ADP
eshr-8982	161	6	proteins	protein	NOUN
eshr-8982	161	7	,	,	PUNCT
eshr-8982	161	8	altering	alter	VERB
eshr-8982	161	9	the	the	DET
eshr-8982	161	10	structure	structure	NOUN
eshr-8982	161	11	and	and	CCONJ
eshr-8982	161	12	function	function	NOUN
eshr-8982	161	13	of	of	ADP
eshr-8982	161	14	cells	cell	NOUN
eshr-8982	161	15	,	,	PUNCT
eshr-8982	161	16	including	include	VERB
eshr-8982	161	17	the	the	DET
eshr-8982	161	18	basal	basal	ADJ
eshr-8982	161	19	membrane	membrane	NOUN
eshr-8982	161	20	of	of	ADP
eshr-8982	161	21	the	the	DET
eshr-8982	161	22	glomerulus	glomerulus	NOUN
eshr-8982	161	23	,	,	PUNCT
eshr-8982	161	24	resulting	result	VERB
eshr-8982	161	25	in	in	ADP
eshr-8982	161	26	a	a	DET
eshr-8982	161	27	broken	broken	ADJ
eshr-8982	161	28	protein	protein	NOUN
eshr-8982	161	29	barrier	barrier	NOUN
eshr-8982	161	30	and	and	CCONJ
eshr-8982	161	31	protein	protein	NOUN
eshr-8982	161	32	leakage	leakage	NOUN
eshr-8982	161	33	into	into	ADP
eshr-8982	161	34	the	the	DET
eshr-8982	161	35	urine	urine	NOUN
eshr-8982	161	36	.	.	PUNCT
eshr-8982	162	1	(	(	PUNCT
eshr-8982	162	2	microalbuminuria	microalbuminuria	PROPN
eshr-8982	162	3	)	)	PUNCT
eshr-8982	162	4	.	.	PUNCT
eshr-8982	163	1	one	one	NUM
eshr-8982	163	2	typical	typical	ADJ
eshr-8982	163	3	complication	complication	NOUN
eshr-8982	163	4	is	be	AUX
eshr-8982	163	5	a	a	DET
eshr-8982	163	6	kidney	kidney	NOUN
eshr-8982	163	7	anomaly	anomaly	NOUN
eshr-8982	163	8	that	that	PRON
eshr-8982	163	9	begins	begin	VERB
eshr-8982	163	10	with	with	ADP
eshr-8982	163	11	microalbuminuria	microalbuminuria	PROPN
eshr-8982	163	12	and	and	CCONJ
eshr-8982	163	13	progresses	progress	VERB
eshr-8982	163	14	to	to	ADP
eshr-8982	163	15	clinical	clinical	ADJ
eshr-8982	163	16	proteinuria	proteinuria	NOUN
eshr-8982	163	17	,	,	PUNCT
eshr-8982	163	18	as	as	ADV
eshr-8982	163	19	well	well	ADV
eshr-8982	163	20	as	as	ADP
eshr-8982	163	21	a	a	DET
eshr-8982	163	22	decline	decline	NOUN
eshr-8982	163	23	in	in	ADP
eshr-8982	163	24	glomerular	glomerular	ADJ
eshr-8982	163	25	filtration	filtration	NOUN
eshr-8982	163	26	rate	rate	NOUN
eshr-8982	163	27	function	function	NOUN
eshr-8982	163	28	,	,	PUNCT
eshr-8982	163	29	which	which	PRON
eshr-8982	163	30	leads	lead	VERB
eshr-8982	163	31	to	to	ADP
eshr-8982	163	32	kidney	kidney	NOUN
eshr-8982	163	33	failure	failure	NOUN
eshr-8982	163	34	and	and	CCONJ
eshr-8982	163	35	requires	require	VERB
eshr-8982	163	36	more	more	ADV
eshr-8982	163	37	extensive	extensive	ADJ
eshr-8982	163	38	management	management	NOUN
eshr-8982	163	39	and	and	CCONJ
eshr-8982	163	40	therapy	therapy	NOUN
eshr-8982	163	41	.	.	PUNCT
eshr-8982	164	1	the	the	DET
eshr-8982	164	2	diagnosis	diagnosis	NOUN
eshr-8982	164	3	of	of	ADP
eshr-8982	164	4	diabetic	diabetic	ADJ
eshr-8982	164	5	nephropathy	nephropathy	NOUN
eshr-8982	164	6	begins	begin	VERB
eshr-8982	164	7	with	with	ADP
eshr-8982	164	8	an	an	DET
eshr-8982	164	9	appearance	appearance	NOUN
eshr-8982	164	10	of	of	ADP
eshr-8982	164	11	albuminuria	albuminuria	NOUN
eshr-8982	164	12	in	in	ADP
eshr-8982	164	13	patients	patient	NOUN
eshr-8982	164	14	with	with	ADP
eshr-8982	164	15	type	type	NOUN
eshr-8982	164	16	2	2	NUM
eshr-8982	164	17	diabetes	diabetes	NOUN
eshr-8982	164	18	.	.	PUNCT
eshr-8982	165	1	when	when	SCONJ
eshr-8982	165	2	the	the	DET
eshr-8982	165	3	amount	amount	NOUN
eshr-8982	165	4	of	of	ADP
eshr-8982	165	5	protein	protein	NOUN
eshr-8982	165	6	and	and	CCONJ
eshr-8982	165	7	albumin	albumin	NOUN
eshr-8982	165	8	in	in	ADP
eshr-8982	165	9	the	the	DET
eshr-8982	165	10	urine	urine	NOUN
eshr-8982	165	11	is	be	AUX
eshr-8982	165	12	still	still	ADV
eshr-8982	165	13	meagre	meagre	ADJ
eshr-8982	165	14	,	,	PUNCT
eshr-8982	165	15	it	it	PRON
eshr-8982	165	16	can	can	AUX
eshr-8982	165	17	be	be	AUX
eshr-8982	165	18	detected	detect	VERB
eshr-8982	165	19	using	use	VERB
eshr-8982	165	20	the	the	DET
eshr-8982	165	21	standard	standard	ADJ
eshr-8982	165	22	urinalysis	urinalysis	NOUN
eshr-8982	165	23	method	method	NOUN
eshr-8982	165	24	;	;	PUNCT
eshr-8982	165	25	however	however	ADV
eshr-8982	165	26	,	,	PUNCT
eshr-8982	165	27	if	if	SCONJ
eshr-8982	165	28	it	it	PRON
eshr-8982	165	29	is	be	AUX
eshr-8982	165	30	greater	great	ADJ
eshr-8982	165	31	than	than	ADP
eshr-8982	165	32	30	30	NUM
eshr-8982	165	33	mg/24	mg/24	PROPN
eshr-8982	165	34	hours	hour	NOUN
eshr-8982	165	35	or	or	CCONJ
eshr-8982	165	36	greater	great	ADJ
eshr-8982	165	37	than	than	ADP
eshr-8982	165	38	20	20	NUM
eshr-8982	165	39	mg	mg	NUM
eshr-8982	165	40	/	/	SYM
eshr-8982	165	41	min	min	NOUN
eshr-8982	165	42	,	,	PUNCT
eshr-8982	165	43	it	it	PRON
eshr-8982	165	44	is	be	AUX
eshr-8982	165	45	also	also	ADV
eshr-8982	165	46	known	know	VERB
eshr-8982	165	47	as	as	ADP
eshr-8982	165	48	microalbuminuria	microalbuminuria	PROPN
eshr-8982	165	49	.	.	PUNCT
eshr-8982	166	1	the	the	DET
eshr-8982	166	2	degree	degree	NOUN
eshr-8982	166	3	of	of	ADP
eshr-8982	166	4	albuminuria	albuminuria	NOUN
eshr-8982	166	5	or	or	CCONJ
eshr-8982	166	6	proteinuria	proteinuria	NOUN
eshr-8982	166	7	can	can	AUX
eshr-8982	166	8	also	also	ADV
eshr-8982	166	9	be	be	AUX
eshr-8982	166	10	measured	measure	VERB
eshr-8982	166	11	by	by	ADP
eshr-8982	166	12	the	the	DET
eshr-8982	166	13	ratio	ratio	NOUN
eshr-8982	166	14	of	of	ADP
eshr-8982	166	15	creatinine	creatinine	NOUN
eshr-8982	166	16	in	in	ADP
eshr-8982	166	17	urine	urine	NOUN
eshr-8982	166	18	taken	take	VERB
eshr-8982	166	19	simultaneously	simultaneously	ADV
eshr-8982	166	20	,	,	PUNCT
eshr-8982	166	21	known	know	VERB
eshr-8982	166	22	as	as	ADP
eshr-8982	166	23	the	the	DET
eshr-8982	166	24	albumin	albumin	NOUN
eshr-8982	166	25	or	or	CCONJ
eshr-8982	166	26	creatinine	creatinine	NOUN
eshr-8982	166	27	ratio	ratio	NOUN
eshr-8982	166	28	(	(	PUNCT
eshr-8982	166	29	acr).22	acr).22	NOUN
eshr-8982	166	30	the	the	DET
eshr-8982	166	31	emergence	emergence	NOUN
eshr-8982	166	32	of	of	ADP
eshr-8982	166	33	chronic	chronic	ADJ
eshr-8982	166	34	kidney	kidney	NOUN
eshr-8982	166	35	disease	disease	NOUN
eshr-8982	166	36	(	(	PUNCT
eshr-8982	166	37	ckd	ckd	NOUN
eshr-8982	166	38	)	)	PUNCT
eshr-8982	166	39	and	and	CCONJ
eshr-8982	166	40	its	its	PRON
eshr-8982	166	41	eventual	eventual	ADJ
eshr-8982	166	42	development	development	NOUN
eshr-8982	166	43	into	into	ADP
eshr-8982	166	44	this	this	DET
eshr-8982	166	45	fatal	fatal	ADJ
eshr-8982	166	46	condition	condition	NOUN
eshr-8982	166	47	continues	continue	VERB
eshr-8982	166	48	to	to	PART
eshr-8982	166	49	be	be	AUX
eshr-8982	166	50	a	a	DET
eshr-8982	166	51	significant	significant	ADJ
eshr-8982	166	52	contributor	contributor	NOUN
eshr-8982	166	53	to	to	PART
eshr-8982	166	54	lower	lower	VERB
eshr-8982	166	55	life	life	NOUN
eshr-8982	166	56	expectancy	expectancy	NOUN
eshr-8982	166	57	and	and	CCONJ
eshr-8982	166	58	early	early	ADJ
eshr-8982	166	59	death	death	NOUN
eshr-8982	166	60	.	.	PUNCT
eshr-8982	167	1	severe	severe	ADJ
eshr-8982	167	2	chronic	chronic	ADJ
eshr-8982	167	3	kidney	kidney	NOUN
eshr-8982	167	4	disease	disease	NOUN
eshr-8982	167	5	(	(	PUNCT
eshr-8982	167	6	ckd	ckd	NOUN
eshr-8982	167	7	)	)	PUNCT
eshr-8982	167	8	requires	require	VERB
eshr-8982	167	9	close	close	ADJ
eshr-8982	167	10	monitoring	monitoring	NOUN
eshr-8982	167	11	for	for	ADP
eshr-8982	167	12	indicators	indicator	NOUN
eshr-8982	167	13	of	of	ADP
eshr-8982	167	14	disease	disease	NOUN
eshr-8982	167	15	progression	progression	NOUN
eshr-8982	167	16	and	and	CCONJ
eshr-8982	167	17	promptly	promptly	ADV
eshr-8982	167	18	referred	refer	VERB
eshr-8982	167	19	to	to	ADP
eshr-8982	167	20	experts	expert	NOUN
eshr-8982	167	21	for	for	ADP
eshr-8982	167	22	dialysis	dialysis	NOUN
eshr-8982	167	23	or	or	CCONJ
eshr-8982	167	24	potential	potential	ADJ
eshr-8982	167	25	renal	renal	ADJ
eshr-8982	167	26	transplant	transplant	NOUN
eshr-8982	167	27	.	.	PUNCT
eshr-8982	168	1	proteinuria	proteinuria	NOUN
eshr-8982	168	2	and	and	CCONJ
eshr-8982	168	3	glomerular	glomerular	ADJ
eshr-8982	168	4	filtration	filtration	NOUN
eshr-8982	168	5	rate	rate	NOUN
eshr-8982	168	6	are	be	AUX
eshr-8982	168	7	kidney	kidney	NOUN
eshr-8982	168	8	damage	damage	NOUN
eshr-8982	168	9	markers	marker	NOUN
eshr-8982	168	10	used	use	VERB
eshr-8982	168	11	by	by	ADP
eshr-8982	168	12	the	the	DET
eshr-8982	168	13	kidney	kidney	NOUN
eshr-8982	168	14	disease	disease	NOUN
eshr-8982	168	15	improving	improve	VERB
eshr-8982	168	16	global	global	ADJ
eshr-8982	168	17	outcomes	outcome	NOUN
eshr-8982	168	18	(	(	PUNCT
eshr-8982	168	19	kdigo	kdigo	PROPN
eshr-8982	168	20	)	)	PUNCT
eshr-8982	168	21	foundation	foundation	NOUN
eshr-8982	168	22	recommendations	recommendation	NOUN
eshr-8982	168	23	to	to	PART
eshr-8982	168	24	characterize	characterize	VERB
eshr-8982	168	25	chronic	chronic	ADJ
eshr-8982	168	26	kidney	kidney	NOUN
eshr-8982	168	27	disease	disease	NOUN
eshr-8982	168	28	(	(	PUNCT
eshr-8982	168	29	ckd	ckd	PROPN
eshr-8982	168	30	)	)	PUNCT
eshr-8982	168	31	.	.	PUNCT
eshr-8982	169	1	chronic	chronic	ADJ
eshr-8982	169	2	renal	renal	ADJ
eshr-8982	169	3	disease	disease	NOUN
eshr-8982	169	4	is	be	AUX
eshr-8982	169	5	defined	define	VERB
eshr-8982	169	6	as	as	ADP
eshr-8982	169	7	having	have	VERB
eshr-8982	169	8	both	both	DET
eshr-8982	169	9	parameters	parameter	NOUN
eshr-8982	169	10	—	—	PUNCT
eshr-8982	169	11	abnormalities	abnormality	NOUN
eshr-8982	169	12	of	of	ADP
eshr-8982	169	13	kidney	kidney	NOUN
eshr-8982	169	14	structure	structure	NOUN
eshr-8982	169	15	or	or	CCONJ
eshr-8982	169	16	function	function	NOUN
eshr-8982	169	17	for	for	ADP
eshr-8982	169	18	longer	long	ADJ
eshr-8982	169	19	than	than	ADP
eshr-8982	169	20	three	three	NUM
eshr-8982	169	21	months	month	NOUN
eshr-8982	169	22	—	—	PUNCT
eshr-8982	169	23	along	along	ADP
eshr-8982	169	24	with	with	ADP
eshr-8982	169	25	glomerular	glomerular	ADJ
eshr-8982	169	26	filtration	filtration	NOUN
eshr-8982	169	27	rate	rate	NOUN
eshr-8982	169	28	[	[	X
eshr-8982	169	29	gfr	gfr	X
eshr-8982	169	30	]	]	X
eshr-8982	169	31	less	less	ADJ
eshr-8982	169	32	than	than	ADP
eshr-8982	169	33	60	60	NUM
eshr-8982	169	34	ml	ml	NOUN
eshr-8982	169	35	/	/	SYM
eshr-8982	169	36	min	min	NOUN
eshr-8982	169	37	and	and	CCONJ
eshr-8982	169	38	albumin	albumin	NOUN
eshr-8982	169	39	greater	great	ADJ
eshr-8982	169	40	than	than	ADP
eshr-8982	169	41	30	30	NUM
eshr-8982	169	42	mg	mg	NOUN
eshr-8982	169	43	per	per	ADP
eshr-8982	169	44	gram	gram	NOUN
eshr-8982	169	45	of	of	ADP
eshr-8982	169	46	creatinine	creatinine	NOUN
eshr-8982	169	47	.	.	PUNCT
eshr-8982	170	1	a	a	DET
eshr-8982	170	2	gfr	gfr	NOUN
eshr-8982	170	3	of	of	ADP
eshr-8982	170	4	less	less	ADJ
eshr-8982	170	5	than	than	ADP
eshr-8982	170	6	15	15	NUM
eshr-8982	170	7	ml	ml	NOUN
eshr-8982	170	8	/	/	SYM
eshr-8982	170	9	min	min	NOUN
eshr-8982	170	10	is	be	AUX
eshr-8982	170	11	considered	consider	VERB
eshr-8982	170	12	end	end	NOUN
eshr-8982	170	13	-	-	PUNCT
eshr-8982	170	14	stage	stage	NOUN
eshr-8982	170	15	renal	renal	NOUN
eshr-8982	170	16	disease.23	disease.23	VERB
eshr-8982	170	17	patients	patient	NOUN
eshr-8982	170	18	with	with	ADP
eshr-8982	170	19	diabetes	diabetes	NOUN
eshr-8982	170	20	may	may	AUX
eshr-8982	170	21	experience	experience	VERB
eshr-8982	170	22	an	an	DET
eshr-8982	170	23	imbalance	imbalance	NOUN
eshr-8982	170	24	in	in	ADP
eshr-8982	170	25	their	their	PRON
eshr-8982	170	26	sex	sex	NOUN
eshr-8982	170	27	hormones	hormone	NOUN
eshr-8982	170	28	.	.	PUNCT
eshr-8982	171	1	research	research	NOUN
eshr-8982	171	2	has	have	AUX
eshr-8982	171	3	indicated	indicate	VERB
eshr-8982	171	4	that	that	SCONJ
eshr-8982	171	5	men	man	NOUN
eshr-8982	171	6	with	with	ADP
eshr-8982	171	7	diabetes	diabetes	NOUN
eshr-8982	171	8	have	have	VERB
eshr-8982	171	9	lower	low	ADJ
eshr-8982	171	10	levels	level	NOUN
eshr-8982	171	11	of	of	ADP
eshr-8982	171	12	testosterone	testosterone	NOUN
eshr-8982	171	13	and	and	CCONJ
eshr-8982	171	14	higher	high	ADJ
eshr-8982	171	15	amounts	amount	NOUN
eshr-8982	171	16	of	of	ADP
eshr-8982	171	17	estradiol	estradiol	PROPN
eshr-8982	171	18	in	in	ADP
eshr-8982	171	19	comparison	comparison	NOUN
eshr-8982	171	20	to	to	ADP
eshr-8982	171	21	those	those	PRON
eshr-8982	171	22	without	without	ADP
eshr-8982	171	23	the	the	DET
eshr-8982	171	24	disease	disease	NOUN
eshr-8982	171	25	.	.	PUNCT
eshr-8982	172	1	nonetheless	nonetheless	ADV
eshr-8982	172	2	,	,	PUNCT
eshr-8982	172	3	women	woman	NOUN
eshr-8982	172	4	with	with	ADP
eshr-8982	172	5	diabetes	diabetes	NOUN
eshr-8982	172	6	had	have	VERB
eshr-8982	172	7	lower	low	ADJ
eshr-8982	172	8	levels	level	NOUN
eshr-8982	172	9	of	of	ADP
eshr-8982	172	10	estrogen	estrogen	NOUN
eshr-8982	172	11	and	and	CCONJ
eshr-8982	172	12	higher	high	ADJ
eshr-8982	172	13	amounts	amount	NOUN
eshr-8982	172	14	of	of	ADP
eshr-8982	172	15	testosterone	testosterone	NOUN
eshr-8982	172	16	than	than	ADP
eshr-8982	172	17	women	woman	NOUN
eshr-8982	172	18	without	without	ADP
eshr-8982	172	19	the	the	DET
eshr-8982	172	20	disease	disease	NOUN
eshr-8982	172	21	,	,	PUNCT
eshr-8982	172	22	indicating	indicate	VERB
eshr-8982	172	23	that	that	SCONJ
eshr-8982	172	24	a	a	DET
eshr-8982	172	25	sex	sex	NOUN
eshr-8982	172	26	hormone	hormone	NOUN
eshr-8982	172	27	imbalance	imbalance	NOUN
eshr-8982	172	28	may	may	AUX
eshr-8982	172	29	be	be	AUX
eshr-8982	172	30	linked	link	VERB
eshr-8982	172	31	to	to	ADP
eshr-8982	172	32	diabetes	diabetes	NOUN
eshr-8982	172	33	.	.	PUNCT
eshr-8982	173	1	when	when	SCONJ
eshr-8982	173	2	compared	compare	VERB
eshr-8982	173	3	to	to	ADP
eshr-8982	173	4	women	woman	NOUN
eshr-8982	173	5	without	without	ADP
eshr-8982	173	6	diabetes	diabetes	NOUN
eshr-8982	173	7	,	,	PUNCT
eshr-8982	173	8	females	female	NOUN
eshr-8982	173	9	with	with	ADP
eshr-8982	173	10	diabetes	diabetes	NOUN
eshr-8982	173	11	may	may	AUX
eshr-8982	173	12	have	have	VERB
eshr-8982	173	13	lower	low	ADJ
eshr-8982	173	14	levels	level	NOUN
eshr-8982	173	15	of	of	ADP
eshr-8982	173	16	estradiol	estradiol	PROPN
eshr-8982	173	17	,	,	PUNCT
eshr-8982	173	18	which	which	PRON
eshr-8982	173	19	might	might	AUX
eshr-8982	173	20	increase	increase	VERB
eshr-8982	173	21	urine	urine	ADJ
eshr-8982	173	22	albumin	albumin	ADJ
eshr-8982	173	23	excretion	excretion	NOUN
eshr-8982	173	24	,	,	PUNCT
eshr-8982	173	25	lower	low	ADJ
eshr-8982	173	26	creatinine	creatinine	NOUN
eshr-8982	173	27	clearance	clearance	NOUN
eshr-8982	173	28	,	,	PUNCT
eshr-8982	173	29	and	and	CCONJ
eshr-8982	173	30	worsen	worsen	VERB
eshr-8982	173	31	tubular	tubular	ADJ
eshr-8982	173	32	fibrosis	fibrosis	NOUN
eshr-8982	173	33	in	in	ADP
eshr-8982	173	34	the	the	DET
eshr-8982	173	35	kidneys	kidney	NOUN
eshr-8982	173	36	.	.	PUNCT
eshr-8982	174	1	these	these	DET
eshr-8982	174	2	effects	effect	NOUN
eshr-8982	174	3	could	could	AUX
eshr-8982	174	4	raise	raise	VERB
eshr-8982	174	5	the	the	DET
eshr-8982	174	6	chance	chance	NOUN
eshr-8982	174	7	of	of	ADP
eshr-8982	174	8	having	have	VERB
eshr-8982	174	9	renal	renal	ADJ
eshr-8982	174	10	problems.24	problems.24	PROPN
eshr-8982	174	11	in	in	ADP
eshr-8982	174	12	diabetic	diabetic	ADJ
eshr-8982	174	13	individuals	individual	NOUN
eshr-8982	174	14	,	,	PUNCT
eshr-8982	174	15	oxidative	oxidative	ADJ
eshr-8982	174	16	stress	stress	NOUN
eshr-8982	174	17	has	have	AUX
eshr-8982	174	18	been	be	AUX
eshr-8982	174	19	implicated	implicate	VERB
eshr-8982	174	20	as	as	ADP
eshr-8982	174	21	a	a	DET
eshr-8982	174	22	pathogenic	pathogenic	ADJ
eshr-8982	174	23	factor	factor	NOUN
eshr-8982	174	24	in	in	ADP
eshr-8982	174	25	the	the	DET
eshr-8982	174	26	development	development	NOUN
eshr-8982	174	27	of	of	ADP
eshr-8982	174	28	nephropathy	nephropathy	NOUN
eshr-8982	174	29	.	.	PUNCT
eshr-8982	175	1	bilirubin	bilirubin	NOUN
eshr-8982	175	2	is	be	AUX
eshr-8982	175	3	a	a	DET
eshr-8982	175	4	potent	potent	ADJ
eshr-8982	175	5	antioxidant	antioxidant	NOUN
eshr-8982	175	6	that	that	SCONJ
eshr-8982	175	7	mainly	mainly	ADV
eshr-8982	175	8	shields	shield	VERB
eshr-8982	175	9	cells	cell	NOUN
eshr-8982	175	10	from	from	ADP
eshr-8982	175	11	fat	fat	ADJ
eshr-8982	175	12	perspiration	perspiration	NOUN
eshr-8982	175	13	.	.	PUNCT
eshr-8982	176	1	from	from	ADP
eshr-8982	176	2	biliverdin	biliverdin	VERB
eshr-8982	176	3	,	,	PUNCT
eshr-8982	176	4	it	it	PRON
eshr-8982	176	5	is	be	AUX
eshr-8982	176	6	produced	produce	VERB
eshr-8982	176	7	by	by	ADP
eshr-8982	176	8	reducer	reducer	NOUN
eshr-8982	176	9	of	of	ADP
eshr-8982	176	10	biliverdin	biliverdin	VERB
eshr-8982	176	11	.	.	PUNCT
eshr-8982	177	1	it	it	PRON
eshr-8982	177	2	is	be	AUX
eshr-8982	177	3	transformed	transform	VERB
eshr-8982	177	4	into	into	ADP
eshr-8982	177	5	biliverdin	biliverdin	VERB
eshr-8982	177	6	during	during	ADP
eshr-8982	177	7	its	its	PRON
eshr-8982	177	8	antioxidant	antioxidant	ADJ
eshr-8982	177	9	action	action	NOUN
eshr-8982	177	10	,	,	PUNCT
eshr-8982	177	11	which	which	PRON
eshr-8982	177	12	happens	happen	VERB
eshr-8982	177	13	immediately	immediately	ADV
eshr-8982	177	14	.	.	PUNCT
eshr-8982	178	1	biliverdin	biliverdin	VERB
eshr-8982	178	2	reductase	reductase	NOUN
eshr-8982	178	3	reduces	reduce	VERB
eshr-8982	178	4	it	it	PRON
eshr-8982	178	5	once	once	ADV
eshr-8982	178	6	more	more	ADV
eshr-8982	178	7	to	to	ADP
eshr-8982	178	8	bilirubin	bilirubin	VERB
eshr-8982	178	9	.	.	PUNCT
eshr-8982	179	1	the	the	DET
eshr-8982	179	2	specific	specific	ADJ
eshr-8982	179	3	nature	nature	NOUN
eshr-8982	179	4	of	of	ADP
eshr-8982	179	5	the	the	DET
eshr-8982	179	6	connection	connection	NOUN
eshr-8982	179	7	between	between	ADP
eshr-8982	179	8	blood	blood	NOUN
eshr-8982	179	9	bilirubin	bilirubin	NOUN
eshr-8982	179	10	level	level	NOUN
eshr-8982	179	11	and	and	CCONJ
eshr-8982	179	12	the	the	DET
eshr-8982	179	13	emergence	emergence	NOUN
eshr-8982	179	14	of	of	ADP
eshr-8982	179	15	diabetic	diabetic	ADJ
eshr-8982	179	16	people	people	NOUN
eshr-8982	179	17	may	may	AUX
eshr-8982	179	18	or	or	CCONJ
eshr-8982	179	19	may	may	AUX
eshr-8982	179	20	not	not	PART
eshr-8982	179	21	have	have	VERB
eshr-8982	179	22	nephropathy	nephropathy	NOUN
eshr-8982	179	23	.	.	PUNCT
eshr-8982	180	1	nevertheless	nevertheless	ADV
eshr-8982	180	2	,	,	PUNCT
eshr-8982	180	3	it	it	PRON
eshr-8982	180	4	is	be	AUX
eshr-8982	180	5	anticipated	anticipate	VERB
eshr-8982	180	6	that	that	SCONJ
eshr-8982	180	7	elevated	elevated	ADJ
eshr-8982	180	8	bilirubin	bilirubin	NOUN
eshr-8982	180	9	levels	level	NOUN
eshr-8982	180	10	in	in	ADP
eshr-8982	180	11	the	the	DET
eshr-8982	180	12	serum	serum	NOUN
eshr-8982	180	13	within	within	ADP
eshr-8982	180	14	a	a	DET
eshr-8982	180	15	normal	normal	ADJ
eshr-8982	180	16	range	range	NOUN
eshr-8982	180	17	can	can	AUX
eshr-8982	180	18	prevent	prevent	VERB
eshr-8982	180	19	oxidative	oxidative	ADJ
eshr-8982	180	20	tension	tension	NOUN
eshr-8982	180	21	and	and	CCONJ
eshr-8982	180	22	inflammation	inflammation	NOUN
eshr-8982	180	23	,	,	PUNCT
eshr-8982	180	24	hence	hence	ADV
eshr-8982	180	25	averting	avert	VERB
eshr-8982	180	26	the	the	DET
eshr-8982	180	27	onset	onset	NOUN
eshr-8982	180	28	of	of	ADP
eshr-8982	180	29	nephropathy	nephropathy	ADJ
eshr-8982	180	30	https://doi.org/10.26555/eshr.v3i1.3629	https://doi.org/10.26555/eshr.v3i1.3629	PROPN
eshr-8982	180	31	https://doi.org/10.26555/eshr.v3i1.3629	https://doi.org/10.26555/eshr.v3i1.3629	PROPN
eshr-8982	180	32	purtaria	purtaria	NOUN
eshr-8982	180	33	et	et	PROPN
eshr-8982	180	34	al	al	PROPN
eshr-8982	180	35	.	.	PUNCT
eshr-8982	181	1	(	(	PUNCT
eshr-8982	181	2	the	the	DET
eshr-8982	181	3	importance	importance	NOUN
eshr-8982	181	4	of	of	ADP
eshr-8982	181	5	uacr	uacr	NOUN
eshr-8982	181	6	(	(	PUNCT
eshr-8982	181	7	urinary	urinary	ADJ
eshr-8982	181	8	albumin	albumin	ADJ
eshr-8982	181	9	creatinine	creatinine	NOUN
eshr-8982	181	10	ratio	ratio	NOUN
eshr-8982	181	11	)	)	PUNCT
eshr-8982	181	12	examination	examination	NOUN
eshr-8982	181	13	in	in	ADP
eshr-8982	181	14	patients	patient	NOUN
eshr-8982	181	15	)	)	PUNCT
eshr-8982	181	16	…	…	PUNCT
eshr-8982	181	17	.	.	PUNCT
eshr-8982	182	1	84	84	NUM
eshr-8982	182	2	vol	vol	NOUN
eshr-8982	182	3	.	.	PROPN
eshr-8982	183	1	6	6	NUM
eshr-8982	183	2	,	,	PUNCT
eshr-8982	183	3	no	no	INTJ
eshr-8982	183	4	.	.	NOUN
eshr-8982	183	5	2	2	NUM
eshr-8982	183	6	,	,	PUNCT
eshr-8982	183	7	2024	2024	NUM
eshr-8982	183	8	,	,	PUNCT
eshr-8982	183	9	pp	pp	ADJ
eshr-8982	183	10	.	.	PUNCT
eshr-8982	184	1	74	74	NUM
eshr-8982	184	2	-	-	SYM
eshr-8982	184	3	86	86	NUM
eshr-8982	184	4	10.26555	10.26555	NUM
eshr-8982	184	5	/	/	SYM
eshr-8982	184	6	eshr.v6i2.8982	eshr.v6i2.8982	NUM
eshr-8982	184	7	caused	cause	VERB
eshr-8982	184	8	by	by	ADP
eshr-8982	184	9	diabetes	diabete	NOUN
eshr-8982	184	10	.	.	PUNCT
eshr-8982	185	1	previously	previously	ADV
eshr-8982	185	2	,	,	PUNCT
eshr-8982	185	3	low	low	ADJ
eshr-8982	185	4	serum	serum	NOUN
eshr-8982	185	5	bilirubin	bilirubin	NOUN
eshr-8982	185	6	levels	level	NOUN
eshr-8982	185	7	have	have	AUX
eshr-8982	185	8	been	be	AUX
eshr-8982	185	9	linked	link	VERB
eshr-8982	185	10	to	to	ADP
eshr-8982	185	11	research	research	NOUN
eshr-8982	185	12	.	.	PUNCT
eshr-8982	186	1	predicts	predict	VERB
eshr-8982	186	2	the	the	DET
eshr-8982	186	3	onset	onset	NOUN
eshr-8982	186	4	of	of	ADP
eshr-8982	186	5	chronic	chronic	ADJ
eshr-8982	186	6	renal	renal	ADJ
eshr-8982	186	7	disease	disease	NOUN
eshr-8982	186	8	among	among	ADP
eshr-8982	186	9	individuals	individual	NOUN
eshr-8982	186	10	with	with	ADP
eshr-8982	186	11	diabetes	diabetes	NOUN
eshr-8982	186	12	mellitus	mellitus	NOUN
eshr-8982	186	13	type	type	VERB
eshr-8982	186	14	2.25	2.25	NUM
eshr-8982	186	15	however	however	ADV
eshr-8982	186	16	,	,	PUNCT
eshr-8982	186	17	many	many	ADJ
eshr-8982	186	18	of	of	ADP
eshr-8982	186	19	these	these	DET
eshr-8982	186	20	consequences	consequence	NOUN
eshr-8982	186	21	can	can	AUX
eshr-8982	186	22	be	be	AUX
eshr-8982	186	23	mitigated	mitigate	VERB
eshr-8982	186	24	by	by	ADP
eshr-8982	186	25	minimizing	minimize	VERB
eshr-8982	186	26	diabetic	diabetic	ADJ
eshr-8982	186	27	complications	complication	NOUN
eshr-8982	186	28	.	.	PUNCT
eshr-8982	187	1	this	this	PRON
eshr-8982	187	2	is	be	AUX
eshr-8982	187	3	possible	possible	ADJ
eshr-8982	187	4	with	with	ADP
eshr-8982	187	5	diabetes	diabetes	NOUN
eshr-8982	187	6	medicines	medicine	NOUN
eshr-8982	187	7	.	.	PUNCT
eshr-8982	188	1	even	even	ADV
eshr-8982	188	2	though	though	SCONJ
eshr-8982	188	3	a	a	DET
eshr-8982	188	4	variety	variety	NOUN
eshr-8982	188	5	of	of	ADP
eshr-8982	188	6	drugs	drug	NOUN
eshr-8982	188	7	have	have	AUX
eshr-8982	188	8	been	be	AUX
eshr-8982	188	9	shown	show	VERB
eshr-8982	188	10	to	to	PART
eshr-8982	188	11	reduce	reduce	VERB
eshr-8982	188	12	blood	blood	NOUN
eshr-8982	188	13	glucose	glucose	NOUN
eshr-8982	188	14	(	(	PUNCT
eshr-8982	188	15	glycaemia	glycaemia	NOUN
eshr-8982	188	16	)	)	PUNCT
eshr-8982	188	17	,	,	PUNCT
eshr-8982	188	18	current	current	ADJ
eshr-8982	188	19	care	care	NOUN
eshr-8982	188	20	has	have	AUX
eshr-8982	188	21	failed	fail	VERB
eshr-8982	188	22	to	to	PART
eshr-8982	188	23	achieve	achieve	VERB
eshr-8982	188	24	and	and	CCONJ
eshr-8982	188	25	maintain	maintain	VERB
eshr-8982	188	26	ideal	ideal	ADJ
eshr-8982	188	27	glycemic	glycemic	ADJ
eshr-8982	188	28	control	control	NOUN
eshr-8982	188	29	in	in	ADP
eshr-8982	188	30	diabetic	diabetic	ADJ
eshr-8982	188	31	patients	patient	NOUN
eshr-8982	188	32	.	.	PUNCT
eshr-8982	189	1	non	non	ADJ
eshr-8982	189	2	-	-	NOUN
eshr-8982	189	3	adherence	adherence	NOUN
eshr-8982	189	4	to	to	ADP
eshr-8982	189	5	diabetes	diabetes	NOUN
eshr-8982	189	6	treatments	treatment	NOUN
eshr-8982	189	7	is	be	AUX
eshr-8982	189	8	one	one	NUM
eshr-8982	189	9	of	of	ADP
eshr-8982	189	10	the	the	DET
eshr-8982	189	11	leading	lead	VERB
eshr-8982	189	12	causes	cause	NOUN
eshr-8982	189	13	of	of	ADP
eshr-8982	189	14	poor	poor	ADJ
eshr-8982	189	15	glycemic	glycemic	ADJ
eshr-8982	189	16	control	control	NOUN
eshr-8982	189	17	.	.	PUNCT
eshr-8982	190	1	noncompliance	noncompliance	NOUN
eshr-8982	190	2	with	with	ADP
eshr-8982	190	3	diabetes	diabetes	NOUN
eshr-8982	190	4	treatment	treatment	NOUN
eshr-8982	190	5	has	have	VERB
eshr-8982	190	6	several	several	ADJ
eshr-8982	190	7	implications	implication	NOUN
eshr-8982	190	8	.	.	PUNCT
eshr-8982	191	1	some	some	PRON
eshr-8982	191	2	of	of	ADP
eshr-8982	191	3	these	these	PRON
eshr-8982	191	4	were	be	AUX
eshr-8982	191	5	higher	high	ADJ
eshr-8982	191	6	out	out	ADP
eshr-8982	191	7	-	-	PUNCT
eshr-8982	191	8	of	of	ADP
eshr-8982	191	9	-	-	PUNCT
eshr-8982	191	10	pocket	pocket	NOUN
eshr-8982	191	11	expenses	expense	NOUN
eshr-8982	191	12	,	,	PUNCT
eshr-8982	191	13	increased	increase	VERB
eshr-8982	191	14	overall	overall	ADJ
eshr-8982	191	15	healthcare	healthcare	NOUN
eshr-8982	191	16	costs	cost	NOUN
eshr-8982	191	17	,	,	PUNCT
eshr-8982	191	18	morbidity	morbidity	NOUN
eshr-8982	191	19	increases	increase	NOUN
eshr-8982	191	20	,	,	PUNCT
eshr-8982	191	21	and	and	CCONJ
eshr-8982	191	22	deaths.26	deaths.26	ADJ
eshr-8982	191	23	patients	patient	NOUN
eshr-8982	191	24	with	with	ADP
eshr-8982	191	25	demanding	demand	VERB
eshr-8982	191	26	glycemic	glycemic	ADJ
eshr-8982	191	27	management	management	NOUN
eshr-8982	191	28	and	and	CCONJ
eshr-8982	191	29	minimal	minimal	ADJ
eshr-8982	191	30	hba1c	hba1c	NOUN
eshr-8982	191	31	variability	variability	NOUN
eshr-8982	191	32	showed	show	VERB
eshr-8982	191	33	steady	steady	ADJ
eshr-8982	191	34	renal	renal	ADJ
eshr-8982	191	35	function	function	NOUN
eshr-8982	191	36	with	with	ADP
eshr-8982	191	37	no	no	DET
eshr-8982	191	38	deterioration	deterioration	NOUN
eshr-8982	191	39	.	.	PUNCT
eshr-8982	192	1	patients	patient	NOUN
eshr-8982	192	2	'	'	PART
eshr-8982	192	3	renal	renal	ADJ
eshr-8982	192	4	function	function	NOUN
eshr-8982	192	5	would	would	AUX
eshr-8982	192	6	not	not	PART
eshr-8982	192	7	decline	decline	VERB
eshr-8982	192	8	if	if	SCONJ
eshr-8982	192	9	they	they	PRON
eshr-8982	192	10	had	have	VERB
eshr-8982	192	11	optimal	optimal	ADJ
eshr-8982	192	12	glucose	glucose	NOUN
eshr-8982	192	13	control	control	NOUN
eshr-8982	192	14	.	.	PUNCT
eshr-8982	193	1	early	early	ADJ
eshr-8982	193	2	glycemic	glycemic	ADJ
eshr-8982	193	3	variability	variability	NOUN
eshr-8982	193	4	reduction	reduction	NOUN
eshr-8982	193	5	(	(	PUNCT
eshr-8982	193	6	before	before	ADP
eshr-8982	193	7	macro	macro	ADJ
eshr-8982	193	8	albuminuria	albuminuria	PROPN
eshr-8982	193	9	)	)	PUNCT
eshr-8982	193	10	can	can	AUX
eshr-8982	193	11	halt	halt	VERB
eshr-8982	193	12	renal	renal	ADJ
eshr-8982	193	13	function	function	NOUN
eshr-8982	193	14	degradation	degradation	NOUN
eshr-8982	193	15	.	.	PUNCT
eshr-8982	194	1	hba1c_cv	hba1c_cv	PROPN
eshr-8982	194	2	should	should	AUX
eshr-8982	194	3	be	be	AUX
eshr-8982	194	4	monitored	monitor	VERB
eshr-8982	194	5	and	and	CCONJ
eshr-8982	194	6	minimized	minimize	VERB
eshr-8982	194	7	regularly	regularly	ADV
eshr-8982	194	8	for	for	ADP
eshr-8982	194	9	diabetes	diabetes	NOUN
eshr-8982	194	10	treatment.21	treatment.21	NOUN
eshr-8982	194	11	this	this	DET
eshr-8982	194	12	study	study	NOUN
eshr-8982	194	13	had	have	VERB
eshr-8982	194	14	some	some	DET
eshr-8982	194	15	limitations	limitation	NOUN
eshr-8982	194	16	;	;	PUNCT
eshr-8982	194	17	the	the	DET
eshr-8982	194	18	data	datum	NOUN
eshr-8982	194	19	retrieved	retrieve	VERB
eshr-8982	194	20	was	be	AUX
eshr-8982	194	21	limited	limit	VERB
eshr-8982	194	22	from	from	ADP
eshr-8982	194	23	article	article	NOUN
eshr-8982	194	24	search	search	NOUN
eshr-8982	194	25	results	result	NOUN
eshr-8982	194	26	in	in	ADP
eshr-8982	194	27	the	the	DET
eshr-8982	194	28	database	database	NOUN
eshr-8982	194	29	with	with	ADP
eshr-8982	194	30	unpaid	unpaid	ADJ
eshr-8982	194	31	criteria	criterion	NOUN
eshr-8982	194	32	due	due	ADP
eshr-8982	194	33	to	to	ADP
eshr-8982	194	34	funding	funding	NOUN
eshr-8982	194	35	limitations	limitation	NOUN
eshr-8982	194	36	.	.	PUNCT
eshr-8982	195	1	conclusion	conclusion	NOUN
eshr-8982	195	2	uacr	uacr	NOUN
eshr-8982	195	3	examination	examination	NOUN
eshr-8982	195	4	is	be	AUX
eshr-8982	195	5	necessary	necessary	ADJ
eshr-8982	195	6	for	for	SCONJ
eshr-8982	195	7	people	people	NOUN
eshr-8982	195	8	with	with	ADP
eshr-8982	195	9	type	type	NOUN
eshr-8982	195	10	2	2	NUM
eshr-8982	195	11	diabetes	diabetes	NOUN
eshr-8982	195	12	to	to	PART
eshr-8982	195	13	monitor	monitor	VERB
eshr-8982	195	14	the	the	DET
eshr-8982	195	15	condition	condition	NOUN
eshr-8982	195	16	of	of	ADP
eshr-8982	195	17	the	the	DET
eshr-8982	195	18	kidneys	kidney	NOUN
eshr-8982	195	19	.	.	PUNCT
eshr-8982	196	1	the	the	DET
eshr-8982	196	2	examination	examination	NOUN
eshr-8982	196	3	was	be	AUX
eshr-8982	196	4	carried	carry	VERB
eshr-8982	196	5	out	out	ADP
eshr-8982	196	6	using	use	VERB
eshr-8982	196	7	the	the	DET
eshr-8982	196	8	patient	patient	NOUN
eshr-8982	196	9	's	's	PART
eshr-8982	196	10	urine	urine	NOUN
eshr-8982	196	11	sample	sample	NOUN
eshr-8982	196	12	.	.	PUNCT
eshr-8982	197	1	low	low	ADJ
eshr-8982	197	2	acr	acr	PROPN
eshr-8982	197	3	levels	level	NOUN
eshr-8982	197	4	will	will	AUX
eshr-8982	197	5	slow	slow	VERB
eshr-8982	197	6	kidney	kidney	NOUN
eshr-8982	197	7	damage	damage	NOUN
eshr-8982	197	8	,	,	PUNCT
eshr-8982	197	9	so	so	ADV
eshr-8982	197	10	routine	routine	ADJ
eshr-8982	197	11	treatment	treatment	NOUN
eshr-8982	197	12	is	be	AUX
eshr-8982	197	13	needed	need	VERB
eshr-8982	197	14	in	in	ADP
eshr-8982	197	15	type	type	NOUN
eshr-8982	197	16	2	2	NUM
eshr-8982	197	17	dm	dm	NOUN
eshr-8982	197	18	patients	patient	NOUN
eshr-8982	197	19	.	.	PUNCT
eshr-8982	198	1	the	the	DET
eshr-8982	198	2	national	national	ADJ
eshr-8982	198	3	social	social	ADJ
eshr-8982	198	4	security	security	NOUN
eshr-8982	198	5	agency	agency	NOUN
eshr-8982	198	6	on	on	ADP
eshr-8982	198	7	health	health	NOUN
eshr-8982	198	8	(	(	PUNCT
eshr-8982	198	9	bpjs	bpjs	NOUN
eshr-8982	198	10	)	)	PUNCT
eshr-8982	198	11	that	that	PRON
eshr-8982	198	12	is	be	AUX
eshr-8982	198	13	the	the	DET
eshr-8982	198	14	chronic	chronic	ADJ
eshr-8982	198	15	disease	disease	NOUN
eshr-8982	198	16	management	management	NOUN
eshr-8982	198	17	program	program	NOUN
eshr-8982	198	18	called	call	VERB
eshr-8982	198	19	as	as	ADP
eshr-8982	198	20	prolanis	prolanis	NOUN
eshr-8982	198	21	,	,	PUNCT
eshr-8982	198	22	which	which	PRON
eshr-8982	198	23	has	have	AUX
eshr-8982	198	24	scheduled	schedule	VERB
eshr-8982	198	25	free	free	ADJ
eshr-8982	198	26	examinations	examination	NOUN
eshr-8982	198	27	every	every	DET
eshr-8982	198	28	6	6	NUM
eshr-8982	198	29	months	month	NOUN
eshr-8982	198	30	for	for	ADP
eshr-8982	198	31	dm	dm	PROPN
eshr-8982	198	32	and	and	CCONJ
eshr-8982	198	33	ht	ht	PROPN
eshr-8982	198	34	patients	patient	NOUN
eshr-8982	198	35	,	,	PUNCT
eshr-8982	198	36	is	be	AUX
eshr-8982	198	37	one	one	NUM
eshr-8982	198	38	of	of	ADP
eshr-8982	198	39	the	the	DET
eshr-8982	198	40	efforts	effort	NOUN
eshr-8982	198	41	of	of	ADP
eshr-8982	198	42	health	health	NOUN
eshr-8982	198	43	services	service	NOUN
eshr-8982	198	44	to	to	PART
eshr-8982	198	45	be	be	AUX
eshr-8982	198	46	able	able	ADJ
eshr-8982	198	47	to	to	PART
eshr-8982	198	48	monitor	monitor	VERB
eshr-8982	198	49	the	the	DET
eshr-8982	198	50	kidney	kidney	NOUN
eshr-8982	198	51	condition	condition	NOUN
eshr-8982	198	52	of	of	ADP
eshr-8982	198	53	dm	dm	PROPN
eshr-8982	198	54	and	and	CCONJ
eshr-8982	198	55	ht	ht	PROPN
eshr-8982	198	56	patients	patient	NOUN
eshr-8982	198	57	so	so	SCONJ
eshr-8982	198	58	that	that	SCONJ
eshr-8982	198	59	the	the	DET
eshr-8982	198	60	first	first	ADJ
eshr-8982	198	61	step	step	NOUN
eshr-8982	198	62	in	in	ADP
eshr-8982	198	63	treatment	treatment	NOUN
eshr-8982	198	64	can	can	AUX
eshr-8982	198	65	be	be	AUX
eshr-8982	198	66	carried	carry	VERB
eshr-8982	198	67	out	out	ADP
eshr-8982	198	68	as	as	ADP
eshr-8982	198	69	a	a	DET
eshr-8982	198	70	follow	follow	NOUN
eshr-8982	198	71	-	-	PUNCT
eshr-8982	198	72	up	up	NOUN
eshr-8982	198	73	to	to	ADP
eshr-8982	198	74	the	the	DET
eshr-8982	198	75	results	result	NOUN
eshr-8982	198	76	of	of	ADP
eshr-8982	198	77	the	the	DET
eshr-8982	198	78	examination	examination	NOUN
eshr-8982	198	79	.	.	PUNCT
eshr-8982	199	1	conflict	conflict	NOUN
eshr-8982	199	2	of	of	ADP
eshr-8982	199	3	interest	interest	NOUN
eshr-8982	199	4	there	there	PRON
eshr-8982	199	5	is	be	VERB
eshr-8982	199	6	no	no	DET
eshr-8982	199	7	conflict	conflict	NOUN
eshr-8982	199	8	of	of	ADP
eshr-8982	199	9	interest	interest	NOUN
eshr-8982	199	10	in	in	ADP
eshr-8982	199	11	this	this	DET
eshr-8982	199	12	research	research	NOUN
eshr-8982	199	13	.	.	PUNCT
eshr-8982	200	1	references	reference	NOUN
eshr-8982	200	2	1	1	NUM
eshr-8982	200	3	.	.	PUNCT
eshr-8982	200	4	rondhianto	rondhianto	ADJ
eshr-8982	200	5	r	r	NOUN
eshr-8982	200	6	,	,	PUNCT
eshr-8982	200	7	siswoyo	siswoyo	NOUN
eshr-8982	200	8	s	s	PART
eshr-8982	200	9	,	,	PUNCT
eshr-8982	200	10	fathoni	fathoni	ADJ
eshr-8982	200	11	a.	a.	NOUN
eshr-8982	200	12	effectiveness	effectiveness	NOUN
eshr-8982	200	13	of	of	ADP
eshr-8982	200	14	empowerment	empowerment	NOUN
eshr-8982	200	15	-	-	PUNCT
eshr-8982	200	16	based	base	VERB
eshr-8982	200	17	diabetes	diabetes	NOUN
eshr-8982	200	18	education	education	NOUN
eshr-8982	200	19	on	on	ADP
eshr-8982	200	20	diabetes	diabetes	NOUN
eshr-8982	200	21	complication	complication	NOUN
eshr-8982	200	22	prevention	prevention	NOUN
eshr-8982	200	23	:	:	PUNCT
eshr-8982	200	24	a	a	DET
eshr-8982	200	25	systematic	systematic	ADJ
eshr-8982	200	26	review	review	NOUN
eshr-8982	200	27	.	.	PUNCT
eshr-8982	201	1	jurnal	jurnal	ADJ
eshr-8982	201	2	aisyah	aisyah	PROPN
eshr-8982	201	3	:	:	PUNCT
eshr-8982	201	4	jurnal	jurnal	ADJ
eshr-8982	201	5	ilmu	ilmu	PROPN
eshr-8982	201	6	kesehatan	kesehatan	PROPN
eshr-8982	201	7	.	.	PUNCT
eshr-8982	202	1	2022;7(4):1123–30	2022;7(4):1123–30	NUM
eshr-8982	202	2	.	.	PUNCT
eshr-8982	203	1	2	2	X
eshr-8982	203	2	.	.	X
eshr-8982	203	3	international	international	ADJ
eshr-8982	203	4	diabetes	diabetes	PROPN
eshr-8982	203	5	federation	federation	PROPN
eshr-8982	203	6	.	.	PUNCT
eshr-8982	204	1	idf	idf	PROPN
eshr-8982	204	2	diabetes	diabetes	PROPN
eshr-8982	204	3	atlas	atlas	PROPN
eshr-8982	204	4	10th	10th	PROPN
eshr-8982	204	5	edition	edition	PROPN
eshr-8982	204	6	2021	2021	NUM
eshr-8982	204	7	.	.	PUNCT
eshr-8982	205	1	available	available	ADJ
eshr-8982	205	2	from	from	ADP
eshr-8982	205	3	:	:	PUNCT
eshr-8982	205	4	https://diabetesatlas.org/data/en/world/	https://diabetesatlas.org/data/en/world/	PROPN
eshr-8982	205	5	3	3	NUM
eshr-8982	205	6	.	.	PUNCT
eshr-8982	206	1	wada	wada	PROPN
eshr-8982	206	2	t	t	PROPN
eshr-8982	206	3	,	,	PUNCT
eshr-8982	206	4	mori	mori	NOUN
eshr-8982	206	5	-	-	PUNCT
eshr-8982	206	6	anai	anai	NOUN
eshr-8982	206	7	k	k	PROPN
eshr-8982	206	8	,	,	PUNCT
eshr-8982	206	9	kawaguchi	kawaguchi	PROPN
eshr-8982	206	10	y	y	PROPN
eshr-8982	206	11	,	,	PUNCT
eshr-8982	206	12	katsumata	katsumata	PROPN
eshr-8982	206	13	h	h	PROPN
eshr-8982	206	14	,	,	PUNCT
eshr-8982	206	15	tsuda	tsuda	NOUN
eshr-8982	206	16	h	h	PROPN
eshr-8982	206	17	,	,	PUNCT
eshr-8982	206	18	iida	iida	PROPN
eshr-8982	206	19	m	m	PROPN
eshr-8982	206	20	,	,	PUNCT
eshr-8982	206	21	et	et	PROPN
eshr-8982	206	22	al	al	PROPN
eshr-8982	206	23	.	.	PROPN
eshr-8982	207	1	renal	renal	ADJ
eshr-8982	207	2	,	,	PUNCT
eshr-8982	207	3	cardiovascular	cardiovascular	ADJ
eshr-8982	207	4	and	and	CCONJ
eshr-8982	207	5	safety	safety	NOUN
eshr-8982	207	6	outcomes	outcome	NOUN
eshr-8982	207	7	of	of	ADP
eshr-8982	207	8	canagli	canagli	PROPN
eshr-8982	207	9	fl	fl	NUM
eshr-8982	207	10	ozin	ozin	NOUN
eshr-8982	207	11	in	in	ADP
eshr-8982	207	12	patients	patient	NOUN
eshr-8982	207	13	with	with	ADP
eshr-8982	207	14	type	type	NOUN
eshr-8982	207	15	2	2	NUM
eshr-8982	207	16	diabetes	diabetes	NOUN
eshr-8982	207	17	and	and	CCONJ
eshr-8982	207	18	nephropathy	nephropathy	NOUN
eshr-8982	207	19	in	in	ADP
eshr-8982	207	20	east	east	PROPN
eshr-8982	207	21	and	and	CCONJ
eshr-8982	207	22	south	south	ADJ
eshr-8982	207	23	-	-	PUNCT
eshr-8982	207	24	east	east	NOUN
eshr-8982	207	25	asian	asian	ADJ
eshr-8982	207	26	countries	country	NOUN
eshr-8982	207	27	:	:	PUNCT
eshr-8982	207	28	results	result	NOUN
eshr-8982	207	29	from	from	ADP
eshr-8982	207	30	the	the	DET
eshr-8982	207	31	canagli	canagli	NOUN
eshr-8982	207	32	fl	fl	NUM
eshr-8982	207	33	ozin	ozin	NOUN
eshr-8982	207	34	and	and	CCONJ
eshr-8982	207	35	renal	renal	ADJ
eshr-8982	207	36	events	event	NOUN
eshr-8982	207	37	in	in	ADP
eshr-8982	207	38	diabetes	diabetes	NOUN
eshr-8982	207	39	with	with	ADP
eshr-8982	207	40	established	establish	VERB
eshr-8982	207	41	nephropathy	nephropathy	ADJ
eshr-8982	207	42	clinical	clinical	PROPN
eshr-8982	207	43	eva	eva	PROPN
eshr-8982	207	44	.	.	PUNCT
eshr-8982	208	1	2022;13(1	2022;13(1	NUM
eshr-8982	208	2	)	)	PUNCT
eshr-8982	208	3	.	.	PUNCT
eshr-8982	209	1	4	4	X
eshr-8982	209	2	.	.	X
eshr-8982	209	3	antwi	antwi	ADJ
eshr-8982	209	4	-	-	PUNCT
eshr-8982	209	5	boasiako	boasiako	PROPN
eshr-8982	209	6	c	c	PROPN
eshr-8982	209	7	,	,	PUNCT
eshr-8982	209	8	amponsah	amponsah	PROPN
eshr-8982	209	9	k	k	NOUN
eshr-8982	209	10	,	,	PUNCT
eshr-8982	209	11	amissah	amissah	PROPN
eshr-8982	209	12	-	-	PUNCT
eshr-8982	209	13	arthur	arthur	PROPN
eshr-8982	209	14	kn	kn	PROPN
eshr-8982	209	15	,	,	PUNCT
eshr-8982	209	16	musah	musah	NOUN
eshr-8982	209	17	l	l	NOUN
eshr-8982	209	18	,	,	PUNCT
eshr-8982	209	19	abaidoo	abaidoo	PROPN
eshr-8982	209	20	b	b	PROPN
eshr-8982	209	21	,	,	PUNCT
eshr-8982	209	22	wedoi	wedoi	PROPN
eshr-8982	209	23	h	h	NOUN
eshr-8982	209	24	,	,	PUNCT
eshr-8982	209	25	et	et	PROPN
eshr-8982	209	26	al	al	PROPN
eshr-8982	209	27	.	.	PROPN
eshr-8982	209	28	association	association	PROPN
eshr-8982	209	29	between	between	ADP
eshr-8982	209	30	albuminuria	albuminuria	PROPN
eshr-8982	209	31	and	and	CCONJ
eshr-8982	209	32	retinal	retinal	ADJ
eshr-8982	209	33	microvascular	microvascular	NOUN
eshr-8982	209	34	dysfunction	dysfunction	NOUN
eshr-8982	209	35	in	in	ADP
eshr-8982	209	36	type	type	NOUN
eshr-8982	209	37	2	2	NUM
eshr-8982	209	38	diabetes	diabetes	NOUN
eshr-8982	209	39	with	with	ADP
eshr-8982	209	40	and	and	CCONJ
eshr-8982	209	41	without	without	ADP
eshr-8982	209	42	hypertension	hypertension	NOUN
eshr-8982	209	43	.	.	PUNCT
eshr-8982	210	1	diabetes	diabetes	NOUN
eshr-8982	210	2	epidemiology	epidemiology	NOUN
eshr-8982	210	3	and	and	CCONJ
eshr-8982	210	4	management	management	NOUN
eshr-8982	210	5	.	.	PUNCT
eshr-8982	211	1	2023;11:100139	2023;11:100139	NUM
eshr-8982	211	2	.	.	PUNCT
eshr-8982	211	3	https://doi.org/10.26555/eshr.v3i1.3629	https://doi.org/10.26555/eshr.v3i1.3629	PROPN
eshr-8982	211	4	https://doi.org/10.26555/eshr.v3i1.3629	https://doi.org/10.26555/eshr.v3i1.3629	X
eshr-8982	211	5	https://diabetesatlas.org/data/en/world/	https://diabetesatlas.org/data/en/world/	PROPN
eshr-8982	211	6	purtaria	purtaria	NOUN
eshr-8982	211	7	et	et	PROPN
eshr-8982	211	8	al	al	PROPN
eshr-8982	211	9	.	.	PUNCT
eshr-8982	212	1	(	(	PUNCT
eshr-8982	212	2	the	the	DET
eshr-8982	212	3	importance	importance	NOUN
eshr-8982	212	4	of	of	ADP
eshr-8982	212	5	uacr	uacr	NOUN
eshr-8982	212	6	(	(	PUNCT
eshr-8982	212	7	urinary	urinary	ADJ
eshr-8982	212	8	albumin	albumin	ADJ
eshr-8982	212	9	creatinine	creatinine	NOUN
eshr-8982	212	10	ratio	ratio	NOUN
eshr-8982	212	11	)	)	PUNCT
eshr-8982	212	12	examination	examination	NOUN
eshr-8982	212	13	in	in	ADP
eshr-8982	212	14	patients	patient	NOUN
eshr-8982	212	15	)	)	PUNCT
eshr-8982	212	16	…	…	PUNCT
eshr-8982	212	17	.	.	PUNCT
eshr-8982	212	18	85	85	NUM
eshr-8982	212	19	vol	vol	NOUN
eshr-8982	212	20	.	.	PROPN
eshr-8982	213	1	6	6	NUM
eshr-8982	213	2	,	,	PUNCT
eshr-8982	213	3	no	no	INTJ
eshr-8982	213	4	.	.	NOUN
eshr-8982	213	5	2	2	NUM
eshr-8982	213	6	,	,	PUNCT
eshr-8982	213	7	2024	2024	NUM
eshr-8982	213	8	,	,	PUNCT
eshr-8982	213	9	pp	pp	ADJ
eshr-8982	213	10	.	.	PUNCT
eshr-8982	214	1	74	74	NUM
eshr-8982	214	2	-	-	SYM
eshr-8982	214	3	86	86	NUM
eshr-8982	214	4	10.26555	10.26555	NUM
eshr-8982	214	5	/	/	SYM
eshr-8982	214	6	eshr.v6i2.8982	eshr.v6i2.8982	NUM
eshr-8982	214	7	5	5	NUM
eshr-8982	214	8	.	.	X
eshr-8982	214	9	afera	afera	NOUN
eshr-8982	214	10	sl	sl	PROPN
eshr-8982	214	11	,	,	PUNCT
eshr-8982	214	12	santoso	santoso	NOUN
eshr-8982	214	13	sd	sd	PROPN
eshr-8982	214	14	,	,	PUNCT
eshr-8982	214	15	santosa	santosa	PROPN
eshr-8982	214	16	ri	ri	PROPN
eshr-8982	214	17	.	.	PROPN
eshr-8982	214	18	rasio	rasio	PROPN
eshr-8982	214	19	albumin	albumin	PROPN
eshr-8982	214	20	kreatinin	kreatinin	PROPN
eshr-8982	214	21	urin	urin	PROPN
eshr-8982	214	22	sebagai	sebagai	PROPN
eshr-8982	214	23	deteksi	deteksi	PROPN
eshr-8982	214	24	dini	dini	PROPN
eshr-8982	214	25	gangguan	gangguan	PROPN
eshr-8982	214	26	fungsi	fungsi	PROPN
eshr-8982	214	27	ginjal	ginjal	PROPN
eshr-8982	214	28	pada	pada	PROPN
eshr-8982	214	29	diabetes	diabetes	PROPN
eshr-8982	214	30	melitus	melitus	NOUN
eshr-8982	214	31	.	.	PUNCT
eshr-8982	215	1	jurnal	jurnal	ADJ
eshr-8982	215	2	sainhealth	sainhealth	PROPN
eshr-8982	215	3	.	.	PUNCT
eshr-8982	216	1	2021;5(2):1–5	2021;5(2):1–5	NUM
eshr-8982	216	2	.	.	PUNCT
eshr-8982	217	1	6	6	NUM
eshr-8982	217	2	.	.	X
eshr-8982	218	1	wang	wang	PROPN
eshr-8982	218	2	z	z	PROPN
eshr-8982	218	3	,	,	PUNCT
eshr-8982	218	4	yuan	yuan	PROPN
eshr-8982	218	5	j	j	PROPN
eshr-8982	218	6	,	,	PUNCT
eshr-8982	218	7	wan	wan	PROPN
eshr-8982	218	8	w	w	PROPN
eshr-8982	218	9	bin	bin	PROPN
eshr-8982	218	10	,	,	PUNCT
eshr-8982	218	11	ding	ding	PROPN
eshr-8982	218	12	j	j	PROPN
eshr-8982	218	13	,	,	PUNCT
eshr-8982	218	14	han	han	PROPN
eshr-8982	218	15	l	l	PROPN
eshr-8982	218	16	,	,	PUNCT
eshr-8982	218	17	zhao	zhao	PROPN
eshr-8982	218	18	p	p	X
eshr-8982	218	19	,	,	PUNCT
eshr-8982	218	20	et	et	PROPN
eshr-8982	218	21	al	al	PROPN
eshr-8982	218	22	.	.	PROPN
eshr-8982	218	23	positive	positive	PROPN
eshr-8982	218	24	association	association	NOUN
eshr-8982	218	25	between	between	ADP
eshr-8982	218	26	urinary	urinary	ADJ
eshr-8982	218	27	albumin	albumin	NOUN
eshr-8982	218	28	-	-	PUNCT
eshr-8982	218	29	creatinine	creatinine	NOUN
eshr-8982	218	30	ratio	ratio	NOUN
eshr-8982	218	31	and	and	CCONJ
eshr-8982	218	32	lower	low	ADJ
eshr-8982	218	33	extremity	extremity	NOUN
eshr-8982	218	34	peripheral	peripheral	ADJ
eshr-8982	218	35	arterial	arterial	ADJ
eshr-8982	218	36	disease	disease	NOUN
eshr-8982	218	37	in	in	ADP
eshr-8982	218	38	chinese	chinese	ADJ
eshr-8982	218	39	diabetes	diabetes	NOUN
eshr-8982	218	40	patients	patient	NOUN
eshr-8982	218	41	:	:	PUNCT
eshr-8982	218	42	a	a	DET
eshr-8982	218	43	cross	cross	ADJ
eshr-8982	218	44	-	-	ADJ
eshr-8982	218	45	section	section	ADJ
eshr-8982	218	46	study	study	NOUN
eshr-8982	218	47	with	with	ADP
eshr-8982	218	48	propensity	propensity	NOUN
eshr-8982	218	49	score	score	NOUN
eshr-8982	218	50	matching	match	VERB
eshr-8982	218	51	analysis	analysis	NOUN
eshr-8982	218	52	.	.	PUNCT
eshr-8982	219	1	nutrition	nutrition	NOUN
eshr-8982	219	2	,	,	PUNCT
eshr-8982	219	3	metabolism	metabolism	NOUN
eshr-8982	219	4	and	and	CCONJ
eshr-8982	219	5	cardiovascular	cardiovascular	ADJ
eshr-8982	219	6	diseases	disease	NOUN
eshr-8982	219	7	.	.	PUNCT
eshr-8982	220	1	2023;33(3):541–50	2023;33(3):541–50	NUM
eshr-8982	220	2	.	.	NOUN
eshr-8982	221	1	7	7	NUM
eshr-8982	221	2	.	.	PUNCT
eshr-8982	221	3	hou	hou	PROPN
eshr-8982	221	4	l	l	PROPN
eshr-8982	221	5	,	,	PUNCT
eshr-8982	221	6	shi	shi	PROPN
eshr-8982	221	7	y	y	PROPN
eshr-8982	221	8	,	,	PUNCT
eshr-8982	221	9	wang	wang	PROPN
eshr-8982	221	10	s	s	PROPN
eshr-8982	221	11	,	,	PUNCT
eshr-8982	221	12	chen	chen	PROPN
eshr-8982	222	1	q	q	PROPN
eshr-8982	222	2	,	,	PUNCT
eshr-8982	222	3	li	li	PROPN
eshr-8982	222	4	q	q	PROPN
eshr-8982	222	5	,	,	PUNCT
eshr-8982	222	6	zhao	zhao	PROPN
eshr-8982	222	7	m	m	PROPN
eshr-8982	222	8	,	,	PUNCT
eshr-8982	222	9	et	et	PROPN
eshr-8982	222	10	al	al	PROPN
eshr-8982	222	11	.	.	PROPN
eshr-8982	222	12	associations	association	NOUN
eshr-8982	222	13	of	of	ADP
eshr-8982	222	14	serum	serum	PROPN
eshr-8982	222	15	uric	uric	ADJ
eshr-8982	222	16	acid	acid	NOUN
eshr-8982	222	17	level	level	NOUN
eshr-8982	222	18	with	with	ADP
eshr-8982	222	19	diabetic	diabetic	ADJ
eshr-8982	222	20	retinopathy	retinopathy	NOUN
eshr-8982	222	21	and	and	CCONJ
eshr-8982	222	22	albuminuria	albuminuria	NOUN
eshr-8982	222	23	in	in	ADP
eshr-8982	222	24	patients	patient	NOUN
eshr-8982	222	25	with	with	ADP
eshr-8982	222	26	type	type	NOUN
eshr-8982	222	27	2	2	NUM
eshr-8982	222	28	diabetes	diabetes	NOUN
eshr-8982	222	29	mellitus	mellitus	NOUN
eshr-8982	222	30	.	.	PUNCT
eshr-8982	223	1	journal	journal	PROPN
eshr-8982	223	2	of	of	ADP
eshr-8982	223	3	international	international	ADJ
eshr-8982	223	4	medical	medical	ADJ
eshr-8982	223	5	research	research	NOUN
eshr-8982	223	6	.	.	PUNCT
eshr-8982	224	1	2020	2020	NUM
eshr-8982	224	2	;	;	PUNCT
eshr-8982	225	1	48(12):300060520963980	48(12):300060520963980	X
eshr-8982	225	2	.	.	NOUN
eshr-8982	225	3	8	8	NUM
eshr-8982	225	4	.	.	PUNCT
eshr-8982	225	5	gerstein	gerstein	NOUN
eshr-8982	225	6	hc	hc	PROPN
eshr-8982	225	7	,	,	PUNCT
eshr-8982	225	8	ramasundarahettige	ramasundarahettige	NOUN
eshr-8982	225	9	c	c	NOUN
eshr-8982	225	10	,	,	PUNCT
eshr-8982	225	11	avezum	avezum	NOUN
eshr-8982	225	12	a	a	PRON
eshr-8982	225	13	,	,	PUNCT
eshr-8982	225	14	basile	basile	PROPN
eshr-8982	225	15	j	j	PROPN
eshr-8982	225	16	,	,	PUNCT
eshr-8982	225	17	conget	conget	VERB
eshr-8982	225	18	i	i	PRON
eshr-8982	225	19	,	,	PUNCT
eshr-8982	225	20	cushman	cushman	PROPN
eshr-8982	225	21	wc	wc	PROPN
eshr-8982	225	22	,	,	PUNCT
eshr-8982	225	23	et	et	PROPN
eshr-8982	225	24	al	al	PROPN
eshr-8982	225	25	.	.	PUNCT
eshr-8982	226	1	a	a	DET
eshr-8982	226	2	novel	novel	ADJ
eshr-8982	226	3	kidney	kidney	NOUN
eshr-8982	226	4	disease	disease	NOUN
eshr-8982	226	5	index	index	NOUN
eshr-8982	226	6	reflecting	reflect	VERB
eshr-8982	226	7	both	both	CCONJ
eshr-8982	226	8	the	the	DET
eshr-8982	226	9	albumin	albumin	NOUN
eshr-8982	226	10	to	to	PART
eshr-8982	226	11	creatinine	creatinine	NOUN
eshr-8982	226	12	ratio	ratio	NOUN
eshr-8982	226	13	and	and	CCONJ
eshr-8982	226	14	estimated	estimate	VERB
eshr-8982	226	15	glomerular	glomerular	ADJ
eshr-8982	226	16	filtration	filtration	NOUN
eshr-8982	226	17	rate	rate	NOUN
eshr-8982	226	18	,	,	PUNCT
eshr-8982	226	19	predicted	predict	VERB
eshr-8982	226	20	cardiovascular	cardiovascular	ADJ
eshr-8982	226	21	and	and	CCONJ
eshr-8982	226	22	kidney	kidney	NOUN
eshr-8982	226	23	outcomes	outcome	NOUN
eshr-8982	226	24	in	in	ADP
eshr-8982	226	25	type	type	NOUN
eshr-8982	226	26	2	2	NUM
eshr-8982	226	27	diabetes	diabetes	NOUN
eshr-8982	226	28	.	.	PUNCT
eshr-8982	227	1	cardiovascular	cardiovascular	ADJ
eshr-8982	227	2	diabetology	diabetology	NOUN
eshr-8982	227	3	.	.	PUNCT
eshr-8982	228	1	2022;1–8	2022;1–8	NUM
eshr-8982	228	2	.	.	PUNCT
eshr-8982	229	1	9	9	X
eshr-8982	229	2	.	.	X
eshr-8982	230	1	ren	ren	PROPN
eshr-8982	230	2	f	f	PROPN
eshr-8982	230	3	,	,	PUNCT
eshr-8982	230	4	li	li	PROPN
eshr-8982	230	5	m	m	PROPN
eshr-8982	230	6	,	,	PUNCT
eshr-8982	230	7	hua	hua	PROPN
eshr-8982	230	8	mm	mm	PROPN
eshr-8982	230	9	,	,	PUNCT
eshr-8982	230	10	bd	bd	PROPN
eshr-8982	230	11	x	x	PROPN
eshr-8982	230	12	,	,	PUNCT
eshr-8982	230	13	qin	qin	PROPN
eshr-8982	230	14	x	x	PROPN
eshr-8982	230	15	,	,	PUNCT
eshr-8982	230	16	mm	mm	PROPN
eshr-8982	230	17	yt	yt	PROPN
eshr-8982	230	18	.	.	PROPN
eshr-8982	230	19	urine	urine	PROPN
eshr-8982	230	20	albumintocreatinine	albumintocreatinine	ADJ
eshr-8982	230	21	ratio	ratio	NOUN
eshr-8982	230	22	within	within	ADP
eshr-8982	230	23	the	the	DET
eshr-8982	230	24	normal	normal	ADJ
eshr-8982	230	25	range	range	NOUN
eshr-8982	230	26	and	and	CCONJ
eshr-8982	230	27	risk	risk	NOUN
eshr-8982	230	28	of	of	ADP
eshr-8982	230	29	hypertension	hypertension	NOUN
eshr-8982	230	30	in	in	ADP
eshr-8982	230	31	the	the	DET
eshr-8982	230	32	general	general	ADJ
eshr-8982	230	33	population	population	NOUN
eshr-8982	230	34	:	:	PUNCT
eshr-8982	230	35	a	a	DET
eshr-8982	230	36	metaanalysis	metaanalysis	NOUN
eshr-8982	230	37	.	.	PUNCT
eshr-8982	231	1	j	j	PROPN
eshr-8982	231	2	clin	clin	PROPN
eshr-8982	231	3	hypertens	hyperten	VERB
eshr-8982	231	4	(	(	PUNCT
eshr-8982	231	5	greenwich	greenwich	PROPN
eshr-8982	231	6	)	)	PUNCT
eshr-8982	231	7	.	.	PUNCT
eshr-8982	232	1	2021;(march):1284–90	2021;(march):1284–90	NUM
eshr-8982	232	2	.	.	PUNCT
eshr-8982	233	1	10	10	NUM
eshr-8982	233	2	.	.	X
eshr-8982	234	1	bpharm	bpharm	PROPN
eshr-8982	234	2	wt	wt	PROPN
eshr-8982	234	3	,	,	PUNCT
eshr-8982	234	4	kerr	kerr	PROPN
eshr-8982	234	5	sj	sj	PROPN
eshr-8982	234	6	,	,	PUNCT
eshr-8982	234	7	boonyakrai	boonyakrai	PROPN
eshr-8982	234	8	c	c	X
eshr-8982	234	9	,	,	PUNCT
eshr-8982	234	10	udomkarnjananun	udomkarnjananun	PROPN
eshr-8982	234	11	s	s	PROPN
eshr-8982	234	12	,	,	PUNCT
eshr-8982	234	13	mrn	mrn	PROPN
eshr-8982	234	14	sc	sc	PROPN
eshr-8982	234	15	,	,	PUNCT
eshr-8982	234	16	sakulbumrungsil	sakulbumrungsil	PROPN
eshr-8982	234	17	r.	r.	PROPN
eshr-8982	234	18	development	development	PROPN
eshr-8982	234	19	and	and	CCONJ
eshr-8982	234	20	validation	validation	NOUN
eshr-8982	234	21	of	of	ADP
eshr-8982	234	22	a	a	DET
eshr-8982	234	23	chronic	chronic	ADJ
eshr-8982	234	24	kidney	kidney	NOUN
eshr-8982	234	25	disease	disease	NOUN
eshr-8982	234	26	prediction	prediction	NOUN
eshr-8982	234	27	model	model	NOUN
eshr-8982	234	28	for	for	ADP
eshr-8982	234	29	type	type	NOUN
eshr-8982	234	30	2	2	NUM
eshr-8982	234	31	diabetes	diabetes	NOUN
eshr-8982	234	32	mellitus	mellitus	NOUN
eshr-8982	234	33	in	in	ADP
eshr-8982	234	34	thailand	thailand	PROPN
eshr-8982	234	35	.	.	PUNCT
eshr-8982	235	1	value	value	PROPN
eshr-8982	235	2	in	in	ADP
eshr-8982	235	3	health	health	NOUN
eshr-8982	235	4	regional	regional	ADJ
eshr-8982	235	5	issues	issue	NOUN
eshr-8982	235	6	.	.	PUNCT
eshr-8982	236	1	2020;24:157–66	2020;24:157–66	X
eshr-8982	236	2	.	.	PROPN
eshr-8982	236	3	11	11	NUM
eshr-8982	236	4	.	.	PUNCT
eshr-8982	237	1	stack	stack	PROPN
eshr-8982	237	2	ag	ag	PROPN
eshr-8982	237	3	,	,	PUNCT
eshr-8982	237	4	dronamraju	dronamraju	NOUN
eshr-8982	237	5	n	n	CCONJ
eshr-8982	237	6	,	,	PUNCT
eshr-8982	237	7	parkinson	parkinson	PROPN
eshr-8982	237	8	j	j	PROPN
eshr-8982	237	9	,	,	PUNCT
eshr-8982	237	10	johansson	johansson	PROPN
eshr-8982	237	11	s	s	PROPN
eshr-8982	237	12	,	,	PUNCT
eshr-8982	237	13	johnsson	johnsson	PROPN
eshr-8982	237	14	e	e	PROPN
eshr-8982	237	15	,	,	PUNCT
eshr-8982	237	16	erlandsson	erlandsson	PROPN
eshr-8982	237	17	f	f	PROPN
eshr-8982	237	18	,	,	PUNCT
eshr-8982	237	19	et	et	PROPN
eshr-8982	237	20	al	al	PROPN
eshr-8982	237	21	.	.	PROPN
eshr-8982	237	22	effect	effect	NOUN
eshr-8982	237	23	of	of	ADP
eshr-8982	237	24	intensive	intensive	ADJ
eshr-8982	237	25	urate	urate	NOUN
eshr-8982	237	26	lowering	lower	VERB
eshr-8982	237	27	with	with	ADP
eshr-8982	237	28	combined	combined	ADJ
eshr-8982	237	29	verinurad	verinurad	NOUN
eshr-8982	237	30	and	and	CCONJ
eshr-8982	237	31	febuxostat	febuxostat	NOUN
eshr-8982	237	32	on	on	ADP
eshr-8982	237	33	albuminuria	albuminuria	NOUN
eshr-8982	237	34	in	in	ADP
eshr-8982	237	35	patients	patient	NOUN
eshr-8982	237	36	with	with	ADP
eshr-8982	237	37	type	type	NOUN
eshr-8982	237	38	2	2	NUM
eshr-8982	237	39	diabetes	diabetes	NOUN
eshr-8982	237	40	:	:	PUNCT
eshr-8982	237	41	a	a	DET
eshr-8982	237	42	randomized	randomized	ADJ
eshr-8982	237	43	trial	trial	NOUN
eshr-8982	237	44	.	.	PUNCT
eshr-8982	238	1	american	american	ADJ
eshr-8982	238	2	journal	journal	PROPN
eshr-8982	238	3	of	of	ADP
eshr-8982	238	4	kidney	kidney	NOUN
eshr-8982	238	5	diseases	disease	NOUN
eshr-8982	238	6	.	.	PUNCT
eshr-8982	239	1	2021;77(4):481–9	2021;77(4):481–9	NUM
eshr-8982	239	2	.	.	PUNCT
eshr-8982	240	1	12	12	NUM
eshr-8982	240	2	.	.	PUNCT
eshr-8982	241	1	xie	xie	PROPN
eshr-8982	241	2	y	y	PROPN
eshr-8982	241	3	,	,	PUNCT
eshr-8982	241	4	jin	jin	PROPN
eshr-8982	241	5	d	d	PROPN
eshr-8982	241	6	,	,	PUNCT
eshr-8982	241	7	qiu	qiu	PROPN
eshr-8982	241	8	h	h	PROPN
eshr-8982	241	9	,	,	PUNCT
eshr-8982	241	10	lin	lin	PROPN
eshr-8982	241	11	l	l	PROPN
eshr-8982	241	12	,	,	PUNCT
eshr-8982	241	13	sun	sun	PROPN
eshr-8982	241	14	s	s	PROPN
eshr-8982	241	15	,	,	PUNCT
eshr-8982	241	16	li	li	PROPN
eshr-8982	241	17	d	d	PROPN
eshr-8982	241	18	,	,	PUNCT
eshr-8982	241	19	et	et	PROPN
eshr-8982	241	20	al	al	PROPN
eshr-8982	241	21	.	.	PROPN
eshr-8982	241	22	assessment	assessment	NOUN
eshr-8982	241	23	of	of	ADP
eshr-8982	241	24	urinary	urinary	ADJ
eshr-8982	241	25	podocalyxin	podocalyxin	NOUN
eshr-8982	241	26	as	as	ADP
eshr-8982	241	27	an	an	DET
eshr-8982	241	28	alternative	alternative	ADJ
eshr-8982	241	29	marker	marker	NOUN
eshr-8982	241	30	for	for	ADP
eshr-8982	241	31	urinary	urinary	ADJ
eshr-8982	241	32	albumin	albumin	ADJ
eshr-8982	241	33	creatinine	creatinine	NOUN
eshr-8982	241	34	ratio	ratio	NOUN
eshr-8982	241	35	in	in	ADP
eshr-8982	241	36	early	early	ADJ
eshr-8982	241	37	stage	stage	NOUN
eshr-8982	241	38	of	of	ADP
eshr-8982	241	39	diabetic	diabetic	ADJ
eshr-8982	241	40	kidney	kidney	NOUN
eshr-8982	241	41	disease	disease	NOUN
eshr-8982	241	42	in	in	ADP
eshr-8982	241	43	older	old	ADJ
eshr-8982	241	44	patients	patient	NOUN
eshr-8982	241	45	.	.	PUNCT
eshr-8982	242	1	nefrologia	nefrologia	PROPN
eshr-8982	242	2	(	(	PUNCT
eshr-8982	242	3	english	english	PROPN
eshr-8982	242	4	edition	edition	PROPN
eshr-8982	242	5	)	)	PUNCT
eshr-8982	242	6	.	.	PUNCT
eshr-8982	243	1	2022;42(6):664–70	2022;42(6):664–70	PROPN
eshr-8982	243	2	.	.	PROPN
eshr-8982	244	1	13	13	NUM
eshr-8982	244	2	.	.	PUNCT
eshr-8982	245	1	nowak	nowak	PROPN
eshr-8982	245	2	n	n	PROPN
eshr-8982	245	3	,	,	PUNCT
eshr-8982	245	4	skupien	skupien	PROPN
eshr-8982	245	5	j	j	PROPN
eshr-8982	245	6	,	,	PUNCT
eshr-8982	245	7	smiles	smile	VERB
eshr-8982	245	8	am	be	AUX
eshr-8982	245	9	,	,	PUNCT
eshr-8982	245	10	yamanouchi	yamanouchi	PROPN
eshr-8982	245	11	m	m	PROPN
eshr-8982	245	12	,	,	PUNCT
eshr-8982	245	13	niewczas	niewczas	PROPN
eshr-8982	245	14	ma	ma	PROPN
eshr-8982	245	15	,	,	PUNCT
eshr-8982	245	16	galecki	galecki	PROPN
eshr-8982	245	17	at	at	ADP
eshr-8982	245	18	,	,	PUNCT
eshr-8982	245	19	et	et	PROPN
eshr-8982	245	20	al	al	PROPN
eshr-8982	245	21	.	.	PUNCT
eshr-8982	246	1	markers	marker	NOUN
eshr-8982	246	2	of	of	ADP
eshr-8982	246	3	early	early	ADJ
eshr-8982	246	4	progressive	progressive	ADJ
eshr-8982	246	5	renal	renal	ADJ
eshr-8982	246	6	decline	decline	NOUN
eshr-8982	246	7	in	in	ADP
eshr-8982	246	8	type	type	NOUN
eshr-8982	246	9	2	2	NUM
eshr-8982	246	10	diabetes	diabetes	NOUN
eshr-8982	246	11	suggest	suggest	VERB
eshr-8982	246	12	different	different	ADJ
eshr-8982	246	13	implications	implication	NOUN
eshr-8982	246	14	for	for	ADP
eshr-8982	246	15	etiological	etiological	ADJ
eshr-8982	246	16	studies	study	NOUN
eshr-8982	246	17	and	and	CCONJ
eshr-8982	246	18	prognostic	prognostic	ADJ
eshr-8982	246	19	tests	test	NOUN
eshr-8982	246	20	development	development	NOUN
eshr-8982	246	21	.	.	PUNCT
eshr-8982	247	1	2018;1198–206	2018;1198–206	X
eshr-8982	247	2	.	.	PROPN
eshr-8982	248	1	14	14	NUM
eshr-8982	248	2	.	.	PUNCT
eshr-8982	249	1	shibata	shibata	PROPN
eshr-8982	249	2	m	m	PROPN
eshr-8982	249	3	,	,	PUNCT
eshr-8982	249	4	nakano	nakano	PROPN
eshr-8982	249	5	t	t	PROPN
eshr-8982	249	6	,	,	PUNCT
eshr-8982	249	7	tsuboi	tsuboi	NOUN
eshr-8982	249	8	n	n	CCONJ
eshr-8982	249	9	,	,	PUNCT
eshr-8982	249	10	oda	oda	PROPN
eshr-8982	249	11	y	y	PROPN
eshr-8982	249	12	,	,	PUNCT
eshr-8982	249	13	kitazono	kitazono	NOUN
eshr-8982	249	14	t.	t.	NOUN
eshr-8982	249	15	pathologic	pathologic	ADJ
eshr-8982	249	16	diabetic	diabetic	ADJ
eshr-8982	249	17	nephropathy	nephropathy	NOUN
eshr-8982	249	18	in	in	ADP
eshr-8982	249	19	autopsied	autopsie	VERB
eshr-8982	249	20	diabetic	diabetic	ADJ
eshr-8982	249	21	cases	case	NOUN
eshr-8982	249	22	with	with	ADP
eshr-8982	249	23	normoalbuminuria	normoalbuminuria	NOUN
eshr-8982	249	24	from	from	ADP
eshr-8982	249	25	a	a	DET
eshr-8982	249	26	japanese	japanese	ADJ
eshr-8982	249	27	community	community	NOUN
eshr-8982	249	28	-	-	PUNCT
eshr-8982	249	29	based	base	VERB
eshr-8982	249	30	study	study	NOUN
eshr-8982	249	31	.	.	PUNCT
eshr-8982	250	1	kidney	kidney	PROPN
eshr-8982	250	2	international	international	ADJ
eshr-8982	250	3	reports	report	NOUN
eshr-8982	250	4	.	.	PUNCT
eshr-8982	251	1	2021;6(12):3035–44	2021;6(12):3035–44	NUM
eshr-8982	251	2	.	.	NOUN
eshr-8982	251	3	15	15	NUM
eshr-8982	251	4	.	.	PUNCT
eshr-8982	252	1	kin	kin	PROPN
eshr-8982	252	2	w	w	PROPN
eshr-8982	252	3	,	,	PUNCT
eshr-8982	252	4	tsai	tsai	PROPN
eshr-8982	252	5	s	s	PROPN
eshr-8982	252	6	sheng	sheng	PROPN
eshr-8982	252	7	,	,	PUNCT
eshr-8982	252	8	li	li	PROPN
eshr-8982	252	9	y	y	PROPN
eshr-8982	252	10	rong	rong	PROPN
eshr-8982	252	11	,	,	PUNCT
eshr-8982	252	12	chou	chou	PROPN
eshr-8982	252	13	w	w	PROPN
eshr-8982	252	14	yu	yu	PROPN
eshr-8982	252	15	.	.	PROPN
eshr-8982	252	16	association	association	PROPN
eshr-8982	252	17	between	between	ADP
eshr-8982	252	18	serum	serum	NOUN
eshr-8982	252	19	bilirubin	bilirubin	NOUN
eshr-8982	252	20	levels	level	NOUN
eshr-8982	252	21	and	and	CCONJ
eshr-8982	252	22	progression	progression	NOUN
eshr-8982	252	23	of	of	ADP
eshr-8982	252	24	albuminuria	albuminuria	PROPN
eshr-8982	252	25	in	in	ADP
eshr-8982	252	26	taiwanese	taiwanese	PROPN
eshr-8982	252	27	with	with	ADP
eshr-8982	252	28	type	type	NOUN
eshr-8982	252	29	2	2	NUM
eshr-8982	252	30	diabetes	diabetes	NOUN
eshr-8982	252	31	mellitus	mellitus	NOUN
eshr-8982	252	32	.	.	PUNCT
eshr-8982	253	1	biomedical	biomedical	ADJ
eshr-8982	253	2	journal	journal	PROPN
eshr-8982	253	3	.	.	PUNCT
eshr-8982	254	1	2021;44(2):201–8	2021;44(2):201–8	NUM
eshr-8982	254	2	.	.	PUNCT
eshr-8982	255	1	16	16	NUM
eshr-8982	255	2	.	.	PUNCT
eshr-8982	256	1	kobayashi	kobayashi	PROPN
eshr-8982	256	2	k	k	PROPN
eshr-8982	256	3	,	,	PUNCT
eshr-8982	256	4	toyoda	toyoda	PROPN
eshr-8982	256	5	m	m	PROPN
eshr-8982	256	6	,	,	PUNCT
eshr-8982	256	7	kimura	kimura	PROPN
eshr-8982	256	8	m	m	PROPN
eshr-8982	256	9	,	,	PUNCT
eshr-8982	256	10	hatori	hatori	PROPN
eshr-8982	256	11	n	n	CCONJ
eshr-8982	256	12	,	,	PUNCT
eshr-8982	256	13	furuki	furuki	PROPN
eshr-8982	256	14	t	t	PROPN
eshr-8982	256	15	,	,	PUNCT
eshr-8982	256	16	sakai	sakai	PROPN
eshr-8982	256	17	h	h	PROPN
eshr-8982	256	18	,	,	PUNCT
eshr-8982	256	19	et	et	PROPN
eshr-8982	256	20	al	al	PROPN
eshr-8982	256	21	.	.	PROPN
eshr-8982	257	1	retrospective	retrospective	ADJ
eshr-8982	257	2	analysis	analysis	NOUN
eshr-8982	257	3	of	of	ADP
eshr-8982	257	4	effects	effect	NOUN
eshr-8982	257	5	of	of	ADP
eshr-8982	257	6	inhibitor	inhibitor	NOUN
eshr-8982	257	7	in	in	ADP
eshr-8982	257	8	japanese	japanese	ADJ
eshr-8982	257	9	type	type	NOUN
eshr-8982	257	10	2	2	NUM
eshr-8982	257	11	diabetes	diabetes	NOUN
eshr-8982	257	12	mellitus	mellitus	NOUN
eshr-8982	257	13	patients	patient	NOUN
eshr-8982	257	14	with	with	ADP
eshr-8982	257	15	chronic	chronic	ADJ
eshr-8982	257	16	kidney	kidney	NOUN
eshr-8982	257	17	disease	disease	NOUN
eshr-8982	257	18	.	.	PUNCT
eshr-8982	258	1	diabetes	diabetes	NOUN
eshr-8982	258	2	and	and	CCONJ
eshr-8982	258	3	vascular	vascular	ADJ
eshr-8982	258	4	disease	disease	NOUN
eshr-8982	258	5	research	research	NOUN
eshr-8982	258	6	.	.	PUNCT
eshr-8982	259	1	2019	2019	NUM
eshr-8982	259	2	;	;	PUNCT
eshr-8982	259	3	16(1):147916411880275	16(1):147916411880275	NUM
eshr-8982	259	4	17	17	NUM
eshr-8982	259	5	.	.	PUNCT
eshr-8982	260	1	xia	xia	PROPN
eshr-8982	260	2	l	l	PROPN
eshr-8982	260	3	,	,	PUNCT
eshr-8982	260	4	cheng	cheng	PROPN
eshr-8982	260	5	l	l	PROPN
eshr-8982	260	6	,	,	PUNCT
eshr-8982	260	7	jiang	jiang	PROPN
eshr-8982	260	8	t	t	PROPN
eshr-8982	260	9	,	,	PUNCT
eshr-8982	260	10	et	et	PROPN
eshr-8982	260	11	al	al	PROPN
eshr-8982	260	12	.	.	PUNCT
eshr-8982	260	13	estimation	estimation	NOUN
eshr-8982	260	14	of	of	ADP
eshr-8982	260	15	the	the	DET
eshr-8982	260	16	prevalence	prevalence	NOUN
eshr-8982	260	17	of	of	ADP
eshr-8982	260	18	type	type	NOUN
eshr-8982	260	19	2	2	NUM
eshr-8982	260	20	diabetes	diabetes	NOUN
eshr-8982	260	21	in	in	ADP
eshr-8982	260	22	combination	combination	NOUN
eshr-8982	260	23	with	with	ADP
eshr-8982	260	24	diabetic	diabetic	ADJ
eshr-8982	260	25	kidney	kidney	NOUN
eshr-8982	260	26	disease	disease	NOUN
eshr-8982	260	27	and	and	CCONJ
eshr-8982	260	28	identification	identification	NOUN
eshr-8982	260	29	of	of	ADP
eshr-8982	260	30	the	the	DET
eshr-8982	260	31	associated	associated	ADJ
eshr-8982	260	32	factors	factor	NOUN
eshr-8982	260	33	in	in	ADP
eshr-8982	260	34	patients	patient	NOUN
eshr-8982	260	35	attending	attend	VERB
eshr-8982	260	36	primary	primary	ADJ
eshr-8982	260	37	hospitals	hospital	NOUN
eshr-8982	260	38	in	in	ADP
eshr-8982	260	39	anhui	anhui	PROPN
eshr-8982	260	40	province	province	PROPN
eshr-8982	260	41	,	,	PUNCT
eshr-8982	260	42	china	china	PROPN
eshr-8982	260	43	.	.	PUNCT
eshr-8982	261	1	journal	journal	PROPN
eshr-8982	261	2	of	of	ADP
eshr-8982	261	3	international	international	ADJ
eshr-8982	261	4	medical	medical	ADJ
eshr-8982	261	5	research	research	NOUN
eshr-8982	261	6	.	.	PUNCT
eshr-8982	262	1	2021;(81	2021;(81	NUM
eshr-8982	262	2	)	)	PUNCT
eshr-8982	262	3	.	.	PUNCT
eshr-8982	263	1	18	18	NUM
eshr-8982	263	2	.	.	PUNCT
eshr-8982	264	1	xie	xie	PROPN
eshr-8982	264	2	y	y	PROPN
eshr-8982	264	3	,	,	PUNCT
eshr-8982	264	4	jin	jin	PROPN
eshr-8982	264	5	d	d	PROPN
eshr-8982	264	6	,	,	PUNCT
eshr-8982	264	7	qiu	qiu	PROPN
eshr-8982	264	8	h	h	PROPN
eshr-8982	264	9	,	,	PUNCT
eshr-8982	264	10	lin	lin	PROPN
eshr-8982	264	11	l	l	PROPN
eshr-8982	264	12	,	,	PUNCT
eshr-8982	264	13	sun	sun	PROPN
eshr-8982	264	14	s	s	PROPN
eshr-8982	264	15	,	,	PUNCT
eshr-8982	264	16	li	li	PROPN
eshr-8982	264	17	d	d	PROPN
eshr-8982	264	18	,	,	PUNCT
eshr-8982	264	19	et	et	PROPN
eshr-8982	264	20	al	al	PROPN
eshr-8982	264	21	.	.	PROPN
eshr-8982	264	22	assessment	assessment	NOUN
eshr-8982	264	23	of	of	ADP
eshr-8982	264	24	urinary	urinary	ADJ
eshr-8982	264	25	podocalyxin	podocalyxin	NOUN
eshr-8982	264	26	as	as	ADP
eshr-8982	264	27	an	an	DET
eshr-8982	264	28	alternative	alternative	ADJ
eshr-8982	264	29	marker	marker	NOUN
eshr-8982	264	30	for	for	ADP
eshr-8982	264	31	urinary	urinary	ADJ
eshr-8982	264	32	albumin	albumin	ADJ
eshr-8982	264	33	creatinine	creatinine	NOUN
eshr-8982	264	34	ratio	ratio	NOUN
eshr-8982	264	35	in	in	ADP
eshr-8982	264	36	early	early	ADJ
eshr-8982	264	37	stage	stage	NOUN
eshr-8982	264	38	of	of	ADP
eshr-8982	264	39	diabetic	diabetic	ADJ
eshr-8982	264	40	kidney	kidney	NOUN
eshr-8982	264	41	disease	disease	NOUN
eshr-8982	264	42	in	in	ADP
eshr-8982	264	43	older	old	ADJ
eshr-8982	264	44	patients	patient	NOUN
eshr-8982	264	45	.	.	PUNCT
eshr-8982	265	1	nefrología	nefrología	PROPN
eshr-8982	265	2	(	(	PUNCT
eshr-8982	265	3	english	english	PROPN
eshr-8982	265	4	edition).2022	edition).2022	PROPN
eshr-8982	265	5	;	;	PUNCT
eshr-8982	265	6	nov	nov	PROPN
eshr-8982	265	7	-	-	PUNCT
eshr-8982	265	8	dec;42(6):664	dec;42(6):664	NOUN
eshr-8982	265	9	-	-	PUNCT
eshr-8982	265	10	670	670	NUM
eshr-8982	265	11	.	.	PUNCT
eshr-8982	266	1	19	19	NUM
eshr-8982	266	2	.	.	PUNCT
eshr-8982	266	3	sauriasari	sauriasari	PROPN
eshr-8982	266	4	r	r	NOUN
eshr-8982	266	5	,	,	PUNCT
eshr-8982	266	6	dafitri	dafitri	ADJ
eshr-8982	266	7	dd	dd	NOUN
eshr-8982	266	8	,	,	PUNCT
eshr-8982	266	9	and	and	CCONJ
eshr-8982	266	10	azmi	azmi	PROPN
eshr-8982	266	11	nu	nu	PROPN
eshr-8982	266	12	.	.	PROPN
eshr-8982	266	13	current	current	ADJ
eshr-8982	266	14	updates	update	NOUN
eshr-8982	266	15	on	on	ADP
eshr-8982	266	16	protein	protein	NOUN
eshr-8982	266	17	as	as	ADP
eshr-8982	266	18	biomarkers	biomarker	NOUN
eshr-8982	266	19	for	for	ADP
eshr-8982	266	20	diabetic	diabetic	ADJ
eshr-8982	266	21	kidney	kidney	NOUN
eshr-8982	266	22	disease	disease	NOUN
eshr-8982	266	23	:	:	PUNCT
eshr-8982	266	24	a	a	DET
eshr-8982	266	25	systematic	systematic	ADJ
eshr-8982	266	26	review	review	NOUN
eshr-8982	266	27	.	.	PUNCT
eshr-8982	267	1	therapeutic	therapeutic	ADJ
eshr-8982	267	2	advances	advance	NOUN
eshr-8982	267	3	in	in	ADP
eshr-8982	267	4	endocrinology	endocrinology	NOUN
eshr-8982	267	5	and	and	CCONJ
eshr-8982	267	6	metabolism	metabolism	NOUN
eshr-8982	267	7	2021;1–13	2021;1–13	NUM
eshr-8982	267	8	.	.	PUNCT
eshr-8982	268	1	20	20	NUM
eshr-8982	268	2	.	.	PUNCT
eshr-8982	268	3	thipsawat	thipsawat	PROPN
eshr-8982	268	4	s.	s.	PROPN
eshr-8982	269	1	early	early	ADJ
eshr-8982	269	2	detection	detection	NOUN
eshr-8982	269	3	of	of	ADP
eshr-8982	269	4	diabetic	diabetic	ADJ
eshr-8982	269	5	nephropathy	nephropathy	NOUN
eshr-8982	269	6	in	in	ADP
eshr-8982	269	7	patient	patient	NOUN
eshr-8982	269	8	with	with	ADP
eshr-8982	269	9	type	type	NOUN
eshr-8982	269	10	2	2	NUM
eshr-8982	269	11	diabetes	diabetes	NOUN
eshr-8982	269	12	mellitus	mellitus	NOUN
eshr-8982	269	13	:	:	PUNCT
eshr-8982	269	14	a	a	DET
eshr-8982	269	15	review	review	NOUN
eshr-8982	269	16	of	of	ADP
eshr-8982	269	17	the	the	DET
eshr-8982	269	18	literature	literature	NOUN
eshr-8982	269	19	.	.	PUNCT
eshr-8982	270	1	diabetes	diabetes	NOUN
eshr-8982	270	2	&	&	CCONJ
eshr-8982	270	3	vascular	vascular	ADJ
eshr-8982	270	4	disease	disease	NOUN
eshr-8982	270	5	research	research	NOUN
eshr-8982	270	6	.	.	PUNCT
eshr-8982	271	1	2021;(december):1–9	2021;(december):1–9	X
eshr-8982	271	2	.	.	PUNCT
eshr-8982	272	1	https://doi.org/10.26555/eshr.v3i1.3629	https://doi.org/10.26555/eshr.v3i1.3629	PROPN
eshr-8982	272	2	https://doi.org/10.26555/eshr.v3i1.3629	https://doi.org/10.26555/eshr.v3i1.3629	PROPN
eshr-8982	272	3	https://journals.sagepub.com/home/dvr	https://journals.sagepub.com/home/dvr	ADP
eshr-8982	272	4	purtaria	purtaria	NOUN
eshr-8982	272	5	et	et	PROPN
eshr-8982	272	6	al	al	PROPN
eshr-8982	272	7	.	.	PUNCT
eshr-8982	273	1	(	(	PUNCT
eshr-8982	273	2	the	the	DET
eshr-8982	273	3	importance	importance	NOUN
eshr-8982	273	4	of	of	ADP
eshr-8982	273	5	uacr	uacr	NOUN
eshr-8982	273	6	(	(	PUNCT
eshr-8982	273	7	urinary	urinary	ADJ
eshr-8982	273	8	albumin	albumin	ADJ
eshr-8982	273	9	creatinine	creatinine	NOUN
eshr-8982	273	10	ratio	ratio	NOUN
eshr-8982	273	11	)	)	PUNCT
eshr-8982	273	12	examination	examination	NOUN
eshr-8982	273	13	in	in	ADP
eshr-8982	273	14	patients	patient	NOUN
eshr-8982	273	15	)	)	PUNCT
eshr-8982	273	16	…	…	PUNCT
eshr-8982	273	17	.	.	PUNCT
eshr-8982	274	1	86	86	NUM
eshr-8982	274	2	vol	vol	NOUN
eshr-8982	274	3	.	.	PROPN
eshr-8982	275	1	6	6	NUM
eshr-8982	275	2	,	,	PUNCT
eshr-8982	275	3	no	no	INTJ
eshr-8982	275	4	.	.	NOUN
eshr-8982	275	5	2	2	NUM
eshr-8982	275	6	,	,	PUNCT
eshr-8982	275	7	2024	2024	NUM
eshr-8982	275	8	,	,	PUNCT
eshr-8982	275	9	pp	pp	ADJ
eshr-8982	275	10	.	.	PUNCT
eshr-8982	276	1	74	74	NUM
eshr-8982	276	2	-	-	SYM
eshr-8982	276	3	86	86	NUM
eshr-8982	276	4	10.26555	10.26555	NUM
eshr-8982	276	5	/	/	SYM
eshr-8982	276	6	eshr.v6i2.8982	eshr.v6i2.8982	NUM
eshr-8982	276	7	21	21	NUM
eshr-8982	276	8	.	.	PUNCT
eshr-8982	277	1	lee	lee	PROPN
eshr-8982	277	2	cl	cl	PROPN
eshr-8982	277	3	,	,	PUNCT
eshr-8982	277	4	chen	chen	PROPN
eshr-8982	277	5	ch	ch	PROPN
eshr-8982	277	6	,	,	PUNCT
eshr-8982	277	7	wu	wu	PROPN
eshr-8982	277	8	mj	mj	PROPN
eshr-8982	277	9	,	,	PUNCT
eshr-8982	277	10	tsai	tsai	PROPN
eshr-8982	277	11	sf	sf	PROPN
eshr-8982	277	12	.	.	PUNCT
eshr-8982	278	1	the	the	DET
eshr-8982	278	2	variability	variability	NOUN
eshr-8982	278	3	of	of	ADP
eshr-8982	278	4	glycated	glycate	VERB
eshr-8982	278	5	hemoglobin	hemoglobin	NOUN
eshr-8982	278	6	is	be	AUX
eshr-8982	278	7	associated	associate	VERB
eshr-8982	278	8	with	with	ADP
eshr-8982	278	9	renal	renal	ADJ
eshr-8982	278	10	function	function	NOUN
eshr-8982	278	11	decline	decline	NOUN
eshr-8982	278	12	in	in	ADP
eshr-8982	278	13	patients	patient	NOUN
eshr-8982	278	14	with	with	ADP
eshr-8982	278	15	type	type	NOUN
eshr-8982	278	16	2	2	NUM
eshr-8982	278	17	diabetes	diabetes	NOUN
eshr-8982	278	18	.	.	PUNCT
eshr-8982	279	1	therapeutic	therapeutic	ADJ
eshr-8982	279	2	advances	advance	NOUN
eshr-8982	279	3	in	in	ADP
eshr-8982	279	4	chronic	chronic	ADJ
eshr-8982	279	5	disease	disease	NOUN
eshr-8982	279	6	.	.	PUNCT
eshr-8982	280	1	2020	2020	NUM
eshr-8982	280	2	jan	jan	PROPN
eshr-8982	280	3	1;11:2040622319898370	1;11:2040622319898370	NUM
eshr-8982	280	4	.	.	PUNCT
eshr-8982	281	1	22	22	NUM
eshr-8982	281	2	.	.	PUNCT
eshr-8982	282	1	suherman	suherman	PROPN
eshr-8982	282	2	,	,	PUNCT
eshr-8982	282	3	sopiah	sopiah	PROPN
eshr-8982	282	4	p	p	PRON
eshr-8982	282	5	,	,	PUNCT
eshr-8982	282	6	ridwan	ridwan	PROPN
eshr-8982	282	7	h.	h.	PROPN
eshr-8982	282	8	literature	literature	PROPN
eshr-8982	282	9	review	review	PROPN
eshr-8982	282	10	:	:	PUNCT
eshr-8982	282	11	hubungan	hubungan	ADJ
eshr-8982	282	12	diabetes	diabetes	NOUN
eshr-8982	282	13	melitus	melitus	PROPN
eshr-8982	282	14	dengan	dengan	PROPN
eshr-8982	282	15	kejadian	kejadian	PROPN
eshr-8982	282	16	gagal	gagal	PROPN
eshr-8982	282	17	ginjal	ginjal	PROPN
eshr-8982	282	18	kronik	kronik	X
eshr-8982	282	19	.	.	PUNCT
eshr-8982	283	1	jurnal	jurnal	ADJ
eshr-8982	283	2	ilmiah	ilmiah	PROPN
eshr-8982	283	3	keperawatan	keperawatan	PROPN
eshr-8982	283	4	(	(	PUNCT
eshr-8982	283	5	scientific	scientific	ADJ
eshr-8982	283	6	journal	journal	NOUN
eshr-8982	283	7	of	of	ADP
eshr-8982	283	8	nursing	nursing	NOUN
eshr-8982	283	9	)	)	PUNCT
eshr-8982	283	10	.	.	PUNCT
eshr-8982	284	1	2023;9(5):639–44	2023;9(5):639–44	NUM
eshr-8982	284	2	.	.	PROPN
eshr-8982	284	3	23	23	NUM
eshr-8982	284	4	.	.	PUNCT
eshr-8982	285	1	hashmi	hashmi	PROPN
eshr-8982	285	2	mf	mf	PROPN
eshr-8982	285	3	,	,	PUNCT
eshr-8982	285	4	benjamin	benjamin	PROPN
eshr-8982	285	5	o	o	PROPN
eshr-8982	285	6	,	,	PUNCT
eshr-8982	285	7	lappin	lappin	PROPN
eshr-8982	285	8	sl	sl	PROPN
eshr-8982	285	9	.	.	PROPN
eshr-8982	285	10	end	end	NOUN
eshr-8982	285	11	-	-	PUNCT
eshr-8982	285	12	stage	stage	NOUN
eshr-8982	285	13	renal	renal	ADJ
eshr-8982	285	14	disease	disease	NOUN
eshr-8982	285	15	.	.	PUNCT
eshr-8982	286	1	[	[	X
eshr-8982	286	2	updated	update	VERB
eshr-8982	286	3	2023	2023	NUM
eshr-8982	286	4	aug	aug	NOUN
eshr-8982	286	5	28	28	NUM
eshr-8982	286	6	]	]	PUNCT
eshr-8982	286	7	.	.	PUNCT
eshr-8982	287	1	in	in	ADP
eshr-8982	287	2	:	:	PUNCT
eshr-8982	287	3	statpearls	statpearl	NOUN
eshr-8982	288	1	[	[	X
eshr-8982	288	2	internet	internet	NOUN
eshr-8982	288	3	]	]	PUNCT
eshr-8982	288	4	.	.	PUNCT
eshr-8982	289	1	treasure	treasure	NOUN
eshr-8982	289	2	island	island	NOUN
eshr-8982	289	3	(	(	PUNCT
eshr-8982	289	4	fl	fl	PROPN
eshr-8982	289	5	):	):	PUNCT
eshr-8982	289	6	statpearls	statpearls	PROPN
eshr-8982	289	7	publishing	publishing	NOUN
eshr-8982	289	8	;	;	PUNCT
eshr-8982	289	9	2024	2024	NUM
eshr-8982	289	10	jan-	jan-	NOUN
eshr-8982	289	11	.	.	PUNCT
eshr-8982	290	1	available	available	ADJ
eshr-8982	290	2	from	from	ADP
eshr-8982	290	3	:	:	PUNCT
eshr-8982	290	4	https://www.ncbi.nlm.nih.gov/books/nbk499861/	https://www.ncbi.nlm.nih.gov/books/nbk499861/	PROPN
eshr-8982	290	5	24	24	NUM
eshr-8982	290	6	.	.	PUNCT
eshr-8982	291	1	liu	liu	PROPN
eshr-8982	291	2	j	j	PROPN
eshr-8982	291	3	,	,	PUNCT
eshr-8982	291	4	liu	liu	PROPN
eshr-8982	291	5	z	z	PROPN
eshr-8982	291	6	,	,	PUNCT
eshr-8982	291	7	sun	sun	PROPN
eshr-8982	291	8	w	w	PROPN
eshr-8982	291	9	,	,	PUNCT
eshr-8982	291	10	luo	luo	PROPN
eshr-8982	291	11	l	l	PROPN
eshr-8982	291	12	,	,	PUNCT
eshr-8982	291	13	an	an	DET
eshr-8982	291	14	x	x	X
eshr-8982	291	15	,	,	PUNCT
eshr-8982	291	16	yu	yu	PROPN
eshr-8982	291	17	d	d	PROPN
eshr-8982	291	18	,	,	PUNCT
eshr-8982	291	19	et	et	PROPN
eshr-8982	291	20	al	al	PROPN
eshr-8982	291	21	.	.	PUNCT
eshr-8982	291	22	role	role	NOUN
eshr-8982	291	23	of	of	ADP
eshr-8982	291	24	sex	sex	NOUN
eshr-8982	291	25	hormones	hormone	NOUN
eshr-8982	291	26	in	in	ADP
eshr-8982	291	27	diabetic	diabetic	ADJ
eshr-8982	291	28	nephropathy	nephropathy	NOUN
eshr-8982	291	29	.	.	PUNCT
eshr-8982	292	1	frontiers	frontier	NOUN
eshr-8982	292	2	in	in	ADP
eshr-8982	292	3	endocrinology	endocrinology	NOUN
eshr-8982	292	4	.	.	PUNCT
eshr-8982	293	1	2023;14(april):1–11	2023;14(april):1–11	X
eshr-8982	293	2	.	.	PUNCT
eshr-8982	294	1	25	25	NUM
eshr-8982	294	2	.	.	PUNCT
eshr-8982	294	3	tahfim	tahfim	PROPN
eshr-8982	294	4	t	t	PROPN
eshr-8982	294	5	,	,	PUNCT
eshr-8982	294	6	sultana	sultana	PROPN
eshr-8982	294	7	gs	gs	NOUN
eshr-8982	294	8	,	,	PUNCT
eshr-8982	294	9	era	era	NOUN
eshr-8982	294	10	msths	msth	NOUN
eshr-8982	294	11	,	,	PUNCT
eshr-8982	294	12	yesmin	yesmin	PROPN
eshr-8982	294	13	f	f	PROPN
eshr-8982	294	14	,	,	PUNCT
eshr-8982	294	15	ruma	ruma	PROPN
eshr-8982	294	16	ra	ra	PROPN
eshr-8982	294	17	,	,	PUNCT
eshr-8982	294	18	sultana	sultana	PROPN
eshr-8982	294	19	l.	l.	PROPN
eshr-8982	294	20	association	association	PROPN
eshr-8982	294	21	between	between	ADP
eshr-8982	294	22	serum	serum	NOUN
eshr-8982	294	23	bilirubin	bilirubin	NOUN
eshr-8982	294	24	and	and	CCONJ
eshr-8982	294	25	estimated	estimate	VERB
eshr-8982	294	26	glomerular	glomerular	ADJ
eshr-8982	294	27	filtration	filtration	NOUN
eshr-8982	294	28	rate	rate	NOUN
eshr-8982	294	29	in	in	ADP
eshr-8982	294	30	diabetic	diabetic	ADJ
eshr-8982	294	31	patients	patient	NOUN
eshr-8982	294	32	with	with	ADP
eshr-8982	294	33	chronic	chronic	ADJ
eshr-8982	294	34	kidney	kidney	NOUN
eshr-8982	294	35	disease	disease	NOUN
eshr-8982	294	36	.	.	PUNCT
eshr-8982	295	1	imc	imc	PROPN
eshr-8982	295	2	journal	journal	PROPN
eshr-8982	295	3	of	of	ADP
eshr-8982	295	4	medical	medical	ADJ
eshr-8982	295	5	science	science	NOUN
eshr-8982	295	6	.	.	PUNCT
eshr-8982	296	1	2023;18(1):1–6	2023;18(1):1–6	NUM
eshr-8982	296	2	.	.	PUNCT
eshr-8982	297	1	26	26	NUM
eshr-8982	297	2	.	.	PUNCT
eshr-8982	298	1	siraj	siraj	PROPN
eshr-8982	298	2	j	j	PROPN
eshr-8982	298	3	,	,	PUNCT
eshr-8982	298	4	abateka	abateka	PROPN
eshr-8982	298	5	t	t	PROPN
eshr-8982	298	6	,	,	PUNCT
eshr-8982	298	7	kebede	kebede	PROPN
eshr-8982	298	8	o.	o.	PROPN
eshr-8982	298	9	patients	patients	PROPN
eshr-8982	298	10	’	'	PUNCT
eshr-8982	298	11	adherence	adherence	NOUN
eshr-8982	298	12	to	to	ADP
eshr-8982	298	13	anti	anti	ADJ
eshr-8982	298	14	-	-	ADJ
eshr-8982	298	15	diabetic	diabetic	ADJ
eshr-8982	298	16	medications	medication	NOUN
eshr-8982	298	17	and	and	CCONJ
eshr-8982	298	18	associated	associated	ADJ
eshr-8982	298	19	factors	factor	NOUN
eshr-8982	298	20	in	in	ADP
eshr-8982	298	21	mizan	mizan	PROPN
eshr-8982	298	22	-	-	PUNCT
eshr-8982	298	23	tepi	tepi	PROPN
eshr-8982	298	24	university	university	PROPN
eshr-8982	298	25	teaching	teaching	NOUN
eshr-8982	298	26	hospital	hospital	NOUN
eshr-8982	298	27	:	:	PUNCT
eshr-8982	298	28	a	a	DET
eshr-8982	298	29	cross	cross	ADJ
eshr-8982	298	30	-	-	ADJ
eshr-8982	298	31	sectional	sectional	ADJ
eshr-8982	298	32	study	study	NOUN
eshr-8982	298	33	.	.	PUNCT
eshr-8982	299	1	inquiry	inquiry	NOUN
eshr-8982	299	2	:	:	PUNCT
eshr-8982	299	3	the	the	DET
eshr-8982	299	4	journal	journal	NOUN
eshr-8982	299	5	of	of	ADP
eshr-8982	299	6	health	health	PROPN
eshr-8982	299	7	care	care	PROPN
eshr-8982	299	8	organization	organization	NOUN
eshr-8982	299	9	,	,	PUNCT
eshr-8982	299	10	provision	provision	NOUN
eshr-8982	299	11	,	,	PUNCT
eshr-8982	299	12	and	and	CCONJ
eshr-8982	299	13	financing	financing	NOUN
eshr-8982	299	14	.	.	PUNCT
eshr-8982	300	1	2021	2021	NUM
eshr-8982	300	2	jan	jan	PROPN
eshr-8982	300	3	1;58:469580211067477	1;58:469580211067477	NUM
eshr-8982	300	4	.	.	PUNCT
eshr-8982	301	1	https://doi.org/10.26555/eshr.v3i1.3629	https://doi.org/10.26555/eshr.v3i1.3629	PROPN
eshr-8982	301	2	https://doi.org/10.26555/eshr.v3i1.3629	https://doi.org/10.26555/eshr.v3i1.3629	NOUN